NEK9
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
T Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: T Sites / T Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| A0A2R8Y4L2 | S95 | Sugiyama | HNRNPA1L3 HNRNPA1P48 | RPHKVDGRVVEPKRAVSREDsQRPDAHLTVKKIFVGGIKED |
| A5A3E0 | S1065 | Sugiyama | POTEF A26C1B | ILASLSTFQQMWISKQEyDEsGPsIVHRKCL__________ |
| A5A3E0 | S1068 | Sugiyama | POTEF A26C1B | SLSTFQQMWISKQEyDEsGPsIVHRKCL_____________ |
| A5A3E0 | T949 | Sugiyama | POTEF A26C1B | TVAsSSSLEKsyELPDGQVItIGNERFRCPEALFQPCFLGM |
| A5A3E0 | Y940 | Sugiyama | POTEF A26C1B | ALDFEQEMATVAsSSSLEKsyELPDGQVItIGNERFRCPEA |
| B2RPK0 | S121 | Sugiyama | HMGB1P1 HMG1L1 HMGB1L1 | AFFLFCSEYHPKIKGEHPGLsIGDVAKKLGEMWNNTAADDK |
| B2RPK0 | S15 | Sugiyama | HMGB1P1 HMG1L1 HMGB1L1 | ______MGKGDPKKPRGKMssyAFFVQtCREEHKKKHSDAS |
| B2RPK0 | T22 | Sugiyama | HMGB1P1 HMG1L1 HMGB1L1 | GKGDPKKPRGKMssyAFFVQtCREEHKKKHSDASVNFSEFS |
| O00115 | S57 | Sugiyama | DNASE2 DNASE2A DNL2 | ALRGSGEAAQRGLQYKyLDEssGGWRDGRALINsPEGAVGR |
| O00151 | S31 | Sugiyama | PDLIM1 CLIM1 CLP36 | PGPWGFRLVGGKDFEQPLAIsRVtPGSKAALANLCIGDVIT |
| O00170 | S53 | Sugiyama | AIP XAP2 | KATFHYRtLHsDDEGtVLDDsRARGKPMELIIGKKFKLPVW |
| O00170 | T48 | Sugiyama | AIP XAP2 | FQDGTKATFHYRtLHsDDEGtVLDDsRARGKPMELIIGKKF |
| O00273 | S302 | Sugiyama | DFFA DFF1 DFF45 H13 | TETVQEACERELALRLQQtQsLHsLRsIsAsKAsPPGDLQN |
| O00273 | T300 | Sugiyama | DFFA DFF1 DFF45 H13 | KKTETVQEACERELALRLQQtQsLHsLRsIsAsKAsPPGDL |
| O14737 | S42 | Sugiyama | PDCD5 TFAR19 | GDPGDAAQQEAKHREAEMRNsILAQVLDQsARARLsNLALV |
| O14737 | S51 | Sugiyama | PDCD5 TFAR19 | EAKHREAEMRNsILAQVLDQsARARLsNLALVKPEKTKAVE |
| O15212 | S53 | Sugiyama | PFDN6 HKE2 PFD6 | LEAQLtENNIVKEELALLDGsNVVFKLLGPVLVKQELGEAR |
| O15355 | S349 | Sugiyama | PPM1G PPM1C | tTAVVALIRGKQLIVANAGDsRCVVsEAGKALDMsyDHKPE |
| O15446 | S64 | Sugiyama | POLR1G ASE1 CAST CD3EAP PAF49 | LIQAPADFAPECFNGRHVPLsGsQIVKGKLAGKRHRyRVLS |
| O43290 | T430 | Sugiyama | SART1 | RKKEKEVVVRADDLLPLGDQtQDGDFGsRLRGRGRRRVsEV |
| O43390 | T141 | Sugiyama | HNRNPR HNRPR | GPDEAKIKALLERtGytLDVttGQRKYGGPPPDSVYSGVQP |
| O43390 | Y136 | Sugiyama | HNRNPR HNRPR | QESTKGPDEAKIKALLERtGytLDVttGQRKYGGPPPDSVY |
| O43399 | S21 | Sugiyama | TPD52L2 | MDsAGQDINLNsPNKGLLsDsMtDVPVDTGVAARtPAVEGL |
| O43423 | S100 | Sugiyama | ANP32CP PP32R1 | AEKCPNLTHLYLSGNKIKDLstIEPLKQLENLKSLDLFNCE |
| O43615 | S94 | Sugiyama | TIMM44 MIMT44 TIM44 | NKEMKESIKKFRDEARRLEEsDVLQEARRKyKtIESETVRT |
| O43715 | S32 | Sugiyama | TRIAP1 15E1.1 HSPC132 | KREYDQCFNRWFAEKFLKGDssGDPCTDLFKRYQQCVQKAI |
| O43852 | S261 | Sugiyama | CALU | RDKNRDGKMDKEEtKDWILPsDyDHAEAEARHLVyEsDQNK |
| O43852 | S44 | Sugiyama | CALU | KKDRVHHEPQLsDKVHNDAQsFDyDHDAFLGAEEAKtFDQL |
| O43852 | S69 | Sugiyama | CALU | HDAFLGAEEAKtFDQLtPEEsKERLGKIVSKIDGDKDGFVt |
| O60506 | T138 | Sugiyama | SYNCRIP HNRPQ NSAP1 | GPDEAKIKALLERtGytLDVttGQRKYGGPPPDSVYSGQQP |
| O60506 | Y133 | Sugiyama | SYNCRIP HNRPQ NSAP1 | ADSSKGPDEAKIKALLERtGytLDVttGQRKYGGPPPDSVY |
| O60814 | S39 | Sugiyama | H2BC12 H2BFT HIRIP1 HIST1H2BK | VTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| O60841 | S222 | Sugiyama | EIF5B IF2 KIAA0741 | KNQKNKPGPNIEsGNEDDDAsFKIKTVAQKKAEKKERERKK |
| O60927 | T75 | Sugiyama | PPP1R11 HCGV TCTE5 | RRssKCCCIyEKPRAFGEsstEsDEEEEEGCGHtHCVRGHR |
| O75348 | S65 | Sugiyama | ATP6V1G1 ATP6G ATP6G1 ATP6J | EQyRLQREKEFKAKEAAALGsRGsCstEVEKETQEKMTILQ |
| O75534 | S782 | Sugiyama | CSDE1 D1S155E KIAA0885 NRU UNR | LDDAsAPRLMVLRQPRGPDNsMGFGAERKIRQAGVID____ |
| O75821 | S189 | Sugiyama | EIF3G EIF3S4 | CPYKDtLGPMQKELAEQLGLstGEKEKLPGELEPVQAtQNK |
| O95218 | S181 | Sugiyama | ZRANB2 ZIS ZNF265 | DEDLsKyKLDEDEDEDDADLsKyNLDAsEEEDsNKKKSNRR |
| O95626 | S104 | Sugiyama | ANP32D PP32R2 | AEKCPNLIHLNLSGNKIKDLstIEPLKKLENLESLDLFTCE |
| O95678 | S162 | Sugiyama | KRT75 K6HF KB18 | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWA |
| O95757 | S599 | Sugiyama | HSPA4L APG1 HSPH3 OSP94 | sIDLPIQssLCRQLGQDLLNsyIENEGKMIMQDKLEKERND |
| O95757 | Y600 | Sugiyama | HSPA4L APG1 HSPH3 OSP94 | IDLPIQssLCRQLGQDLLNsyIENEGKMIMQDKLEKERNDA |
| P00338 | S105 | Sugiyama | LDHA PIG19 | VTANsKLVIItAGARQQEGEsRLNLVQRNVNIFKFIIPNVV |
| P00338 | S161 | Sugiyama | LDHA PIG19 | DILTYVAWKISGFPKNRVIGsGCNLDsARFRyLMGERLGVH |
| P00338 | S167 | Sugiyama | LDHA PIG19 | AWKISGFPKNRVIGsGCNLDsARFRyLMGERLGVHPLSCHG |
| P00338 | T322 | Sugiyama | LDHA PIG19 | DLVKVTLtsEEEARLKKsADtLWGIQKELQF__________ |
| P02538 | S176 | Sugiyama | KRT6A K6A KRT6D | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWT |
| P04075 | S336 | Sugiyama | ALDOA ALDA | GKKENLKAAQEEYVKRALANsLACQGKytPsGQAGAAAsEs |
| P04075 | S39 | Sugiyama | ALDOA ALDA | IAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRRFy |
| P04075 | S46 | Sugiyama | ALDOA ALDA | PGKGILAADEstGsIAKRLQsIGtENtEENRRFyRQLLLtA |
| P04083 | S201 | Sugiyama | ANXA1 ANX1 LPC1 | LsLAKGDRsEDFGVNEDLADsDARALyEAGERRKGtDVNVF |
| P04259 | S176 | Sugiyama | KRT6B K6B KRTL1 | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLDTKWT |
| P04406 | S151 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | FVMGVNHEKYDNSLKIIsNAsCttNCLAPLAKVIHDNFGIV |
| P04406 | S241 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | IPELNGKLtGMAFRVPtANVsVVDLtCRLEKPAKyDDIKKV |
| P04406 | S312 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | sstFDAGAGIALNDHFVKLIsWyDNEFGysNRVVDLMAHMA |
| P04406 | S321 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | IALNDHFVKLIsWyDNEFGysNRVVDLMAHMAsKE______ |
| P04406 | T154 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | GVNHEKYDNSLKIIsNAsCttNCLAPLAKVIHDNFGIVEGL |
| P04406 | T246 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | GKLtGMAFRVPtANVsVVDLtCRLEKPAKyDDIKKVVKQAS |
| P04792 | S187 | Sugiyama | HSPB1 HSP27 HSP28 | APMPKLAtQsNEItIPVtFEsRAQLGGPEAAKsDETAAK__ |
| P04792 | S82 | Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P04792 | S86 | Sugiyama | HSPB1 HSP27 HSP28 | PAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVNHFAP |
| P04792 | T180 | Sugiyama | HSPB1 HSP27 HSP28 | EGtLTVEAPMPKLAtQsNEItIPVtFEsRAQLGGPEAAKsD |
| P05198 | S219 | Sugiyama | EIF2S1 EIF2A | CYGYEGIDAVKEALRAGLNCsTENMPIKINLIAPPRYVMTT |
| P05386 | S101 | Sugiyama | RPLP1 RRP1 | APstAAAPAEEKKVEAKKEEsEEsDDDMGFGLFD_______ |
| P05387 | S102 | Sugiyama | RPLP2 D11S2243E RPP2 | PAAGsAPAAAEEKKDEKKEEsEEsDDDMGFGLFD_______ |
| P05455 | S325 | Sugiyama | SSB | VLEGEVEKEALKKIIEDQQEsLNKWKSKGRRFKGKGKGNKA |
| P05787 | S104 | Sugiyama | KRT8 CYK8 | IQAVRTQEKEQIKTLNNKFAsFIDKVRFLEQQNKMLETKWS |
| P06703 | S46 | Sugiyama | S100A6 CACY | KHTLSKKELKELIQKELtIGsKLQDAEIARLMEDLDRNKDQ |
| P06703 | T43 | Sugiyama | S100A6 CACY | EGDKHTLSKKELKELIQKELtIGsKLQDAEIARLMEDLDRN |
| P06733 | S14 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | _______MSILKIHAREIFDsRGNPtVEVDLFtsKGLFRAA |
| P06733 | S27 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | HAREIFDsRGNPtVEVDLFtsKGLFRAAVPsGAstGIyEAL |
| P06733 | S37 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | NPtVEVDLFtsKGLFRAAVPsGAstGIyEALELRDNDKtRY |
| P06733 | T100 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | KKLNVtEQEKIDKLMIEMDGtENKsKFGANAILGVsLAVCK |
| P06733 | T205 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | GAEVyHNLKNVIKEKyGKDAtNVGDEGGFAPNILENKEGLE |
| P06733 | T41 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | EVDLFtsKGLFRAAVPsGAstGIyEALELRDNDKtRYMGKG |
| P06748 | S137 | Sugiyama | NPM1 NPM | VAVEEDAEsEDEEEEDVKLLsIsGKRsAPGGGsKVPQKKVK |
| P07195 | S106 | Sugiyama | LDHB | VtANSKIVVVtAGVRQQEGEsRLNLVQRNVNVFKFIIPQIV |
| P07195 | S162 | Sugiyama | LDHB | DILTYVTWKLSGLPKHRVIGsGCNLDsARFRyLMAEKLGIH |
| P07195 | S168 | Sugiyama | LDHB | TWKLSGLPKHRVIGsGCNLDsARFRyLMAEKLGIHPSSCHG |
| P07195 | S303 | Sugiyama | LDHB | GIENEVFLSLPCILNARGLtsVINQKLKDDEVAQLKKsADt |
| P07195 | S44 | Sugiyama | LDHB | ITVVGVGQVGMACAISILGKsLADELALVDVLEDKLKGEMM |
| P07195 | T302 | Sugiyama | LDHB | YGIENEVFLSLPCILNARGLtsVINQKLKDDEVAQLKKsAD |
| P07305 | S66 | Sugiyama | H1-0 H1F0 H1FV | SRQsIQKYIKSHYKVGENADsQIKLsIKRLVTTGVLKQTKG |
| P07305 | S71 | Sugiyama | H1-0 H1F0 H1FV | QKYIKSHYKVGENADsQIKLsIKRLVTTGVLKQTKGVGASG |
| P07437 | S115 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | sGAGNNWAKGHytEGAELVDsVLDVVRKEAESCDCLQGFQL |
| P07437 | S75 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | tGGKyVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVFGQs |
| P07737 | S57 | Sugiyama | PFN1 | GKtFVNITPAEVGVLVGKDRssFyVNGLtLGGQKCsVIRDs |
| P07737 | S85 | Sugiyama | PFN1 | tLGGQKCsVIRDsLLQDGEFsMDLRtKstGGAPTFNVtVtK |
| P07737 | T65 | Sugiyama | PFN1 | PAEVGVLVGKDRssFyVNGLtLGGQKCsVIRDsLLQDGEFs |
| P07814 | S335 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | PIEKNLQMWEEMKKGsQFGQsCCLRAKIDMSSNNGCMRDPt |
| P07814 | T1506 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | LCELQPGAKCVCGKNPAKyytLFGRsy______________ |
| P07864 | S161 | Sugiyama | LDHC LDH3 LDHX | DILTYIVWKISGLPVTRVIGsGCNLDsARFRYLIGEKLGVH |
| P07864 | S167 | Sugiyama | LDHC LDH3 LDHX | VWKISGLPVTRVIGsGCNLDsARFRYLIGEKLGVHPTSCHG |
| P07900 | S399 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | PEYLNFIRGVVDsEDLPLNIsREMLQQsKILKVIRKNLVKK |
| P07900 | S53 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | IINtFySNKEIFLRELIsNssDALDKIRyEsLtDPsKLDsG |
| P08195 | S292 | Sugiyama | SLC3A2 MDU1 | VAQtDLLQIDPNFGsKEDFDsLLQsAKKKSIRVILDLTPNY |
| P08195 | S296 | Sugiyama | SLC3A2 MDU1 | DLLQIDPNFGsKEDFDsLLQsAKKKSIRVILDLTPNYRGEN |
| P08195 | S403 | Sugiyama | SLC3A2 MDU1 | SDLQQILSLLESNKDLLLtssyLsDsGstGEHtKSLVTQYL |
| P08195 | S598 | Sugiyama | SLC3A2 MDU1 | LQASDLPASASLPAKADLLLstQPGREEGsPLELERLKLEP |
| P08195 | T599 | Sugiyama | SLC3A2 MDU1 | QASDLPASASLPAKADLLLstQPGREEGsPLELERLKLEPH |
| P08238 | S391 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | PEYLNFIRGVVDsEDLPLNIsREMLQQsKILKVIRKNIVKK |
| P08238 | S45 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | MSLIINTFYSNKEIFLRELIsNAsDALDKIRyEsLtDPsKL |
| P08238 | S468 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | RRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKsIyyItG |
| P08238 | S470 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | RLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKsIyyItGEs |
| P08238 | S48 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | IINTFYSNKEIFLRELIsNAsDALDKIRyEsLtDPsKLDsG |
| P08238 | S497 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | KEtQKsIyyItGEsKEQVANsAFVERVRKRGFEVVyMtEPI |
| P08238 | S532 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | yMtEPIDEyCVQQLKEFDGKsLVsVtKEGLELPEDEEEKKK |
| P08238 | S535 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | EPIDEyCVQQLKEFDGKsLVsVtKEGLELPEDEEEKKKMEE |
| P08238 | Y457 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | LKLGIHEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMK |
| P08729 | S104 | Sugiyama | KRT7 SCL | LQRVRQEESEQIKTLNNKFAsFIDKVRFLEQQNKLLETKWT |
| P09104 | S37 | Sugiyama | ENO2 | NPtVEVDLyTAKGLFRAAVPsGAstGIyEALELRDGDKQRY |
| P09104 | T41 | Sugiyama | ENO2 | EVDLyTAKGLFRAAVPsGAstGIyEALELRDGDKQRYLGKG |
| P09382 | S63 | Sugiyama | LGALS1 | CLHFNPRFNAHGDANtIVCNsKDGGAWGTEQREAVFPFQPG |
| P09382 | T58 | Sugiyama | LGALS1 | DsNNLCLHFNPRFNAHGDANtIVCNsKDGGAWGTEQREAVF |
| P09429 | S121 | Sugiyama | HMGB1 HMG1 | AFFLFCSEYRPKIKGEHPGLsIGDVAKKLGEMWNNTAADDK |
| P09429 | S15 | Sugiyama | HMGB1 HMG1 | ______MGKGDPKKPRGKMssyAFFVQtCREEHKKKHPDAs |
| P09429 | S35 | Sugiyama | HMGB1 HMG1 | syAFFVQtCREEHKKKHPDAsVNFsEFsKKCsERWKtMsAK |
| P09429 | S42 | Sugiyama | HMGB1 HMG1 | tCREEHKKKHPDAsVNFsEFsKKCsERWKtMsAKEKGKFED |
| P09429 | T22 | Sugiyama | HMGB1 HMG1 | GKGDPKKPRGKMssyAFFVQtCREEHKKKHPDAsVNFsEFs |
| P09651 | S95 | Sugiyama | HNRNPA1 HNRPA1 | RPHKVDGRVVEPKRAVsREDsQRPGAHLtVKKIFVGGIKED |
| P09661 | S212 | Sugiyama | SNRPA1 | KKGGPsPGDVEAIKNAIANAstLAEVERLKGLLQsGQIPGR |
| P09661 | S226 | Sugiyama | SNRPA1 | NAIANAstLAEVERLKGLLQsGQIPGRERRsGPtDDGEEEM |
| P09874 | S185 | Sugiyama | PARP1 ADPRT PPOL | KNREELGFRPEYsAsQLKGFsLLAtEDKEALKKQLPGVKSE |
| P09874 | T189 | Sugiyama | PARP1 ADPRT PPOL | ELGFRPEYsAsQLKGFsLLAtEDKEALKKQLPGVKSEGKRK |
| P0CG38 | S1065 | Sugiyama | POTEI | ILASLSTFQQMWISKQEyDEsGPsIVHRKCF__________ |
| P0CG38 | S1068 | Sugiyama | POTEI | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P0CG39 | S1028 | Sugiyama | POTEJ | ILASLSTFQQMWISKQEyDEsGPsIVHRKCF__________ |
| P0CG39 | S1031 | Sugiyama | POTEJ | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P0DPH7 | T73 | Sugiyama | TUBA3C TUBA2 | FsEtGAGKHVPRAVFVDLEPtVVDEVRtGtyRQLFHPEQLI |
| P0DPH7 | T80 | Sugiyama | TUBA3C TUBA2 | KHVPRAVFVDLEPtVVDEVRtGtyRQLFHPEQLItGKEDAA |
| P0DPH7 | T82 | Sugiyama | TUBA3C TUBA2 | VPRAVFVDLEPtVVDEVRtGtyRQLFHPEQLItGKEDAANN |
| P0DPH7 | Y83 | Sugiyama | TUBA3C TUBA2 | PRAVFVDLEPtVVDEVRtGtyRQLFHPEQLItGKEDAANNy |
| P10412 | S41 | Sugiyama | H1-4 H1F4 HIST1H1E | KKKARKsAGAAKRKAsGPPVsELItKAVAASKERsGVsLAA |
| P10412 | S55 | Sugiyama | H1-4 H1F4 HIST1H1E | AsGPPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEK |
| P10412 | S58 | Sugiyama | H1-4 H1F4 HIST1H1E | PPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEKNNS |
| P10412 | T45 | Sugiyama | H1-4 H1F4 HIST1H1E | RKsAGAAKRKAsGPPVsELItKAVAASKERsGVsLAALKKA |
| P10809 | S453 | Sugiyama | HSPD1 HSP60 | EEGIVLGGGCALLRCIPALDsLtPANEDQKIGIEIIKRTLK |
| P10809 | T428 | Sugiyama | HSPD1 HSP60 | GtsDVEVNEKKDRVtDALNAtRAAVEEGIVLGGGCALLRCI |
| P11142 | S85 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | NtVFDAKRLIGRRFDDAVVQsDMKHWPFMVVNDAGRPKVQV |
| P11142 | T163 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VVtVPAyFNDsQRQAtKDAGtIAGLNVLRIINEPtAAAIAy |
| P11142 | T47 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | EIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAMNPtNtV |
| P11142 | Y41 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | FQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAM |
| P11940 | T191 | Sugiyama | PABPC1 PAB1 PABP PABP1 PABPC2 | GRFKSRKEREAELGARAKEFtNVyIKNFGEDMDDERLKDLF |
| P11940 | T319 | Sugiyama | PABPC1 PAB1 PABP PABP1 PABPC2 | KNLDDGIDDERLRKEFsPFGtItsAKVMMEGGRSKGFGFVC |
| P11940 | Y194 | Sugiyama | PABPC1 PAB1 PABP PABP1 PABPC2 | KSRKEREAELGARAKEFtNVyIKNFGEDMDDERLKDLFGKF |
| P12035 | S211 | Sugiyama | KRT3 | IGQVKAQEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWN |
| P13639 | S38 | Sugiyama | EEF2 EF2 | NIRNMsVIAHVDHGKStLtDsLVCKAGIIAsARAGEtRFtD |
| P13639 | S732 | Sugiyama | EEF2 EF2 | DAIHRGGGQIIPtARRCLyAsVLtAQPRLMEPIyLVEIQCP |
| P13639 | T735 | Sugiyama | EEF2 EF2 | HRGGGQIIPtARRCLyAsVLtAQPRLMEPIyLVEIQCPEQV |
| P13647 | S181 | Sugiyama | KRT5 | IQRVRTEEREQIKTLNNKFAsFIDKVRFLEQQNKVLDTKWT |
| P13667 | S468 | Sugiyama | PDIA4 ERP70 ERP72 | ytFAIADEEDyAGEVKDLGLsEsGEDVNAAILDEsGKKFAM |
| P13667 | S482 | Sugiyama | PDIA4 ERP70 ERP72 | VKDLGLsEsGEDVNAAILDEsGKKFAMEPEEFDsDtLREFV |
| P13929 | S37 | Sugiyama | ENO3 | NPtVEVDLHtAKGRFRAAVPsGAstGIyEALELRDGDKGRY |
| P13929 | T41 | Sugiyama | ENO3 | EVDLHtAKGRFRAAVPsGAstGIyEALELRDGDKGRYLGKG |
| P13987 | T76 | Sugiyama | CD59 MIC11 MIN1 MIN2 MIN3 MSK21 | AGLQVYNKCWKFEHCNFNDVtTRLRENELtyyCCKKDLCNF |
| P14314 | S478 | Sugiyama | PRKCSH G19P1 | DKFSAMKyEQGtGCWQGPNRstTVRLLCGKEtMVtStTEPS |
| P14618 | S202 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | SLQVKQKGADFLVtEVENGGsLGsKKGVNLPGAAVDLPAVs |
| P14618 | S205 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | VKQKGADFLVtEVENGGsLGsKKGVNLPGAAVDLPAVsEKD |
| P14618 | S77 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | sVEtLKEMIKsGMNVARLNFsHGtHEyHAEtIKNVRtAtEs |
| P14618 | T195 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | yVDDGLISLQVKQKGADFLVtEVENGGsLGsKKGVNLPGAA |
| P14618 | T87 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | sGMNVARLNFsHGtHEyHAEtIKNVRtAtEsFAsDPILyRP |
| P14625 | S106 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | MKLIINSLYKNKEIFLRELIsNAsDALDKIRLISLTDENAL |
| P14625 | S109 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | IINSLYKNKEIFLRELIsNAsDALDKIRLISLTDENALSGN |
| P14625 | S64 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | tDDEVVQREEEAIQLDGLNAsQIRELREKSEKFAFQAEVNR |
| P14625 | S674 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | WsGNMERIMKAQAYQtGKDIstNyyAsQKKTFEINPRHPLI |
| P15311 | S413 | Sugiyama | EZR VIL2 | RMAALRAKEELERQAVDQIKsQEQLAAELAEytAKIALLEE |
| P15311 | S535 | Sugiyama | EZR VIL2 | EKRITEAEKNERVQRQLLtLssELsQARDENKRTHNDIIHN |
| P15311 | T425 | Sugiyama | EZR VIL2 | RQAVDQIKsQEQLAAELAEytAKIALLEEARRRKEDEVEEW |
| P15311 | T533 | Sugiyama | EZR VIL2 | NEEKRITEAEKNERVQRQLLtLssELsQARDENKRTHNDII |
| P16070 | T76 | Sugiyama | CD44 LHR MDU2 MDU3 MIC4 | FNSTLPTMAQMEKALsIGFEtCRyGFIEGHVVIPRIHPNSI |
| P16402 | S42 | Sugiyama | H1-3 H1F3 HIST1H1D | KKAKKAGATAGKRKAsGPPVsELItKAVAASKERsGVsLAA |
| P16402 | S56 | Sugiyama | H1-3 H1F3 HIST1H1D | AsGPPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEK |
| P16402 | S59 | Sugiyama | H1-3 H1F3 HIST1H1D | PPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEKNNS |
| P16402 | T46 | Sugiyama | H1-3 H1F3 HIST1H1D | KAGATAGKRKAsGPPVsELItKAVAASKERsGVsLAALKKA |
| P16403 | S41 | Sugiyama | H1-2 H1F2 HIST1H1C | KKKAAKKAGGtPRKAsGPPVsELItKAVAASKERsGVsLAA |
| P16403 | S55 | Sugiyama | H1-2 H1F2 HIST1H1C | AsGPPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEK |
| P16403 | S58 | Sugiyama | H1-2 H1F2 HIST1H1C | PPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEKNNS |
| P16403 | T45 | Sugiyama | H1-2 H1F2 HIST1H1C | AKKAGGtPRKAsGPPVsELItKAVAASKERsGVsLAALKKA |
| P17275 | S312 | Sugiyama | JUNB | RIARLEDKVKTLKAENAGLSstAGLLREQVAQLKQKVMTHV |
| P17275 | T313 | Sugiyama | JUNB | IARLEDKVKTLKAENAGLSstAGLLREQVAQLKQKVMTHVS |
| P17987 | S119 | Sugiyama | TCP1 CCT1 CCTA | ELLKNADELVKQKIHPTSVIsGYRLACKEAVRYINENLIVN |
| P18615 | S135 | Sugiyama | NELFE RD RDBP | sADDDLQEsSRRPQRKsLyEsFVsssDRLRELGPDGEEAEG |
| P18615 | S138 | Sugiyama | NELFE RD RDBP | DDLQEsSRRPQRKsLyEsFVsssDRLRELGPDGEEAEGPGA |
| P18621 | S141 | Sugiyama | RPL17 | KAPKMRRRTYRAHGRINPyMssPCHIEMILtEKEQIVPKPE |
| P18621 | T151 | Sugiyama | RPL17 | RAHGRINPyMssPCHIEMILtEKEQIVPKPEEEVAQKKKIS |
| P19338 | S458 | Sugiyama | NCL | TEADAEKTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKN |
| P19338 | S460 | Sugiyama | NCL | ADAEKTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKNST |
| P19338 | S619 | Sugiyama | NCL | RIVTDRETGssKGFGFVDFNsEEDAKAAKEAMEDGEIDGNK |
| P20042 | S67 | Sugiyama | EIF2S2 EIF2B | EPtEDKDLEADEEDTRKKDAsDDLDDLNFFNQKKKKKKTKK |
| P20290 | S30 | Sugiyama | BTF3 NACB OK/SW-cl.8 | ADSRGRGRARGGCPGGEAtLsQPPPRGGTRGQEPQMKETIM |
| P20290 | T28 | Sugiyama | BTF3 NACB OK/SW-cl.8 | AQADSRGRGRARGGCPGGEAtLsQPPPRGGTRGQEPQMKET |
| P20618 | S157 | Sugiyama | PSMB1 PSC5 | IIGGLDEEGKGAVysFDPVGsyQRDsFKAGGSASAMLQPLL |
| P20618 | S162 | Sugiyama | PSMB1 PSC5 | DEEGKGAVysFDPVGsyQRDsFKAGGSASAMLQPLLDNQVG |
| P20674 | T105 | Sugiyama | COX5A | EPKIIDAALRACRRLNDFAstVRILEVVKDKAGPHKEIYPY |
| P20810 | S297 | Sugiyama | CAST | KKRKVEKDtMsDQALEALsAsLGTRQAEPELDLRsIKEVDE |
| P22626 | S212 | Sugiyama | HNRNPA2B1 HNRPA2B1 | EMQEVQssRsGRGGNFGFGDsRGGGGNFGPGPGsNFRGGsD |
| P23246 | S283 | Sugiyama | SFPQ PSF | GPGGRsEEKIsDsEGFKANLsLLRRPGEKTyTQRCRLFVGN |
| P23396 | S35 | Sugiyama | RPS3 OK/SW-cl.26 | GIFKAELNEFLtRELAEDGysGVEVRVtPTRTEIIILATRT |
| P23396 | T26 | Sugiyama | RPS3 OK/SW-cl.26 | sKKRKFVADGIFKAELNEFLtRELAEDGysGVEVRVtPTRT |
| P23526 | S183 | Sugiyama | AHCY SAHH | NLyKMMANGILKVPAINVNDsVtKsKFDNLyGCRESLIDGI |
| P23528 | T63 | Sugiyama | CFL1 CFL | DKKNIILEEGKEILVGDVGQtVDDPyAtFVKMLPDKDCRyA |
| P25398 | S107 | Sugiyama | RPS12 | EWVGLCKIDREGKPRKVVGCsCVVVKDYGKESQAKDVIEEy |
| P25786 | T11 | Sugiyama | PSMA1 HC2 NU PROS30 PSC2 | __________MFRNQyDNDVtVWsPQGRIHQIEYAMEAVKQ |
| P26038 | S576 | Sugiyama | MSN | YKtLRQIRQGNTKQRIDEFEsM___________________ |
| P26373 | S181 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | YKKEKARVItEEEKNFKAFAsLRMARANARLFGIRAKRAKE |
| P26373 | S77 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PIVRCPTVRYHTKVRAGRGFsLEELRVAGIHKKVARTIGIs |
| P26373 | T148 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PRKPSAPKKGDssAEELKLAtQLtGPVMPVRNVYKKEKARV |
| P26373 | T151 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PSAPKKGDssAEELKLAtQLtGPVMPVRNVYKKEKARVItE |
| P26583 | S15 | Sugiyama | HMGB2 HMG2 | ______MGKGDPNKPRGKMssyAFFVQtCREEHKKKHPDss |
| P26583 | S35 | Sugiyama | HMGB2 HMG2 | syAFFVQtCREEHKKKHPDssVNFAEFSKKCSERWKTMSAK |
| P26583 | T22 | Sugiyama | HMGB2 HMG2 | GKGDPNKPRGKMssyAFFVQtCREEHKKKHPDssVNFAEFS |
| P26639 | S522 | Sugiyama | TARS1 TARS | PEKFLGDIEVWDQAEKQLENsLNEFGEKWELNsGDGAFyGP |
| P27348 | S145 | Sugiyama | YWHAQ | YFRyLAEVACGDDRKQtIDNsQGAyQEAFDIsKKEMQPTHP |
| P27348 | S156 | Sugiyama | YWHAQ | DDRKQtIDNsQGAyQEAFDIsKKEMQPTHPIRLGLALNFSV |
| P27695 | S129 | Sugiyama | APEX1 APE APE1 APEX APX HAP1 REF1 | QELPGLSHQYWSAPsDKEGysGVGLLsRQCPLKVsyGIGDE |
| P27695 | S135 | Sugiyama | APEX1 APE APE1 APEX APX HAP1 REF1 | SHQYWSAPsDKEGysGVGLLsRQCPLKVsyGIGDEEHDQEG |
| P27695 | T97 | Sugiyama | APEX1 APE APE1 APEX APX HAP1 REF1 | KKKGLDWVKEEAPDILCLQEtKCSENKLPAELQELPGLSHQ |
| P27695 | Y128 | Sugiyama | APEX1 APE APE1 APEX APX HAP1 REF1 | LQELPGLSHQYWSAPsDKEGysGVGLLsRQCPLKVsyGIGD |
| P27797 | S52 | Sugiyama | CALR CRTC | GWtsRWIEsKHKSDFGKFVLssGKFyGDEEKDKGLQTSQDA |
| P27797 | S53 | Sugiyama | CALR CRTC | WtsRWIEsKHKSDFGKFVLssGKFyGDEEKDKGLQTSQDAR |
| P29401 | S190 | Sugiyama | TKT | ASIYKLDNLVAILDINRLGQsDPAPLQHQMDIyQKRCEAFG |
| P29692 | S37 | Sugiyama | EEF1D EF1D | KYDDAERRFyEQMNGPVAGAsRQENGAsVILRDIARARENI |
| P29692 | S44 | Sugiyama | EEF1D EF1D | RFyEQMNGPVAGAsRQENGAsVILRDIARARENIQKsLAGs |
| P29692 | S64 | Sugiyama | EEF1D EF1D | sVILRDIARARENIQKsLAGssGPGAssGtsGDHGELVVRI |
| P29692 | S65 | Sugiyama | EEF1D EF1D | VILRDIARARENIQKsLAGssGPGAssGtsGDHGELVVRIA |
| P30041 | S186 | Sugiyama | PRDX6 AOP2 KIAA0106 | SLQLTAEKRVAtPVDWKDGDsVMVLPtIPEEEAKKLFPKGV |
| P30041 | T192 | Sugiyama | PRDX6 AOP2 KIAA0106 | EKRVAtPVDWKDGDsVMVLPtIPEEEAKKLFPKGVFtKELP |
| P30050 | S138 | Sugiyama | RPL12 | HRSLARELsGtIKEILGtAQsVGCNVDGRHPHDIIDDINsG |
| P30050 | S26 | Sugiyama | RPL12 | DPNEIKVVYLRCtGGEVGAtsALAPKIGPLGLsPKKVGDDI |
| P30086 | S139 | Sugiyama | PEBP1 PBP PEBP | RyVWLVyEQDRPLKCDEPILsNRsGDHRGKFKVAsFRKKyE |
| P30086 | S52 | Sugiyama | PEBP1 PBP PEBP | AAVDELGKVLtPtQVKNRPtsIsWDGLDsGKLytLVLtDPD |
| P30086 | S60 | Sugiyama | PEBP1 PBP PEBP | VLtPtQVKNRPtsIsWDGLDsGKLytLVLtDPDAPsRKDPK |
| P30533 | S230 | Sugiyama | LRPAP1 A2MRAP | SDIKGSVLHSRHTELKEKLRsINQGLDRLRRVsHQGystEA |
| P31943 | S285 | Sugiyama | HNRNPH1 HNRPH HNRPH1 | NyCFsGMsDHRyGDGGstFQsttGHCVHMRGLPYRAtENDI |
| P31948 | S16 | Sugiyama | STIP1 | _____MEQVNELKEKGNKALsVGNIDDALQCysEAIKLDPH |
| P31948 | S28 | Sugiyama | STIP1 | KEKGNKALsVGNIDDALQCysEAIKLDPHNHVLysNRsAAy |
| P31948 | S459 | Sugiyama | STIP1 | EAMKDytKAMDVYQKALDLDssCKEAADGYQRCMMAQyNRH |
| P31948 | S460 | Sugiyama | STIP1 | AMKDytKAMDVYQKALDLDssCKEAADGYQRCMMAQyNRHD |
| P33176 | S443 | Sugiyama | KIF5B KNS KNS1 | EEIAKLYKQLDDKDEEINQQsQLVEKLKTQMLDQEELLAST |
| P33176 | S950 | Sugiyama | KIF5B KNS KNS1 | PAAsPtHPSAIRGGGAFVQNsQPVAVRGGGGKQV_______ |
| P33316 | S164 | Sugiyama | DUT | YTIPPMEKAVVKTDIQIALPsGCyGRVAPRSGLAAKHFIDV |
| P34931 | T49 | Sugiyama | HSPA1L | EIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAMNPQNTV |
| P34931 | Y43 | Sugiyama | HSPA1L | FQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAM |
| P35269 | S431 | Sugiyama | GTF2F1 RAP74 | GKRVSEMPAAKRLRLDtGPQsLsGKstPQPPsGKttPNsGD |
| P35269 | S436 | Sugiyama | GTF2F1 RAP74 | EMPAAKRLRLDtGPQsLsGKstPQPPsGKttPNsGDVQVTE |
| P35269 | T437 | Sugiyama | GTF2F1 RAP74 | MPAAKRLRLDtGPQsLsGKstPQPPsGKttPNsGDVQVTED |
| P35579 | S1304 | Sugiyama | MYH9 | NVtGLLsQsDSKSSKLTKDFsALEsQLQDtQELLQEENRQK |
| P35579 | S1308 | Sugiyama | MYH9 | LLsQsDSKSSKLTKDFsALEsQLQDtQELLQEENRQKLsLs |
| P35579 | S1714 | Sugiyama | MYH9 | RAKRQAQQERDELADEIANssGKGALALEEKRRLEARIAQL |
| P35579 | S1892 | Sugiyama | MYH9 | LKQLKRQLEEAEEEAQRANAsRRKLQRELEDAtEtADAMNR |
| P35579 | S1915 | Sugiyama | MYH9 | KLQRELEDAtEtADAMNREVssLKNKLRRGDLPFVVPRRMA |
| P35579 | S1916 | Sugiyama | MYH9 | LQRELEDAtEtADAMNREVssLKNKLRRGDLPFVVPRRMAR |
| P35579 | S876 | Sugiyama | MYH9 | KVREKQLAAENRLTEMEtLQsQLMAEKLQLQEQLQAETELC |
| P35579 | T1313 | Sugiyama | MYH9 | DSKSSKLTKDFsALEsQLQDtQELLQEENRQKLsLstKLKQ |
| P35579 | T1904 | Sugiyama | MYH9 | EEAQRANAsRRKLQRELEDAtEtADAMNREVssLKNKLRRG |
| P35579 | T1906 | Sugiyama | MYH9 | AQRANAsRRKLQRELEDAtEtADAMNREVssLKNKLRRGDL |
| P35579 | T873 | Sugiyama | MYH9 | ELVKVREKQLAAENRLTEMEtLQsQLMAEKLQLQEQLQAET |
| P35580 | S1371 | Sugiyama | MYH10 | QQEEEEEARKNLEKQVLALQsQLADtKKKVDDDLGTIESLE |
| P35580 | T1376 | Sugiyama | MYH10 | EEARKNLEKQVLALQsQLADtKKKVDDDLGTIESLEEAKKK |
| P35637 | S360 | Sugiyama | FUS TLS | sFDDPPsAKAAIDWFDGKEFsGNPIKVsFATRRADFNRGGG |
| P35908 | S191 | Sugiyama | KRT2 KRT2A KRT2E | IQNVKAQEREQIKTLNNKFAsFIDKVRFLEQQNQVLQTKWE |
| P36578 | S365 | Sugiyama | RPL4 RPL1 | RNHKLRVDKAAAAAAALQAKsDEKAAVAGKKPVVGKKGKKA |
| P36578 | S55 | Sugiyama | RPL4 RPL1 | DIVNFVHTNLRKNNRQPyAVsELAGHQtsAEsWGtGRAVAR |
| P36578 | S66 | Sugiyama | RPL4 RPL1 | KNNRQPyAVsELAGHQtsAEsWGtGRAVARIPRVRGGGtHR |
| P36578 | S87 | Sugiyama | RPL4 RPL1 | WGtGRAVARIPRVRGGGtHRsGQGAFGNMCRGGRMFAPTKT |
| P36578 | T62 | Sugiyama | RPL4 RPL1 | TNLRKNNRQPyAVsELAGHQtsAEsWGtGRAVARIPRVRGG |
| P36578 | T69 | Sugiyama | RPL4 RPL1 | RQPyAVsELAGHQtsAEsWGtGRAVARIPRVRGGGtHRsGQ |
| P36578 | T84 | Sugiyama | RPL4 RPL1 | AEsWGtGRAVARIPRVRGGGtHRsGQGAFGNMCRGGRMFAP |
| P37802 | S145 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | VQRTLMNLGGLAVARDDGLFsGDPNWFPKKSKENPRNFsDN |
| P37802 | S163 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | LFsGDPNWFPKKSKENPRNFsDNQLQEGKNVIGLQMGtNRG |
| P37802 | S185 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | NQLQEGKNVIGLQMGtNRGAsQAGMtGyGMPRQIL______ |
| P37802 | T180 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | RNFsDNQLQEGKNVIGLQMGtNRGAsQAGMtGyGMPRQIL_ |
| P37802 | T190 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | GKNVIGLQMGtNRGAsQAGMtGyGMPRQIL___________ |
| P37802 | Y192 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | NVIGLQMGtNRGAsQAGMtGyGMPRQIL_____________ |
| P38646 | T116 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | DGERLVGMPAKRQAVtNPNNtFyAtKRLIGRRYDDPEVQKD |
| P38646 | T120 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | LVGMPAKRQAVtNPNNtFyAtKRLIGRRYDDPEVQKDIKNV |
| P38646 | Y118 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | ERLVGMPAKRQAVtNPNNtFyAtKRLIGRRYDDPEVQKDIK |
| P39019 | S59 | Sugiyama | RPS19 | LAKHKELAPyDENWFytRAAstARHLYLRGGAGVGsMTKIY |
| P39019 | S93 | Sugiyama | RPS19 | GsMTKIYGGRQRNGVMPsHFsRGsKsVARRVLQALEGLKMV |
| P39019 | T36 | Sugiyama | RPS19 | RALAAFLKKSGKLKVPEWVDtVKLAKHKELAPyDENWFytR |
| P39019 | T55 | Sugiyama | RPS19 | DtVKLAKHKELAPyDENWFytRAAstARHLYLRGGAGVGsM |
| P39019 | T60 | Sugiyama | RPS19 | AKHKELAPyDENWFytRAAstARHLYLRGGAGVGsMTKIYG |
| P39019 | Y54 | Sugiyama | RPS19 | VDtVKLAKHKELAPyDENWFytRAAstARHLYLRGGAGVGs |
| P39687 | S104 | Sugiyama | ANP32A C15orf1 LANP MAPM PHAP1 | AEKCPNLTHLNLsGNKIKDLstIEPLKKLENLKsLDLFNCE |
| P39687 | S27 | Sugiyama | ANP32A C15orf1 LANP MAPM PHAP1 | IHLELRNRtPsDVKELVLDNsRsNEGKLEGLTDEFEELEFL |
| P42677 | S78 | Sugiyama | RPS27 MPS1 | GCSTVLCQPTGGKARLtEGCsFRRKQH______________ |
| P42766 | S29 | Sugiyama | RPL35 | LRGKKKEELLKQLDDLKVELsQLRVAKVTGGAASKLsKIRV |
| P43487 | S60 | Sugiyama | RANBP1 | TLEEDEEELFKMRAKLFRFAsENDLPEWKERGTGDVKLLKH |
| P46776 | S68 | Sugiyama | RPL27A | yHPGyFGKVGMKHYHLKRNQsFCPtVNLDKLWtLVsEQtRV |
| P46776 | S83 | Sugiyama | RPL27A | LKRNQsFCPtVNLDKLWtLVsEQtRVNAAKNKtGAAPIIDV |
| P46776 | T72 | Sugiyama | RPL27A | yFGKVGMKHYHLKRNQsFCPtVNLDKLWtLVsEQtRVNAAK |
| P46776 | T80 | Sugiyama | RPL27A | HYHLKRNQsFCPtVNLDKLWtLVsEQtRVNAAKNKtGAAPI |
| P46777 | S172 | Sugiyama | RPL5 MSTP030 | RTTTGNKVFGALKGAVDGGLsIPHstKRFPGyDsEsKEFNA |
| P46777 | S176 | Sugiyama | RPL5 MSTP030 | GNKVFGALKGAVDGGLsIPHstKRFPGyDsEsKEFNAEVHR |
| P46777 | T177 | Sugiyama | RPL5 MSTP030 | NKVFGALKGAVDGGLsIPHstKRFPGyDsEsKEFNAEVHRK |
| P46778 | T29 | Sugiyama | RPL21 | RGTRYMFSRPFRKHGVVPLAtyMRIYKKGDIVDIKGMGTVQ |
| P46778 | Y30 | Sugiyama | RPL21 | GTRYMFSRPFRKHGVVPLAtyMRIYKKGDIVDIKGMGTVQK |
| P46783 | S146 | Sugiyama | RPS10 | TYRRSAVPPGADKKAEAGAGsAtEFQFRGGFGRGRGQPPQ_ |
| P46783 | T148 | Sugiyama | RPS10 | RRSAVPPGADKKAEAGAGsAtEFQFRGGFGRGRGQPPQ___ |
| P46937 | S388 | Sugiyama | YAP1 YAP65 | PGMsQELRTMttNssDPFLNsGtyHsRDEstDsGLsMssys |
| P46937 | S405 | Sugiyama | YAP1 YAP65 | FLNsGtyHsRDEstDsGLsMssysVPRtPDDFLNsVDEMDT |
| P47756 | S192 | Sugiyama | CAPZB | TVMLWLQTNKSGsGtMNLGGsLtRQMEKDEtVsDCsPHIAN |
| P47914 | S142 | Sugiyama | RPL29 | KAKAKAKAKDQTKAQAAAPAsVPAQAPKRtQAPtKAsE___ |
| P47914 | T151 | Sugiyama | RPL29 | DQTKAQAAAPAsVPAQAPKRtQAPtKAsE____________ |
| P48668 | S176 | Sugiyama | KRT6C KRT6E | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLDTKWT |
| P50991 | S51 | Sugiyama | CCT4 CCTD SRB | AQIRFsNISAAKAVADAIRtsLGPKGMDKMIQDGKGDVtIt |
| P50991 | T50 | Sugiyama | CCT4 CCTD SRB | PAQIRFsNISAAKAVADAIRtsLGPKGMDKMIQDGKGDVtI |
| P51116 | S601 | Sugiyama | FXR2 FMR1L2 | RPQRRNRSRRRRNRGNRtDGsIsGDRQPVtVADyIsRAEsQ |
| P51116 | T598 | Sugiyama | FXR2 FMR1L2 | DESRPQRRNRSRRRRNRGNRtDGsIsGDRQPVtVADyIsRA |
| P51116 | T610 | Sugiyama | FXR2 FMR1L2 | RRRNRGNRtDGsIsGDRQPVtVADyIsRAEsQsRQRPPLER |
| P52272 | S633 | Sugiyama | HNRNPM HNRPM NAGR1 | GGGGAsFDRAIEMERGNFGGsFAGsFGGAGGHAPGVARKAC |
| P52272 | S637 | Sugiyama | HNRNPM HNRPM NAGR1 | AsFDRAIEMERGNFGGsFAGsFGGAGGHAPGVARKACQIFV |
| P54652 | T48 | Sugiyama | HSPA2 | EIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAMNPTNTI |
| P54652 | Y42 | Sugiyama | HSPA2 | FQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAM |
| P55854 | S27 | Sugiyama | SUMO3 SMT3A SMT3H1 | KEGVKTENDHINLKVAGQDGsVVQFKIKRHTPLSKLMKAYC |
| P57053 | S39 | Sugiyama | H2BC12L H2BFS H2BS1 | VTKAQKKDGRKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| P58876 | S39 | Sugiyama | H2BC5 H2BFB HIRIP2 HIST1H2BD | VTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| P60174 | S212 | Sugiyama | TPI1 TPI | WLKsNVsDAVAQstRIIyGGsVtGAtCKELASQPDVDGFLV |
| P60174 | S97 | Sugiyama | TPI1 TPI | GEIsPGMIKDCGAtWVVLGHsERRHVFGEsDELIGQKVAHA |
| P60174 | T217 | Sugiyama | TPI1 TPI | VsDAVAQstRIIyGGsVtGAtCKELASQPDVDGFLVGGAsL |
| P60174 | T90 | Sugiyama | TPI1 TPI | VTNGAFtGEIsPGMIKDCGAtWVVLGHsERRHVFGEsDELI |
| P60709 | S199 | Sugiyama | ACTB | DLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyV |
| P60709 | S365 | Sugiyama | ACTB | ILAsLstFQQMWISKQEyDEsGPsIVHRKCF__________ |
| P60709 | S368 | Sugiyama | ACTB | sLstFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P60709 | S52 | Sugiyama | ACTB | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P60709 | S60 | Sugiyama | ACTB | HQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEHGIVTNWD |
| P60709 | T249 | Sugiyama | ACTB | tAAssssLEKsyELPDGQVItIGNERFRCPEALFQPsFLGM |
| P60709 | Y240 | Sugiyama | ACTB | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| P60709 | Y53 | Sugiyama | ACTB | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEH |
| P60842 | S78 | Sugiyama | EIF4A1 DDX2A EIF4A | IQQRAILPCIKGyDVIAQAQsGtGKTATFAISILQQIELDL |
| P61221 | Y594 | Sugiyama | ABCE1 RLI RNASEL1 RNASELI RNS4I OK/SW-cl.40 | RPRINKLNsIKDVEQKKsGNyFFLDD_______________ |
| P61247 | S263 | Sugiyama | RPS3A FTE1 MFTL | GDEtGAKVERADGyEPPVQEsV___________________ |
| P61313 | S100 | Sugiyama | RPL15 EC45 TCBAP0781 | tyGKPVHHGVNQLKFARsLQsVAEERAGRHCGALRVLNsyW |
| P61313 | S97 | Sugiyama | RPL15 EC45 TCBAP0781 | KGAtyGKPVHHGVNQLKFARsLQsVAEERAGRHCGALRVLN |
| P61353 | S34 | Sugiyama | RPL27 | LAGRYSGRKAVIVKNIDDGtsDRPysHALVAGIDRyPRKVT |
| P61353 | T33 | Sugiyama | RPL27 | VLAGRYSGRKAVIVKNIDDGtsDRPysHALVAGIDRyPRKV |
| P61353 | Y38 | Sugiyama | RPL27 | YSGRKAVIVKNIDDGtsDRPysHALVAGIDRyPRKVTAAMG |
| P61604 | T45 | Sugiyama | HSPE1 | TVTKGGIMLPEKSQGKVLQAtVVAVGsGsKGKGGEIQPVsV |
| P61956 | S28 | Sugiyama | SUMO2 SMT3B SMT3H2 | EGVKtENNDHINLKVAGQDGsVVQFKIKRHTPLSKLMKAYC |
| P61978 | S401 | Sugiyama | HNRNPK HNRPK | GDLGGPIIttQVtIPKDLAGsIIGKGGQRIKQIRHEsGAsI |
| P61978 | T70 | Sugiyama | HNRNPK HNRPK | QSKNAGAVIGKGGKNIKALRtDyNAsVsVPDssGPERILsI |
| P62249 | S9 | Sugiyama | RPS16 | ____________MPsKGPLQsVQVFGRKKTATAVAHCKRGN |
| P62258 | S148 | Sugiyama | YWHAE | YHRyLAEFAtGNDRKEAAENsLVAyKAAsDIAMtELPPTHP |
| P62263 | S70 | Sugiyama | RPS14 PRO2640 | KETICRVTGGMKVKADRDEssPyAAMLAAQDVAQRCKELGI |
| P62266 | S45 | Sugiyama | RPS23 | KQYKKAHLGtALKANPFGGAsHAKGIVLEKVGVEAKQPNSA |
| P62273 | S9 | Sugiyama | RPS29 | ____________MGHQQLyWsHPRKFGQGSRSCRVCSNRHG |
| P62273 | Y7 | Sugiyama | RPS29 | ______________MGHQQLyWsHPRKFGQGSRSCRVCSNR |
| P62277 | S14 | Sugiyama | RPS13 | _______MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDDVK |
| P62280 | T28 | Sugiyama | RPS11 | RAyQKQPtIFQNKKRVLLGEtGKEKLPRYYKNIGLGFKtPK |
| P62280 | T54 | Sugiyama | RPS11 | PRYYKNIGLGFKtPKEAIEGtyIDKKCPFTGNVsIRGRILs |
| P62316 | S30 | Sugiyama | SNRPD2 SNRPD1 | EMtPEELQKREEEEFNtGPLsVLtQsVKNNtQVLINCRNNK |
| P62316 | S35 | Sugiyama | SNRPD2 SNRPD1 | ELQKREEEEFNtGPLsVLtQsVKNNtQVLINCRNNKKLLGR |
| P62316 | T26 | Sugiyama | SNRPD2 SNRPD1 | KPKsEMtPEELQKREEEEFNtGPLsVLtQsVKNNtQVLINC |
| P62424 | T84 | Sugiyama | RPL7A SURF-3 SURF3 | QRQRAILyKRLKVPPAINQFtQALDRQTAtQLLKLAHKYRP |
| P62736 | S54 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P62736 | S62 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P62736 | T251 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P62736 | Y242 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P62736 | Y55 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P62750 | T126 | Sugiyama | RPL23A | KHQIKQAVKKLyDIDVAKVNtLIRPDGEKKAYVRLAPDyDA |
| P62753 | S148 | Sugiyama | RPS6 OK/SW-cl.2 | tVPRRLGPKRASRIRKLFNLsKEDDVRQyVVRKPLNKEGKK |
| P62753 | T127 | Sugiyama | RPS6 OK/SW-cl.2 | SVLNLVIVKKGEKDIPGLtDttVPRRLGPKRASRIRKLFNL |
| P62753 | T128 | Sugiyama | RPS6 OK/SW-cl.2 | VLNLVIVKKGEKDIPGLtDttVPRRLGPKRASRIRKLFNLs |
| P62807 | S39 | Sugiyama | H2BC4 H2BFL HIST1H2BC; H2BC6 H2BFH HIST1H2BE; H2BC7 H2BFG HIST1H2BF; H2BC8 H2BFA HIST1H2BG; H2BC10 H2BFK HIST1H2BI | VTKAQKKDGKKRKRsRKEsysVyVyKVLKQVHPDTGIssKA |
| P62826 | T66 | Sugiyama | RAN ARA24 OK/SW-cl.81 | EVHPLVFHTNRGPIKFNVWDtAGQEKFGGLRDGYYIQAQCA |
| P62829 | S115 | Sugiyama | RPL23 | FLYFEDNAGVIVNNKGEMKGsAItGPVAKECADLWPRIASN |
| P62829 | T118 | Sugiyama | RPL23 | FEDNAGVIVNNKGEMKGsAItGPVAKECADLWPRIASNAGs |
| P62851 | S74 | Sugiyama | RPS25 | tyDKLCKEVPNYKLItPAVVsERLKIRGSLARAALQELLsK |
| P62857 | S39 | Sugiyama | RPS28 | GRtGsQGQCtQVRVEFMDDtsRsIIRNVKGPVREGDVLtLL |
| P62857 | S61 | Sugiyama | RPS28 | sIIRNVKGPVREGDVLtLLEsEREARRLR____________ |
| P62857 | T38 | Sugiyama | RPS28 | LGRtGsQGQCtQVRVEFMDDtsRsIIRNVKGPVREGDVLtL |
| P62857 | T57 | Sugiyama | RPS28 | DtsRsIIRNVKGPVREGDVLtLLEsEREARRLR________ |
| P62899 | S15 | Sugiyama | RPL31 | ______MAPAKKGGEKKKGRsAINEVVtREytINIHKRIHG |
| P62899 | T107 | Sugiyama | RPL31 | RLSRKRNEDEDsPNKLytLVtyVPVttFKNLQtVNVDEN__ |
| P62899 | T113 | Sugiyama | RPL31 | NEDEDsPNKLytLVtyVPVttFKNLQtVNVDEN________ |
| P62899 | T22 | Sugiyama | RPL31 | APAKKGGEKKKGRsAINEVVtREytINIHKRIHGVGFKKRA |
| P62899 | T26 | Sugiyama | RPL31 | KGGEKKKGRsAINEVVtREytINIHKRIHGVGFKKRAPRAL |
| P62899 | Y108 | Sugiyama | RPL31 | LSRKRNEDEDsPNKLytLVtyVPVttFKNLQtVNVDEN___ |
| P62906 | S113 | Sugiyama | RPL10A NEDD6 | LNKNKKLVKKLAKKyDAFLAsEsLIKQIPRILGPGLNKAGK |
| P62906 | S115 | Sugiyama | RPL10A NEDD6 | KNKKLVKKLAKKyDAFLAsEsLIKQIPRILGPGLNKAGKFP |
| P62913 | S51 | Sugiyama | RPL11 | DRLtRAAKVLEQLtGQtPVFsKARyTVRsFGIRRNEKIAVH |
| P62913 | T44 | Sugiyama | RPL11 | ICVGEsGDRLtRAAKVLEQLtGQtPVFsKARyTVRsFGIRR |
| P62917 | S130 | Sugiyama | RPL8 | GTIVCCLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKL |
| P62917 | S138 | Sugiyama | RPL8 | EKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKLPSGSKKVI |
| P62917 | S14 | Sugiyama | RPL8 | _______MGRVIRGQRKGAGsVFRAHVKHRKGAARLRAVDF |
| P62917 | T135 | Sugiyama | RPL8 | CLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKLPSGSK |
| P62917 | T143 | Sugiyama | RPL8 | RGKLARAsGNyAtVIsHNPEtKKtRVKLPSGSKKVISSANR |
| P62917 | Y133 | Sugiyama | RPL8 | VCCLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKLPSG |
| P62942 | T7 | Sugiyama | FKBP1A FKBP1 FKBP12 | ______________MGVQVEtIsPGDGRtFPKRGQtCVVHy |
| P62979 | S123 | Sugiyama | RPS27A UBA80 UBCEP1 | LKYYKVDENGKIsRLRRECPsDECGAGVFMAsHFDRHyCGK |
| P62979 | S134 | Sugiyama | RPS27A UBA80 UBCEP1 | IsRLRRECPsDECGAGVFMAsHFDRHyCGKCCLtyCFNKPE |
| P63104 | S145 | Sugiyama | YWHAZ | YYRyLAEVAAGDDKKGIVDQsQQAyQEAFEIsKKEMQPTHP |
| P63104 | S156 | Sugiyama | YWHAZ | DDKKGIVDQsQQAyQEAFEIsKKEMQPTHPIRLGLALNFSV |
| P63104 | S28 | Sugiyama | YWHAZ | QKAKLAEQAERyDDMAACMKsVtEQGAELsNEERNLLsVAy |
| P63173 | T14 | Sugiyama | RPL38 | _______MPRKIEEIKDFLLtARRKDAKSVKIKKNKDNVKF |
| P63220 | S65 | Sugiyama | RPS21 | RFNGQFKtyAICGAIRRMGEsDDsILRLAKADGIVSKNF__ |
| P63220 | S68 | Sugiyama | RPS21 | GQFKtyAICGAIRRMGEsDDsILRLAKADGIVSKNF_____ |
| P63261 | S199 | Sugiyama | ACTG1 ACTG | DLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyV |
| P63261 | S365 | Sugiyama | ACTG1 ACTG | ILAsLstFQQMWISKQEyDEsGPsIVHRKCF__________ |
| P63261 | S368 | Sugiyama | ACTG1 ACTG | sLstFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P63261 | S52 | Sugiyama | ACTG1 ACTG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P63261 | S60 | Sugiyama | ACTG1 ACTG | HQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEHGIVTNWD |
| P63261 | T249 | Sugiyama | ACTG1 ACTG | tAAssssLEKsyELPDGQVItIGNERFRCPEALFQPsFLGM |
| P63261 | Y240 | Sugiyama | ACTG1 ACTG | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| P63261 | Y53 | Sugiyama | ACTG1 ACTG | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEH |
| P63267 | S53 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P63267 | S61 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P63267 | T250 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P63267 | Y241 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P63267 | Y54 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P67809 | S102 | Sugiyama | YBX1 NSEP1 YB1 | EDVFVHQtAIKKNNPRKyLRsVGDGEtVEFDVVEGEKGAEA |
| P67809 | S136 | Sugiyama | YBX1 NSEP1 YB1 | GEKGAEAANVtGPGGVPVQGsKYAADRNHYRRYPRRRGPPR |
| P67809 | S209 | Sugiyama | YBX1 NSEP1 YB1 | RRRRFPPyyMRRPYGRRPQysNPPVQGEVMEGADNQGAGEQ |
| P67809 | T108 | Sugiyama | YBX1 NSEP1 YB1 | QtAIKKNNPRKyLRsVGDGEtVEFDVVEGEKGAEAANVtGP |
| P67809 | Y99 | Sugiyama | YBX1 NSEP1 YB1 | DtKEDVFVHQtAIKKNNPRKyLRsVGDGEtVEFDVVEGEKG |
| P68032 | S54 | Sugiyama | ACTC1 ACTC | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68032 | S62 | Sugiyama | ACTC1 ACTC | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P68032 | T251 | Sugiyama | ACTC1 ACTC | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P68032 | Y242 | Sugiyama | ACTC1 ACTC | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P68032 | Y55 | Sugiyama | ACTC1 ACTC | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P68133 | S54 | Sugiyama | ACTA1 ACTA | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68133 | S62 | Sugiyama | ACTA1 ACTA | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P68133 | T251 | Sugiyama | ACTA1 ACTA | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P68133 | Y242 | Sugiyama | ACTA1 ACTA | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P68133 | Y55 | Sugiyama | ACTA1 ACTA | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P83731 | S86 | Sugiyama | RPL24 | EIQKKRTRRAVKFQRAItGAsLADIMAKRNQKPEVRKAQRE |
| P83731 | T52 | Sugiyama | RPL24 | LNAKCEsAFLSKRNPRQINWtVLyRRKHKKGQsEEIQKKRT |
| P83731 | T83 | Sugiyama | RPL24 | QsEEIQKKRTRRAVKFQRAItGAsLADIMAKRNQKPEVRKA |
| P83731 | Y55 | Sugiyama | RPL24 | KCEsAFLSKRNPRQINWtVLyRRKHKKGQsEEIQKKRTRRA |
| P84098 | S12 | Sugiyama | RPL19 | _________MSMLRLQKRLAssVLRCGKKKVWLDPNEtNEI |
| P84098 | S122 | Sugiyama | RPL19 | LRRLLRRYRESKKIDRHMyHsLyLKVKGNVFKNKRILMEHI |
| P84098 | S13 | Sugiyama | RPL19 | ________MSMLRLQKRLAssVLRCGKKKVWLDPNEtNEIA |
| P84098 | S37 | Sugiyama | RPL19 | CGKKKVWLDPNEtNEIANANsRQQIRKLIKDGLIIRKPVtV |
| P84098 | T29 | Sugiyama | RPL19 | RLAssVLRCGKKKVWLDPNEtNEIANANsRQQIRKLIKDGL |
| P84098 | Y124 | Sugiyama | RPL19 | RLLRRYRESKKIDRHMyHsLyLKVKGNVFKNKRILMEHIHK |
| Q00839 | S585 | Sugiyama | HNRNPU C1orf199 HNRPU SAFA U21.1 | KFIEIAARKKRNFILDQtNVsAAAQRRKMCLFAGFQRKAVV |
| Q00839 | T582 | Sugiyama | HNRNPU C1orf199 HNRPU SAFA U21.1 | CLGKFIEIAARKKRNFILDQtNVsAAAQRRKMCLFAGFQRK |
| Q01082 | S1388 | Sugiyama | SPTBN1 SPTB2 | TTQTKAQRLFDANKAELFtQsCADLDKWLHGLESQIQSDDy |
| Q01105 | S161 | Sugiyama | SET | FDENPyFENKVLSKEFHLNEsGDPssKstEIKWKSGKDLTK |
| Q01546 | S196 | Sugiyama | KRT76 KRT2B KRT2P | IGQVKAQEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWE |
| Q02818 | S378 | Sugiyama | NUCB1 NUC | EAELNAKAQRLsQETEALGRsQGRLEAQKRELQQAVLHMEQ |
| Q02878 | T213 | Sugiyama | RPL6 TXREB1 | FVIAtsTKIDISNVKIPKHLtDAyFKKKKLRKPRHQEGEIF |
| Q02878 | Y216 | Sugiyama | RPL6 TXREB1 | AtsTKIDISNVKIPKHLtDAyFKKKKLRKPRHQEGEIFDtE |
| Q06323 | S55 | Sugiyama | PSME1 IFI5111 | KKIsELDAFLKEPALNEANLsNLKAPLDIPVPDPVKEKEKE |
| Q06830 | S152 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | IIDDKGILRQItVNDLPVGRsVDEtLRLVQAFQFtDKHGEV |
| Q06830 | T156 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | KGILRQItVNDLPVGRsVDEtLRLVQAFQFtDKHGEVCPAG |
| Q07020 | S140 | Sugiyama | RPL18 | ILtFDQLALDsPKGCGtVLLsGPRKGREVYRHFGKAPGtPH |
| Q07020 | T136 | Sugiyama | RPL18 | AGGKILtFDQLALDsPKGCGtVLLsGPRKGREVYRHFGKAP |
| Q07020 | T39 | Sugiyama | RPL18 | KSQDIyLRLLVKLYRFLARRtNstFNQVVLKRLFMSRtNRP |
| Q07020 | T42 | Sugiyama | RPL18 | DIyLRLLVKLYRFLARRtNstFNQVVLKRLFMSRtNRPPLs |
| Q13243 | S153 | Sugiyama | SRSF5 HRS SFRS5 SRP40 | EVTFADAHRPKLNEGVVEFAsYGDLKNAIEKLSGKEINGRK |
| Q13283 | S362 | Sugiyama | G3BP1 G3BP | LFIGNLPHEVDKSELKDFFQsyGNVVELRINsGGKLPNFGF |
| Q13283 | S38 | Sugiyama | G3BP1 G3BP | QyytLLNQAPDMLHRFYGKNssyVHGGLDsNGKPADAVyGQ |
| Q13283 | S47 | Sugiyama | G3BP1 G3BP | PDMLHRFYGKNssyVHGGLDsNGKPADAVyGQKEIHRKVMs |
| Q13310 | T191 | Sugiyama | PABPC4 APP1 PABP4 | GRFKSRKEREAELGAKAKEFtNVyIKNFGEEVDDEsLKELF |
| Q13310 | Y194 | Sugiyama | PABPC4 APP1 PABP4 | KSRKEREAELGAKAKEFtNVyIKNFGEEVDDEsLKELFsQF |
| Q13428 | S1410 | Sugiyama | TCOF1 | AKRDKASGDVKEKKGKGsLGsQGAKDEPEEELQKGMGTVEG |
| Q13509 | S115 | Sugiyama | TUBB3 TUBB4 | SGAGNNWAKGHytEGAELVDsVLDVVRKECENCDCLQGFQL |
| Q13509 | S75 | Sugiyama | TUBB3 TUBB4 | SSHKYVPRAILVDLEPGtMDsVRSGAFGHLFRPDNFIFGQS |
| Q13561 | S391 | Sugiyama | DCTN2 DCTN50 | LTQVQTTMRENLATVEGNFAsIDERMKKLGK__________ |
| Q13601 | S284 | Sugiyama | KRR1 HRB2 | KEYtPFPPPQPESQIDKELAsGEyFLKANQKKRQKMEAIKA |
| Q13765 | S117 | Sugiyama | NACA HSD48 | RKSKNILFVITKPDVYKSPAsDtyIVFGEAKIEDLsQQAQL |
| Q13765 | S132 | Sugiyama | NACA HSD48 | YKSPAsDtyIVFGEAKIEDLsQQAQLAAAEKFKVQGEAVsN |
| Q13765 | S186 | Sugiyama | NACA HSD48 | sEEEEVDEtGVEVKDIELVMsQANVsRAKAVRALKNNSNDI |
| Q13765 | S191 | Sugiyama | NACA HSD48 | VDEtGVEVKDIELVMsQANVsRAKAVRALKNNSNDIVNAIM |
| Q13765 | T119 | Sugiyama | NACA HSD48 | SKNILFVITKPDVYKSPAsDtyIVFGEAKIEDLsQQAQLAA |
| Q13765 | Y120 | Sugiyama | NACA HSD48 | KNILFVITKPDVYKSPAsDtyIVFGEAKIEDLsQQAQLAAA |
| Q13885 | S115 | Sugiyama | TUBB2A TUBB2 | sGAGNNWAKGHytEGAELVDsVLDVVRKESESCDCLQGFQL |
| Q13885 | S75 | Sugiyama | TUBB2A TUBB2 | AGNKYVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVFGQs |
| Q14103 | S271 | Sugiyama | HNRNPD AUF1 HNRPD | KCEIKVAMSKEQyQQQQQWGsRGGFAGRARGRGGGPSQNWN |
| Q14151 | S613 | Sugiyama | SAFB2 KIAA0138 | ERSSKSQDRKSESKEKRDILsFDKIKEQRERERQRQREREI |
| Q14152 | S584 | Sugiyama | EIF3A EIF3S10 KIAA0139 | EHQRILARRQtIEERKERLEsLNIQREKEELEQREAELQKV |
| Q14157 | S859 | Sugiyama | UBAP2L KIAA0144 NICE4 | FPtPttPLtGRDGsLAsNPysGDLtKFGRGDASSPAPATTL |
| Q14157 | T23 | Sugiyama | UBAP2L KIAA0144 NICE4 | TSVGTNRARGNWEQPQNQNQtQHKQRPQATAEQIRLAQMIS |
| Q14192 | T234 | Sugiyama | FHL2 DRAL SLIM3 | CDLyAKKCAGCTNPISGLGGtKyIsFEERQWHNDCFNCKKC |
| Q14240 | S79 | Sugiyama | EIF4A2 DDX2B EIF4F | IQQRAIIPCIKGyDVIAQAQsGtGKTATFAISILQQLEIEF |
| Q14247 | S117 | Sugiyama | CTTN EMS1 | KsAVGHEyQSKLsKHCsQVDsVRGFGGKFGVQMDRVDQsAV |
| Q14444 | T303 | Sugiyama | CAPRIN1 GPIAP1 GPIP137 M11S1 RNG105 | YTEQSEVESTEYVNRQFMAEtQFtsGEKEQVDEWTVETVEV |
| Q14568 | S53 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | IINTFYSNKEIFLRELIsNssDALDKIWYESLTDPSKLDSG |
| Q14677 | S166 | Sugiyama | CLINT1 ENTH EPN4 EPNR KIAA0171 | REERKKAKKNKDKyVGVssDsVGGFRysERYDPEPKSKWDE |
| Q14847 | S99 | Sugiyama | LASP1 MLN50 | ELQsQVRYKEEFEKNKGKGFsVVADtPELQRIKKTQDQIsN |
| Q14978 | S637 | Sugiyama | NOLC1 KIAA0035 NS5ATP13 | GEKRAssPFRRVREEEIEVDsRVADNsFDAKRGAAGDWGER |
| Q14978 | S643 | Sugiyama | NOLC1 KIAA0035 NS5ATP13 | sPFRRVREEEIEVDsRVADNsFDAKRGAAGDWGERANQVLK |
| Q14CN4 | S138 | Sugiyama | KRT72 K6IRS2 KB35 KRT6 KRT6IRS2 | IQRVRAQEREQIKALNNKFAsFIDKVRFLEQQNQVLETKWN |
| Q15056 | S66 | Sugiyama | EIF4H KIAA0038 WBSCR1 WSCR1 | VGNLPFNTVQGDIDAIFKDLsIRsVRLVRDKDTDKFKGFCy |
| Q15056 | S69 | Sugiyama | EIF4H KIAA0038 WBSCR1 WSCR1 | LPFNTVQGDIDAIFKDLsIRsVRLVRDKDTDKFKGFCyVEF |
| Q15084 | S169 | Sugiyama | PDIA6 ERP5 P5 TXNDC7 | GKQGRSDsSSKKDVIELtDDsFDKNVLDSEDVWMVEFYAPW |
| Q15185 | S118 | Sugiyama | PTGES3 P23 TEBP | WLsVDFNNWKDWEDDsDEDMsNFDRFSEMMNNMGGDEDVDL |
| Q15293 | T100 | Sugiyama | RCN1 RCN | sKERLGKIVDRIDNDGDGFVttEELKtWIKRVQKRyIFDNV |
| Q32P51 | S95 | Sugiyama | HNRNPA1L2 HNRNPA1L | TPHKVDGRVVEPKRAVsREDsQRPGAHLtVKKIFVGGIKED |
| Q3SY84 | S143 | Sugiyama | KRT71 K6IRS1 KB34 KRT6IRS1 | IQKVRAQEREQIKALNNKFAsFIDKVRFLEQQNQVLETKWE |
| Q562R1 | T107 | Sugiyama | ACTBL2 | WYHTFYNELRVAPDEHPILLtEAPLNPKINREKMTQIMFEA |
| Q562R1 | T250 | Sugiyama | ACTBL2 | RAAAssSPERsyELPDGQVItIGNERFRCPEAIFQPSFLGI |
| Q562R1 | Y241 | Sugiyama | ACTBL2 | ALDFEQEMVRAAAssSPERsyELPDGQVItIGNERFRCPEA |
| Q58FF7 | S370 | Sugiyama | HSP90AB3P HSP90BC | KETQKSTYYITGESKEQVANsAFVERVRKQGFEVVYMTEPI |
| Q58FF7 | S405 | Sugiyama | HSP90AB3P HSP90BC | YMTEPIDEYCVQQLKEFDGKsLVsVtKEGLELPEDEEEKKK |
| Q58FF7 | S408 | Sugiyama | HSP90AB3P HSP90BC | EPIDEYCVQQLKEFDGKsLVsVtKEGLELPEDEEEKKKMEE |
| Q58FF8 | S305 | Sugiyama | HSP90AB2P HSP90BB | RVVYMTEPIDGYQLKEFDGKsLVsVtKEGLELPEDGEEKKR |
| Q58FF8 | S308 | Sugiyama | HSP90AB2P HSP90BB | YMTEPIDGYQLKEFDGKsLVsVtKEGLELPEDGEEKKRMEE |
| Q5QNW6 | S39 | Sugiyama | H2BC18 HIST2H2BF | VTKVQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| Q5T3I0 | S272 | Sugiyama | GPATCH4 GPATC4 | VsDEREGTTKGNEKEDAAGtsGLGELNSREQtNQSLRKGKK |
| Q5XKE5 | S155 | Sugiyama | KRT79 K6L KB38 KRT6L | IQRVRTQEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWA |
| Q6EEV6 | S28 | Sugiyama | SUMO4 SMT3H4 | EEVKTENNNHINLKVAGQDGsVVQFKIKRQTPLSKLMKAYC |
| Q6PEY2 | T73 | Sugiyama | TUBA3E | FsEtGAGKHVPRAVFVDLEPtVVDEVRtGtyRQLFHPEQLI |
| Q6PEY2 | T80 | Sugiyama | TUBA3E | KHVPRAVFVDLEPtVVDEVRtGtyRQLFHPEQLITGKEDAA |
| Q6PEY2 | T82 | Sugiyama | TUBA3E | VPRAVFVDLEPtVVDEVRtGtyRQLFHPEQLITGKEDAASN |
| Q6PEY2 | Y83 | Sugiyama | TUBA3E | PRAVFVDLEPtVVDEVRtGtyRQLFHPEQLITGKEDAASNY |
| Q6S8J3 | S1065 | Sugiyama | POTEE A26C1A POTE2 | ILASLSTFQQMWISKQEyDEsGPsIVHRKCF__________ |
| Q6S8J3 | S1068 | Sugiyama | POTEE A26C1A POTE2 | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| Q6S8J3 | T949 | Sugiyama | POTEE A26C1A POTE2 | tAAssssLEKsyELPDGQVItIGNERFRCPEALFQPCFLGM |
| Q6S8J3 | Y940 | Sugiyama | POTEE A26C1A POTE2 | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| Q6ZMR3 | S161 | Sugiyama | LDHAL6A LDHL2 | DILTYVAWKLSGFPKNRVIGsGCNLDsARFRYFIGQRLGIH |
| Q6ZMR3 | S167 | Sugiyama | LDHAL6A LDHL2 | AWKLSGFPKNRVIGsGCNLDsARFRYFIGQRLGIHSESCHG |
| Q71UM5 | S78 | Sugiyama | RPS27L | GCSTVLCQPTGGKARLtEGCsFRRKQH______________ |
| Q7KZI7 | S479 | Sugiyama | MARK2 EMK1 | PGLERKKttPtPstNSVLststNRsRNsPLLERAsLGQAsI |
| Q7RTS7 | S153 | Sugiyama | KRT74 K6IRS4 KB37 KRT5C KRT6IRS4 | IQKVRAQEREQIKVLNDKFAsFIDKVRFLEQQNQVLETKWE |
| Q7Z417 | S652 | Sugiyama | NUFIP2 KIAA1321 PIG1 | NtLLGsAKEQRYQRGLERNDsWGsFDLRAAIVYHTKEMEsI |
| Q7Z4V5 | S369 | Sugiyama | HDGFL2 HDGF2 HDGFRP2 HRP2 UNQ785/PRO1604 | EKERRRERADRGEAERGsGGssGDELREDDEPVKKRGRKGR |
| Q7Z794 | S177 | Sugiyama | KRT77 KRT1B | IQRIKTQEREQIMVLNNKFAsFIDKVRFLEQQNQVLQTKWE |
| Q86SG6 | T162 | EPSD | NEK8 JCK NEK12A | VVKIGDFGISKILSSKSKAYtVVGTPCYISPELCEGKPYNQ |
| Q86U42 | S235 | Sugiyama | PABPN1 PAB2 PABP2 | FAyIEFSDKEsVRTSLALDEsLFRGRQIKVIPKRTNRPGIS |
| Q86V81 | S145 | Sugiyama | ALYREF ALY BEF THOC4 | LFAEFGtLKKAAVHYDRsGRsLGtADVHFERKADALKAMKQ |
| Q86V81 | S8 | Sugiyama | ALYREF ALY BEF THOC4 | _____________MADKMDMsLDDIIKLNRSQRGGRGGGRG |
| Q86Y46 | S145 | Sugiyama | KRT73 K6IRS3 KB36 KRT6IRS3 | IQKVRAQEREQIKVLNNKFAsFIDKVRFLEQQNQVLETKWE |
| Q8N6H7 | S368 | Sugiyama | ARFGAP2 ZNF289 Nbla10535 | VGTFASGPPKYKDNPFsLGEsFGsRWDTDAAWGMDRVEEKE |
| Q8NBS9 | S255 | Sugiyama | TXNDC5 TLP46 UNQ364/PRO700 | EHSETVKIGKVDCtQHyELCsGNQVRGyPtLLWFRDGKKVD |
| Q8NHV4 | S377 | SIGNOR|EPSD|PSP | NEDD1 | MTSAMGKGTVAVQEKAGLPRsINTDtLSKEtDsGKNQDFss |
| Q8TAM6 | S280 | Sugiyama | ERMN KIAA1189 | TISYRKIRKGNTKQRIDEFEsMMHL________________ |
| Q8TD19 | S29 | iPTMNet|EPSD | NEK9 KIAA1995 NEK8 NERCC | RHCDsINSDFGSEsGGCGDssPGPSASQGPRAGGGAAEQEE |
| Q8TD19 | S332 | iPTMNet|EPSD | NEK9 KIAA1995 NEK8 NERCC | RREMEEKVTLLNAPTKRPRsstVtEAPIAVVTSRTSEVYVW |
| Q8TD19 | S735 | iPTMNet|EPSD | NEK9 KIAA1995 NEK8 NERCC | CRGWHTILIVEKVLNSKTIRsNssGLsIGtVFQSssPGGGG |
| Q8TD19 | S76 | Sugiyama | NEK9 KIAA1995 NEK8 NERCC | RVLGRGAFGEAtLyRRTEDDsLVVWKEVDLTRLSEKERRDA |
| Q8TD19 | S855 | Sugiyama | NEK9 KIAA1995 NEK8 NERCC | FsEsEKDTLPyEELQGLKVAsEAPLEHKPQVEAssPRLNPA |
| Q8TD19 | S868 | iPTMNet|EPSD|Sugiyama | NEK9 KIAA1995 NEK8 NERCC | LQGLKVAsEAPLEHKPQVEAssPRLNPAVtCAGKGtPLtPP |
| Q8TD19 | S869 | Sugiyama | NEK9 KIAA1995 NEK8 NERCC | QGLKVAsEAPLEHKPQVEAssPRLNPAVtCAGKGtPLtPPA |
| Q8TD19 | S944 | SIGNOR|EPSD|PSP|Sugiyama | NEK9 KIAA1995 NEK8 NERCC | FTQLQKLNKKLEGGQQVGMHsKGTQTAKEEMEMDPKPDLDS |
| Q8TD19 | T210 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | NEK9 KIAA1995 NEK8 NERCC | IKLGDYGLAKKLNSEYSMAEtLVGtPYYMSPELCQGVKYNF |
| Q8TD19 | T333 | iPTMNet|EPSD|Sugiyama | NEK9 KIAA1995 NEK8 NERCC | REMEEKVTLLNAPTKRPRsstVtEAPIAVVTSRTSEVYVWG |
| Q8TD19 | T335 | iPTMNet|EPSD | NEK9 KIAA1995 NEK8 NERCC | MEEKVTLLNAPTKRPRsstVtEAPIAVVTSRTSEVYVWGGG |
| Q8TD19 | T358 | iPTMNet|EPSD | NEK9 KIAA1995 NEK8 NERCC | PIAVVTSRTSEVYVWGGGKStPQKLDVIKSGCSARQVCAGN |
| Q8TD19 | T67 | Sugiyama | NEK9 KIAA1995 NEK8 NERCC | QEELHyIPIRVLGRGAFGEAtLyRRTEDDsLVVWKEVDLTR |
| Q8TD19 | T877 | Sugiyama | NEK9 KIAA1995 NEK8 NERCC | APLEHKPQVEAssPRLNPAVtCAGKGtPLtPPACACSSLQV |
| Q8TD19 | T886 | iPTMNet|EPSD | NEK9 KIAA1995 NEK8 NERCC | EAssPRLNPAVtCAGKGtPLtPPACACSSLQVEVERLQGLV |
| Q8TD19 | Y52 | Sugiyama | NEK9 KIAA1995 NEK8 NERCC | PSASQGPRAGGGAAEQEELHyIPIRVLGRGAFGEAtLyRRT |
| Q8TD19 | Y69 | Sugiyama | NEK9 KIAA1995 NEK8 NERCC | ELHyIPIRVLGRGAFGEAtLyRRTEDDsLVVWKEVDLTRLS |
| Q8TDX7 | S195 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | NEK7 | VKLGDLGLGRFFssKttAAHsLVGtPyYMsPERIHENGYNF |
| Q92522 | T101 | Sugiyama | H1-10 H1FX | DQQNGRTYLKYSIKALVQNDtLLQVKGTGANGSFKLNRKKL |
| Q92890 | S299 | Sugiyama | UFD1 UFD1L | KKVEEDEAGGRFVAFsGEGQsLRKKGRKP____________ |
| Q93079 | S39 | Sugiyama | H2BC9 H2BFJ HIST1H2BH | VTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| Q96HC4 | T80 | Sugiyama | PDLIM5 ENH L9 | GMTHLEAQNKIKGCTGsLNMtLQRAsAAPKPEPVPVQKGEP |
| Q99848 | S270 | Sugiyama | EBNA1BP2 EBP2 | FGGKKKGSKWNtREsyDDVssFRAKTAHGRGLKRPGKKGSN |
| Q99877 | S39 | Sugiyama | H2BC15 H2BFD HIST1H2BN | VTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| Q99879 | S39 | Sugiyama | H2BC14 H2BFE HIST1H2BM | INKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| Q99880 | S39 | Sugiyama | H2BC13 H2BFC HIST1H2BL | VTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| Q9BQ39 | S140 | Sugiyama | DDX50 | KSSDNKLEETLTREQKEGAFsNFPIsEEtIKLLKGRGVTYL |
| Q9BQ39 | S145 | Sugiyama | DDX50 | KLEETLTREQKEGAFsNFPIsEEtIKLLKGRGVTYLFPIQV |
| Q9BVA1 | S115 | Sugiyama | TUBB2B | sGAGNNWAKGHytEGAELVDsVLDVVRKESESCDCLQGFQL |
| Q9BVA1 | S75 | Sugiyama | TUBB2B | tGNKYVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVFGQs |
| Q9BX40 | S349 | Sugiyama | LSM14B C20orf40 FAM61B RAP55B | SSRRTTWAEERKLNtEtFGVsGRFLRGRSSRGGFRGGRGNG |
| Q9BX40 | T345 | Sugiyama | LSM14B C20orf40 FAM61B RAP55B | ELKTSSRRTTWAEERKLNtEtFGVsGRFLRGRSSRGGFRGG |
| Q9BYX7 | S365 | Sugiyama | POTEKP ACTBL3 FKSG30 | ILASLSTFQQMWISKQEyDEsGPsIVHRKCF__________ |
| Q9BYX7 | S368 | Sugiyama | POTEKP ACTBL3 FKSG30 | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| Q9BYX7 | T249 | Sugiyama | POTEKP ACTBL3 FKSG30 | MAASSSSVEKsyELPDGQVItIGNERFRCPEALFQPCFLGM |
| Q9BYX7 | Y240 | Sugiyama | POTEKP ACTBL3 FKSG30 | ALDSEQEMAMAASSSSVEKsyELPDGQVItIGNERFRCPEA |
| Q9BZI7 | S166 | Sugiyama | UPF3B RENT3B UPF3X | KRDTKVGtIDDDPEyRKFLEsyAtDNEKMTstPEtLLEEIE |
| Q9GZQ8 | T50 | SIGNOR|PSP | MAP1LC3B MAP1ALC3 | KIPVIIERYKGEKQLPVLDKtKFLVPDHVNMSELIKIIRRR |
| Q9H444 | T85 | Sugiyama | CHMP4B C20orf178 SHAX1 | ALQALKRKKRYEKQLAQIDGtLstIEFQREALENANtNtEV |
| Q9H444 | T88 | Sugiyama | CHMP4B C20orf178 SHAX1 | ALKRKKRYEKQLAQIDGtLstIEFQREALENANtNtEVLKN |
| Q9H788 | S159 | Sugiyama | SH2D4A PPP1R38 SH2A | NQQtKDIWKKVAEKEELEQGsRPAPTLEEEKIRSLSSSSRN |
| Q9HC98 | S206 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | NEK6 | VKLGDLGLGRFFssEttAAHsLVGtPYYMSPERIHENGYNF |
| Q9NQ39 | S157 | Sugiyama | RPS10P5 RPS10L | TYRRCSVPPGADKKAEAGAGsAtEFQFRGRCGRGRGQPPQ_ |
| Q9NQ39 | T159 | Sugiyama | RPS10P5 RPS10L | RRCSVPPGADKKAEAGAGsAtEFQFRGRCGRGRGQPPQ___ |
| Q9NR30 | S189 | Sugiyama | DDX21 | EEsNsEIEQEIPVEQKEGAFsNFPIsEEtIKLLKGRGVTFL |
| Q9NR30 | S194 | Sugiyama | DDX21 | EIEQEIPVEQKEGAFsNFPIsEEtIKLLKGRGVTFLFPIQA |
| Q9NSB2 | S178 | Sugiyama | KRT84 KRTHB4 | AQRVKKDEKEQIKTLNNKFAsFIDKVRFLEQQNKLLETKWS |
| Q9NZZ3 | S86 | Sugiyama | CHMP5 C9orf83 SNF7DC2 CGI-34 HSPC177 PNAS-114 PNAS-2 | LRVLKQKRMYEQQRDNLAQQsFNMEQANytIQsLKDTKTTV |
| Q9NZZ3 | T95 | Sugiyama | CHMP5 C9orf83 SNF7DC2 CGI-34 HSPC177 PNAS-114 PNAS-2 | YEQQRDNLAQQsFNMEQANytIQsLKDTKTTVDAMKLGVKE |
| Q9NZZ3 | Y94 | Sugiyama | CHMP5 C9orf83 SNF7DC2 CGI-34 HSPC177 PNAS-114 PNAS-2 | MYEQQRDNLAQQsFNMEQANytIQsLKDTKTTVDAMKLGVK |
| Q9UI15 | S185 | Sugiyama | TAGLN3 NP25 | EQLRQGQNVIGLQMGSNKGAsQAGMtGyGMPRQIM______ |
| Q9UI15 | T190 | Sugiyama | TAGLN3 NP25 | GQNVIGLQMGSNKGAsQAGMtGyGMPRQIM___________ |
| Q9UI15 | Y192 | Sugiyama | TAGLN3 NP25 | NVIGLQMGSNKGAsQAGMtGyGMPRQIM_____________ |
| Q9UII2 | S39 | Sugiyama | ATP5IF1 ATPI ATPIF1 | TMQARGFGsDQSENVDRGAGsIREAGGAFGKREQAEEERyF |
| Q9UKX7 | S52 | Sugiyama | NUP50 NPAP60L PRO1146 | EEVLKNRAIKKAKRRNVGFEsDtGGAFKGFKGLVVPSGGGR |
| Q9UPQ9 | S1086 | Sugiyama | TNRC6B KIAA1093 | FSNMGLLSQTEDNPSSKMDLsVGSLSDKKFDVDKRAMNLGD |
| Q9UQ35 | S1653 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | PRRSRSGSSSKGRGPsPEGssstEssPEHPPKSRTARRGsR |
| Q9UQ35 | S2459 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | LLPPAQDQPRsPVPsAFsDQsRCLIAQTTPVAGSQSLSSGA |
| Q9UQ35 | S2692 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | ERRSRSPRKPIDsLRDsRsLsysPVERRRPsPQPsPRDQQS |
| Q9Y2B0 | S115 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | QIDPstHRKNYVRVVGRNGEssELDLQGIRIDsDISGtLKF |
| Q9Y2B0 | S55 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | VDELEWEIAQVDPKKTIQMGsFRINPDGsQsVVEVPyARsE |
| Q9Y2B0 | S63 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | AQVDPKKTIQMGsFRINPDGsQsVVEVPyARsEAHLtELLE |
| Q9Y2B0 | S65 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | VDPKKTIQMGsFRINPDGsQsVVEVPyARsEAHLtELLEEI |
| Q9Y2W1 | T227 | Sugiyama | THRAP3 BCLAF2 TRAP150 | sGGtsQDTKAsEssKPWPDAtyGtGsAsRAsAVsELsPRER |
| Q9Y2W1 | T230 | Sugiyama | THRAP3 BCLAF2 TRAP150 | tsQDTKAsEssKPWPDAtyGtGsAsRAsAVsELsPRERsPA |
| Q9Y3U8 | S91 | Sugiyama | RPL36 | KFIKKRVGTHIRAKRKREELsNVLAAMRKAAAKKD______ |
| Q9Y3U8 | Y53 | Sugiyama | RPL36 | LTKHTKFVRDMIREVCGFAPyERRAMELLKVSKDKRALKFI |
| Q9Y5L4 | S57 | Sugiyama | TIMM13 TIM13B TIMM13A TIMM13B | ELLQRMTDKCFRKCIGKPGGsLDNSEQKCIAMCMDRyMDAW |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Cell Cycle | R-HSA-1640170 | 9.534484e-11 | 10.021 | 1 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 9.846102e-11 | 10.007 | 1 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 5.682269e-10 | 9.245 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 1.488732e-09 | 8.827 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 6.428402e-09 | 8.192 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 8.660099e-09 | 8.062 | 1 | 1 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 1.177490e-08 | 7.929 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 1.862810e-08 | 7.730 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 4.035060e-08 | 7.394 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 7.691514e-08 | 7.114 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 1.218367e-07 | 6.914 | 0 | 0 |
| M Phase | R-HSA-68886 | 1.218208e-07 | 6.914 | 1 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 1.688891e-07 | 6.772 | 1 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 1.746770e-07 | 6.758 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 2.485003e-07 | 6.605 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 2.901967e-07 | 6.537 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 2.809702e-07 | 6.551 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 3.396289e-07 | 6.469 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 4.070341e-07 | 6.390 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 5.282307e-07 | 6.277 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 6.975832e-07 | 6.156 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 6.782215e-07 | 6.169 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 1.235395e-06 | 5.908 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 1.340759e-06 | 5.873 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 1.347442e-06 | 5.870 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 1.966063e-06 | 5.706 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 2.214147e-06 | 5.655 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 2.346265e-06 | 5.630 | 0 | 0 |
| Kinesins | R-HSA-983189 | 5.856841e-06 | 5.232 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 8.787213e-06 | 5.056 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 9.128249e-06 | 5.040 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 9.415360e-06 | 5.026 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 9.961177e-06 | 5.002 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 1.075912e-05 | 4.968 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 1.067805e-05 | 4.972 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 1.287166e-05 | 4.890 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 1.522375e-05 | 4.817 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 1.592005e-05 | 4.798 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 1.911146e-05 | 4.719 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 2.159559e-05 | 4.666 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 2.238164e-05 | 4.650 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 2.321601e-05 | 4.634 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 2.542489e-05 | 4.595 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 3.126052e-05 | 4.505 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 3.863687e-05 | 4.413 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 4.372658e-05 | 4.359 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 5.292430e-05 | 4.276 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 5.715747e-05 | 4.243 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 6.503919e-05 | 4.187 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 6.476425e-05 | 4.189 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 6.476425e-05 | 4.189 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 6.931159e-05 | 4.159 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 8.075672e-05 | 4.093 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 8.211478e-05 | 4.086 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 9.835155e-05 | 4.007 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 9.963189e-05 | 4.002 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 1.003937e-04 | 3.998 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 1.013943e-04 | 3.994 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 1.119602e-04 | 3.951 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 1.389177e-04 | 3.857 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 1.389177e-04 | 3.857 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 1.389177e-04 | 3.857 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 1.310901e-04 | 3.882 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 1.389177e-04 | 3.857 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 1.310901e-04 | 3.882 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 1.504454e-04 | 3.823 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 1.640094e-04 | 3.785 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 2.422854e-04 | 3.616 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 2.560348e-04 | 3.592 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 2.658542e-04 | 3.575 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 2.887961e-04 | 3.539 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 2.933322e-04 | 3.533 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 3.117807e-04 | 3.506 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 3.234334e-04 | 3.490 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 3.448293e-04 | 3.462 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 3.588421e-04 | 3.445 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 4.008082e-04 | 3.397 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 4.039792e-04 | 3.394 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 4.178553e-04 | 3.379 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 4.324062e-04 | 3.364 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 5.277450e-04 | 3.278 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 5.030571e-04 | 3.298 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 5.535839e-04 | 3.257 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 5.862120e-04 | 3.232 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 6.142663e-04 | 3.212 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 8.170959e-04 | 3.088 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 8.189494e-04 | 3.087 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 8.231694e-04 | 3.085 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 9.653003e-04 | 3.015 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 1.023040e-03 | 2.990 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 1.048165e-03 | 2.980 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 1.077242e-03 | 2.968 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 1.079417e-03 | 2.967 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 1.097631e-03 | 2.960 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 1.127630e-03 | 2.948 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 1.211008e-03 | 2.917 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 1.178514e-03 | 2.929 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 1.271348e-03 | 2.896 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 1.296953e-03 | 2.887 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 1.342348e-03 | 2.872 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 1.587313e-03 | 2.799 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 1.495856e-03 | 2.825 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 1.609538e-03 | 2.793 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 1.625575e-03 | 2.789 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 1.637760e-03 | 2.786 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 1.700716e-03 | 2.769 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 1.986068e-03 | 2.702 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 2.059121e-03 | 2.686 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 2.329612e-03 | 2.633 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 2.522125e-03 | 2.598 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 2.542899e-03 | 2.595 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 2.552521e-03 | 2.593 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 2.572130e-03 | 2.590 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 2.611668e-03 | 2.583 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 2.636338e-03 | 2.579 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 2.861452e-03 | 2.543 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 2.902369e-03 | 2.537 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 3.006423e-03 | 2.522 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 3.038767e-03 | 2.517 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 3.218098e-03 | 2.492 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 3.293079e-03 | 2.482 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 3.764680e-03 | 2.424 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 3.764680e-03 | 2.424 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 3.922745e-03 | 2.406 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 3.860934e-03 | 2.413 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 3.727652e-03 | 2.429 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 4.142082e-03 | 2.383 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 4.144008e-03 | 2.383 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 4.178612e-03 | 2.379 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 4.610585e-03 | 2.336 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 4.610585e-03 | 2.336 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 4.610585e-03 | 2.336 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 4.610585e-03 | 2.336 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 4.610585e-03 | 2.336 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 4.610585e-03 | 2.336 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 4.610585e-03 | 2.336 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 4.610585e-03 | 2.336 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 4.610585e-03 | 2.336 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 4.610585e-03 | 2.336 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 4.610585e-03 | 2.336 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 4.556332e-03 | 2.341 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 4.351759e-03 | 2.361 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 4.977197e-03 | 2.303 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 5.564629e-03 | 2.255 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 5.617413e-03 | 2.250 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 6.197410e-03 | 2.208 | 1 | 0 |
| Integrin signaling | R-HSA-354192 | 6.234607e-03 | 2.205 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in invasion | R-HSA-9854909 | 6.499845e-03 | 2.187 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 6.805406e-03 | 2.167 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 6.805406e-03 | 2.167 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 6.685330e-03 | 2.175 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 6.303405e-03 | 2.200 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 6.826203e-03 | 2.166 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 6.847606e-03 | 2.164 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 7.151714e-03 | 2.146 | 0 | 0 |
| Protein folding | R-HSA-391251 | 7.206072e-03 | 2.142 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 7.970981e-03 | 2.098 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 7.970981e-03 | 2.098 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 8.578773e-03 | 2.067 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 9.578806e-03 | 2.019 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 9.635386e-03 | 2.016 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 9.883340e-03 | 2.005 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 1.110281e-02 | 1.955 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 1.110281e-02 | 1.955 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 1.052754e-02 | 1.978 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 1.052754e-02 | 1.978 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 1.094754e-02 | 1.961 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 1.136073e-02 | 1.945 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 1.148419e-02 | 1.940 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 1.177575e-02 | 1.929 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 1.210942e-02 | 1.917 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 1.284350e-02 | 1.891 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 1.316221e-02 | 1.881 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 1.316221e-02 | 1.881 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 1.467418e-02 | 1.833 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 1.443801e-02 | 1.840 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 1.418602e-02 | 1.848 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 1.361069e-02 | 1.866 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 1.467418e-02 | 1.833 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 1.447561e-02 | 1.839 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 1.361104e-02 | 1.866 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 1.328462e-02 | 1.877 | 1 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 1.345105e-02 | 1.871 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 1.339343e-02 | 1.873 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 1.339343e-02 | 1.873 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 1.490075e-02 | 1.827 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 1.524043e-02 | 1.817 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 1.538615e-02 | 1.813 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 1.550277e-02 | 1.810 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 1.555000e-02 | 1.808 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 1.555000e-02 | 1.808 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 1.585999e-02 | 1.800 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 1.809145e-02 | 1.743 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 1.809145e-02 | 1.743 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 1.809145e-02 | 1.743 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 1.754082e-02 | 1.756 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 1.802615e-02 | 1.744 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 1.802615e-02 | 1.744 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 1.802615e-02 | 1.744 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 1.802615e-02 | 1.744 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 1.802615e-02 | 1.744 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 1.802615e-02 | 1.744 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 1.808691e-02 | 1.743 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 1.658066e-02 | 1.780 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 1.814473e-02 | 1.741 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 1.772954e-02 | 1.751 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 1.802615e-02 | 1.744 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 1.808691e-02 | 1.743 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 1.685552e-02 | 1.773 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 1.924557e-02 | 1.716 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 1.926092e-02 | 1.715 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 2.063051e-02 | 1.685 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 2.185112e-02 | 1.661 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 2.190652e-02 | 1.659 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 2.190652e-02 | 1.659 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 2.190652e-02 | 1.659 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 2.217059e-02 | 1.654 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 2.292891e-02 | 1.640 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 2.319586e-02 | 1.635 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 2.380786e-02 | 1.623 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 2.429331e-02 | 1.615 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 2.460191e-02 | 1.609 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 2.592678e-02 | 1.586 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 2.606055e-02 | 1.584 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 2.606055e-02 | 1.584 | 0 | 0 |
| Diseases of Cellular Senescence | R-HSA-9630747 | 2.910350e-02 | 1.536 | 0 | 0 |
| Diseases of cellular response to stress | R-HSA-9675132 | 2.910350e-02 | 1.536 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 2.910350e-02 | 1.536 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 2.988955e-02 | 1.524 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 2.988955e-02 | 1.524 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 2.988955e-02 | 1.524 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 2.988955e-02 | 1.524 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 2.914991e-02 | 1.535 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 2.954459e-02 | 1.530 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 2.697237e-02 | 1.569 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 2.890835e-02 | 1.539 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 2.821134e-02 | 1.550 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 2.954459e-02 | 1.530 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 2.821134e-02 | 1.550 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 2.847777e-02 | 1.545 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 3.066523e-02 | 1.513 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 3.070800e-02 | 1.513 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 3.094915e-02 | 1.509 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 3.094915e-02 | 1.509 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 3.245261e-02 | 1.489 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 3.293953e-02 | 1.482 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 3.335753e-02 | 1.477 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 3.570935e-02 | 1.447 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 3.570935e-02 | 1.447 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 3.605978e-02 | 1.443 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 3.684618e-02 | 1.434 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 3.684618e-02 | 1.434 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 3.718509e-02 | 1.430 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 3.718509e-02 | 1.430 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 3.718972e-02 | 1.430 | 0 | 0 |
| Formation of editosomes by ADAR proteins | R-HSA-77042 | 4.346866e-02 | 1.362 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 4.346866e-02 | 1.362 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 4.346866e-02 | 1.362 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 4.346866e-02 | 1.362 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 4.346866e-02 | 1.362 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 4.346866e-02 | 1.362 | 0 | 0 |
| Loss of MECP2 binding ability to 5hmC-DNA | R-HSA-9022534 | 4.346866e-02 | 1.362 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 4.346866e-02 | 1.362 | 0 | 0 |
| Defective Mismatch Repair Associated With PMS2 | R-HSA-5632987 | 4.346866e-02 | 1.362 | 0 | 0 |
| Defective Mismatch Repair Associated With MLH1 | R-HSA-5545483 | 4.346866e-02 | 1.362 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 3.957213e-02 | 1.403 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 3.987695e-02 | 1.399 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 3.987695e-02 | 1.399 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 3.987695e-02 | 1.399 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 3.887910e-02 | 1.410 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 4.193312e-02 | 1.377 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 4.204011e-02 | 1.376 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 4.204011e-02 | 1.376 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 4.204011e-02 | 1.376 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 4.065898e-02 | 1.391 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 4.229883e-02 | 1.374 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 3.887910e-02 | 1.410 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 3.887910e-02 | 1.410 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 4.223296e-02 | 1.374 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 4.193312e-02 | 1.377 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 3.957213e-02 | 1.403 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 4.358760e-02 | 1.361 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 4.446691e-02 | 1.352 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 4.446691e-02 | 1.352 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 4.457905e-02 | 1.351 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 4.488140e-02 | 1.348 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 4.488140e-02 | 1.348 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 4.570654e-02 | 1.340 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 4.618589e-02 | 1.335 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 4.667506e-02 | 1.331 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 4.763224e-02 | 1.322 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 4.843573e-02 | 1.315 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 4.867812e-02 | 1.313 | 1 | 1 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 4.957316e-02 | 1.305 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 4.987581e-02 | 1.302 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 4.987581e-02 | 1.302 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 5.001358e-02 | 1.301 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 5.001358e-02 | 1.301 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 5.001358e-02 | 1.301 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 5.001358e-02 | 1.301 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 5.001358e-02 | 1.301 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 5.050316e-02 | 1.297 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 5.050316e-02 | 1.297 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 5.052414e-02 | 1.297 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 5.052414e-02 | 1.297 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 5.055725e-02 | 1.296 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 5.063111e-02 | 1.296 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 5.104011e-02 | 1.292 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 5.104011e-02 | 1.292 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 5.104011e-02 | 1.292 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 5.104011e-02 | 1.292 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 5.183439e-02 | 1.285 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 6.289577e-02 | 1.201 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 5.809070e-02 | 1.236 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 6.149457e-02 | 1.211 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 6.149457e-02 | 1.211 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 5.635971e-02 | 1.249 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 5.410054e-02 | 1.267 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 6.125139e-02 | 1.213 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 5.320944e-02 | 1.274 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 6.133054e-02 | 1.212 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 6.152607e-02 | 1.211 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 6.200232e-02 | 1.208 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 6.149457e-02 | 1.211 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 6.216953e-02 | 1.206 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 6.133054e-02 | 1.212 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 5.623412e-02 | 1.250 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 6.434292e-02 | 1.191 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 6.560941e-02 | 1.183 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 6.560941e-02 | 1.183 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 6.586301e-02 | 1.181 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 6.751061e-02 | 1.171 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 6.751061e-02 | 1.171 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 6.765187e-02 | 1.170 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 6.840514e-02 | 1.165 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 6.863955e-02 | 1.163 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 7.058189e-02 | 1.151 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 7.058189e-02 | 1.151 | 0 | 0 |
| Defective Base Excision Repair Associated with OGG1 | R-HSA-9656249 | 8.800375e-02 | 1.055 | 0 | 0 |
| Transport of glycerol from adipocytes to the liver by Aquaporins | R-HSA-432030 | 8.800375e-02 | 1.055 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to p16INK4A Defects | R-HSA-9630750 | 8.800375e-02 | 1.055 | 0 | 0 |
| TGFBR3 regulates FGF2 signaling | R-HSA-9839397 | 8.800375e-02 | 1.055 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 8.800375e-02 | 1.055 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to p16INK4A Defects | R-HSA-9632693 | 8.800375e-02 | 1.055 | 0 | 0 |
| IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR) | R-HSA-5603027 | 8.800375e-02 | 1.055 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | R-HSA-9632700 | 8.800375e-02 | 1.055 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | R-HSA-9630794 | 8.800375e-02 | 1.055 | 0 | 0 |
| IKBKB deficiency causes SCID | R-HSA-5602636 | 8.800375e-02 | 1.055 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 7.762499e-02 | 1.110 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 7.762499e-02 | 1.110 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 7.762499e-02 | 1.110 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 7.762499e-02 | 1.110 | 0 | 0 |
| Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling | R-HSA-2644607 | 7.762499e-02 | 1.110 | 0 | 0 |
| Defective LFNG causes SCDO3 | R-HSA-5083630 | 7.762499e-02 | 1.110 | 0 | 0 |
| Signaling by MAP2K mutants | R-HSA-9652169 | 7.762499e-02 | 1.110 | 0 | 0 |
| FBXW7 Mutants and NOTCH1 in Cancer | R-HSA-2644605 | 7.762499e-02 | 1.110 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 8.472640e-02 | 1.072 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 8.472640e-02 | 1.072 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 8.361420e-02 | 1.078 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 7.949319e-02 | 1.100 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 8.868847e-02 | 1.052 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 8.114992e-02 | 1.091 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 7.784995e-02 | 1.109 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 7.784995e-02 | 1.109 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 7.784995e-02 | 1.109 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 8.911762e-02 | 1.050 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 8.911762e-02 | 1.050 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 8.224963e-02 | 1.085 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 8.391873e-02 | 1.076 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 8.408481e-02 | 1.075 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 8.408481e-02 | 1.075 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 8.351565e-02 | 1.078 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 8.351565e-02 | 1.078 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 8.289877e-02 | 1.081 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 8.211891e-02 | 1.086 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 8.211891e-02 | 1.086 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 8.614016e-02 | 1.065 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 7.585804e-02 | 1.120 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 8.711118e-02 | 1.060 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 7.406594e-02 | 1.130 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 7.406594e-02 | 1.130 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 8.589948e-02 | 1.066 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 8.531002e-02 | 1.069 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 7.277063e-02 | 1.138 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 8.048534e-02 | 1.094 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 8.911762e-02 | 1.050 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 8.361420e-02 | 1.078 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 8.048534e-02 | 1.094 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 8.224963e-02 | 1.085 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 8.211891e-02 | 1.086 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 8.868847e-02 | 1.052 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 8.800375e-02 | 1.055 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 8.575311e-02 | 1.067 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 7.342054e-02 | 1.134 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 7.427159e-02 | 1.129 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 8.114992e-02 | 1.091 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 7.426703e-02 | 1.129 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 7.762499e-02 | 1.110 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 8.224963e-02 | 1.085 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 7.949319e-02 | 1.100 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 7.784995e-02 | 1.109 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 9.121250e-02 | 1.040 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 9.243074e-02 | 1.034 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 9.243074e-02 | 1.034 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 9.246831e-02 | 1.034 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 9.246831e-02 | 1.034 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 9.246831e-02 | 1.034 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 9.310748e-02 | 1.031 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 9.646793e-02 | 1.016 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 9.646793e-02 | 1.016 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 9.646793e-02 | 1.016 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 9.752841e-02 | 1.011 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 9.879525e-02 | 1.005 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 9.879525e-02 | 1.005 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 9.896766e-02 | 1.005 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 1.013142e-01 | 0.994 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 1.014583e-01 | 0.994 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 1.014583e-01 | 0.994 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 1.014583e-01 | 0.994 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 1.014583e-01 | 0.994 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 1.014583e-01 | 0.994 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 1.022359e-01 | 0.990 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 1.027646e-01 | 0.988 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 1.027646e-01 | 0.988 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 1.027646e-01 | 0.988 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 1.027646e-01 | 0.988 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 1.030222e-01 | 0.987 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 1.034284e-01 | 0.985 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 1.039483e-01 | 0.983 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 1.039483e-01 | 0.983 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 1.045758e-01 | 0.981 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 1.045758e-01 | 0.981 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 1.045758e-01 | 0.981 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 1.047591e-01 | 0.980 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 1.051839e-01 | 0.978 | 0 | 0 |
| NFE2L2 regulating TCA cycle genes | R-HSA-9818025 | 1.097713e-01 | 0.960 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 1.097713e-01 | 0.960 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 1.097713e-01 | 0.960 | 0 | 0 |
| IRS activation | R-HSA-74713 | 1.097713e-01 | 0.960 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 1.097713e-01 | 0.960 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 1.097386e-01 | 0.960 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 1.376246e-01 | 0.861 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 1.264798e-01 | 0.898 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 1.264798e-01 | 0.898 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 1.264798e-01 | 0.898 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 1.264798e-01 | 0.898 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 1.264798e-01 | 0.898 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 1.152108e-01 | 0.939 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 1.356355e-01 | 0.868 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 1.356355e-01 | 0.868 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 1.356355e-01 | 0.868 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 1.356355e-01 | 0.868 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 1.356355e-01 | 0.868 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 1.356355e-01 | 0.868 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 1.218887e-01 | 0.914 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 1.218887e-01 | 0.914 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 1.218887e-01 | 0.914 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 1.218887e-01 | 0.914 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 1.218887e-01 | 0.914 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 1.144319e-01 | 0.941 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 1.144319e-01 | 0.941 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 1.248073e-01 | 0.904 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 1.341782e-01 | 0.872 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 1.168688e-01 | 0.932 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 1.124125e-01 | 0.949 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 1.057720e-01 | 0.976 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 1.168688e-01 | 0.932 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 1.144319e-01 | 0.941 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 1.302850e-01 | 0.885 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 1.058778e-01 | 0.975 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 1.365510e-01 | 0.865 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 1.230342e-01 | 0.910 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 1.097386e-01 | 0.960 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 1.136660e-01 | 0.944 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 1.151361e-01 | 0.939 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 1.238690e-01 | 0.907 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 1.097386e-01 | 0.960 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 1.300024e-01 | 0.886 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 1.205608e-01 | 0.919 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 1.058778e-01 | 0.975 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 1.400686e-01 | 0.854 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 1.275536e-01 | 0.894 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 1.275536e-01 | 0.894 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 1.277196e-01 | 0.894 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 1.376246e-01 | 0.861 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 1.218887e-01 | 0.914 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 1.257296e-01 | 0.901 | 0 | 0 |
| Co-inhibition by BTLA | R-HSA-9927353 | 1.097713e-01 | 0.960 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 1.387494e-01 | 0.858 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 1.341782e-01 | 0.872 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 1.124484e-01 | 0.949 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 1.226724e-01 | 0.911 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 1.210895e-01 | 0.917 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 1.275536e-01 | 0.894 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 1.146583e-01 | 0.941 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 1.144319e-01 | 0.941 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 1.284549e-01 | 0.891 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 1.402725e-01 | 0.853 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 1.144319e-01 | 0.941 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 1.283154e-01 | 0.892 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 1.235282e-01 | 0.908 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 1.406963e-01 | 0.852 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 1.409324e-01 | 0.851 | 0 | 0 |
| mRNA Editing: A to I Conversion | R-HSA-75064 | 1.409967e-01 | 0.851 | 0 | 0 |
| Regulation of TP53 Expression | R-HSA-6804754 | 1.409967e-01 | 0.851 | 0 | 0 |
| C6 deamination of adenosine | R-HSA-75102 | 1.409967e-01 | 0.851 | 0 | 0 |
| RUNX3 regulates RUNX1-mediated transcription | R-HSA-8951911 | 1.409967e-01 | 0.851 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 1.429468e-01 | 0.845 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 1.429468e-01 | 0.845 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 1.432781e-01 | 0.844 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 1.433592e-01 | 0.844 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 1.433592e-01 | 0.844 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 1.435676e-01 | 0.843 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 1.436948e-01 | 0.843 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 1.436948e-01 | 0.843 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 1.450162e-01 | 0.839 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 1.460935e-01 | 0.835 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 1.460935e-01 | 0.835 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 1.460935e-01 | 0.835 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 1.460935e-01 | 0.835 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 1.460935e-01 | 0.835 | 0 | 0 |
| SLC15A4:TASL-dependent IRF5 activation | R-HSA-9860276 | 1.460935e-01 | 0.835 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 1.460935e-01 | 0.835 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 1.462286e-01 | 0.835 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 1.479818e-01 | 0.830 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 1.495586e-01 | 0.825 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 1.510334e-01 | 0.821 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 1.510334e-01 | 0.821 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 1.510334e-01 | 0.821 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 1.510334e-01 | 0.821 | 0 | 0 |
| Drug resistance of KIT mutants | R-HSA-9669937 | 1.514788e-01 | 0.820 | 0 | 0 |
| KIT mutants bind TKIs | R-HSA-9669921 | 1.514788e-01 | 0.820 | 0 | 0 |
| Loss of Function of TP53 in Cancer | R-HSA-9723907 | 1.514788e-01 | 0.820 | 0 | 0 |
| Loss of function of TP53 in cancer due to loss of tetramerization ability | R-HSA-9723905 | 1.514788e-01 | 0.820 | 0 | 0 |
| Nilotinib-resistant KIT mutants | R-HSA-9669926 | 1.514788e-01 | 0.820 | 0 | 0 |
| Dasatinib-resistant KIT mutants | R-HSA-9669914 | 1.514788e-01 | 0.820 | 0 | 0 |
| Imatinib-resistant KIT mutants | R-HSA-9669917 | 1.514788e-01 | 0.820 | 0 | 0 |
| Regorafenib-resistant KIT mutants | R-HSA-9669929 | 1.514788e-01 | 0.820 | 0 | 0 |
| Defective OGG1 Substrate Binding | R-HSA-9656255 | 1.514788e-01 | 0.820 | 0 | 0 |
| Sorafenib-resistant KIT mutants | R-HSA-9669936 | 1.514788e-01 | 0.820 | 0 | 0 |
| Sunitinib-resistant KIT mutants | R-HSA-9669934 | 1.514788e-01 | 0.820 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to p14ARF Defects | R-HSA-9646304 | 1.514788e-01 | 0.820 | 0 | 0 |
| Defective OGG1 Localization | R-HSA-9657050 | 1.514788e-01 | 0.820 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to p14ARF Defects | R-HSA-9646303 | 1.514788e-01 | 0.820 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 1.514788e-01 | 0.820 | 0 | 0 |
| Masitinib-resistant KIT mutants | R-HSA-9669924 | 1.514788e-01 | 0.820 | 0 | 0 |
| Deletions in the AXIN1 gene destabilize the destruction complex | R-HSA-5467345 | 1.514788e-01 | 0.820 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 1.538743e-01 | 0.813 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 1.545357e-01 | 0.811 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 1.545357e-01 | 0.811 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 1.566087e-01 | 0.805 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 1.570186e-01 | 0.804 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 1.574780e-01 | 0.803 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 1.574780e-01 | 0.803 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 1.576293e-01 | 0.802 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 1.576293e-01 | 0.802 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 1.581025e-01 | 0.801 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 1.581025e-01 | 0.801 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 1.581058e-01 | 0.801 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 1.581149e-01 | 0.801 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 1.581149e-01 | 0.801 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 1.608498e-01 | 0.794 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 1.610627e-01 | 0.793 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 1.612603e-01 | 0.792 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 1.612603e-01 | 0.792 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 1.612603e-01 | 0.792 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 1.622653e-01 | 0.790 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 1.680152e-01 | 0.775 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 1.680152e-01 | 0.775 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 1.680152e-01 | 0.775 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 1.680152e-01 | 0.775 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 1.680152e-01 | 0.775 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 1.680152e-01 | 0.775 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 1.690483e-01 | 0.772 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 1.690483e-01 | 0.772 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 1.708564e-01 | 0.767 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 1.988651e-01 | 0.701 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 1.988651e-01 | 0.701 | 0 | 0 |
| IRAK4 deficiency (TLR5) | R-HSA-5603037 | 1.988651e-01 | 0.701 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 1.988651e-01 | 0.701 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 1.856887e-01 | 0.731 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 1.856887e-01 | 0.731 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 1.856887e-01 | 0.731 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 2.276650e-01 | 0.643 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 2.276650e-01 | 0.643 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 2.276650e-01 | 0.643 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 2.276650e-01 | 0.643 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 2.276650e-01 | 0.643 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 2.276650e-01 | 0.643 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 2.276650e-01 | 0.643 | 0 | 0 |
| Pre-NOTCH Processing in the Endoplasmic Reticulum | R-HSA-1912399 | 2.276650e-01 | 0.643 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 2.005039e-01 | 0.698 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 1.773997e-01 | 0.751 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 1.773997e-01 | 0.751 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 2.346670e-01 | 0.630 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 2.346670e-01 | 0.630 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 2.053447e-01 | 0.688 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 2.053447e-01 | 0.688 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 1.810578e-01 | 0.742 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 1.810578e-01 | 0.742 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 2.057689e-01 | 0.687 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 2.346180e-01 | 0.630 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 1.806030e-01 | 0.743 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 1.806030e-01 | 0.743 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 1.784649e-01 | 0.748 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 2.008974e-01 | 0.697 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 1.756790e-01 | 0.755 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 1.756790e-01 | 0.755 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 2.583702e-01 | 0.588 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 2.220578e-01 | 0.654 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 2.220578e-01 | 0.654 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 2.512451e-01 | 0.600 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 2.110589e-01 | 0.676 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 2.297666e-01 | 0.639 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 2.490741e-01 | 0.604 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 1.921467e-01 | 0.716 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 2.187947e-01 | 0.660 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 2.342554e-01 | 0.630 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 2.368282e-01 | 0.626 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 1.755093e-01 | 0.756 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 2.231917e-01 | 0.651 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 2.572132e-01 | 0.590 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 2.368009e-01 | 0.626 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 1.752658e-01 | 0.756 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 1.810578e-01 | 0.742 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 2.346670e-01 | 0.630 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 2.490741e-01 | 0.604 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 1.806030e-01 | 0.743 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 1.752658e-01 | 0.756 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 1.810578e-01 | 0.742 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 2.220578e-01 | 0.654 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 1.973776e-01 | 0.705 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 1.741745e-01 | 0.759 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 1.741745e-01 | 0.759 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 1.741745e-01 | 0.759 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 2.490741e-01 | 0.604 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 2.110589e-01 | 0.676 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 2.276650e-01 | 0.643 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 2.187947e-01 | 0.660 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 1.791021e-01 | 0.747 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 1.971511e-01 | 0.705 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 2.090047e-01 | 0.680 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 1.936410e-01 | 0.713 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 1.936410e-01 | 0.713 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 1.936410e-01 | 0.713 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 2.572132e-01 | 0.590 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 2.485284e-01 | 0.605 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 1.810578e-01 | 0.742 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 1.752658e-01 | 0.756 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 1.842060e-01 | 0.735 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 2.010425e-01 | 0.697 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 2.516064e-01 | 0.599 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 2.501408e-01 | 0.602 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 1.784649e-01 | 0.748 | 0 | 0 |
| Depurination | R-HSA-73927 | 2.110589e-01 | 0.676 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 2.485284e-01 | 0.605 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 2.155283e-01 | 0.666 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 2.229343e-01 | 0.652 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 2.490741e-01 | 0.604 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 2.490741e-01 | 0.604 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 2.576173e-01 | 0.589 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 2.211354e-01 | 0.655 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 1.932554e-01 | 0.714 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 2.005039e-01 | 0.698 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 2.053447e-01 | 0.688 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 2.070464e-01 | 0.684 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 2.271720e-01 | 0.644 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 2.271720e-01 | 0.644 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 2.027504e-01 | 0.693 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 1.971511e-01 | 0.705 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 2.576173e-01 | 0.589 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 2.439916e-01 | 0.613 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 2.039477e-01 | 0.690 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 2.583702e-01 | 0.588 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 1.930111e-01 | 0.714 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 1.996045e-01 | 0.700 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 2.053447e-01 | 0.688 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 2.127046e-01 | 0.672 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 2.238862e-01 | 0.650 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 2.583702e-01 | 0.588 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 2.039477e-01 | 0.690 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 2.297666e-01 | 0.639 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 2.490741e-01 | 0.604 | 0 | 0 |
| MECP2 regulates transcription of genes involved in GABA signaling | R-HSA-9022927 | 2.589173e-01 | 0.587 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 2.589173e-01 | 0.587 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 2.589173e-01 | 0.587 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 2.589173e-01 | 0.587 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 2.589173e-01 | 0.587 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 2.589173e-01 | 0.587 | 0 | 0 |
| Dopamine receptors | R-HSA-390651 | 2.589173e-01 | 0.587 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 2.589173e-01 | 0.587 | 0 | 0 |
| SARS-CoV-1-mediated effects on programmed cell death | R-HSA-9692913 | 2.589173e-01 | 0.587 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 2.590030e-01 | 0.587 | 0 | 0 |
| Defective OGG1 Substrate Processing | R-HSA-9656256 | 2.800191e-01 | 0.553 | 0 | 0 |
| TGFBR2 MSI Frameshift Mutants in Cancer | R-HSA-3642279 | 2.800191e-01 | 0.553 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 | R-HSA-9630791 | 2.800191e-01 | 0.553 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 2.800191e-01 | 0.553 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH6 | R-HSA-5632968 | 2.800191e-01 | 0.553 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 | R-HSA-9632697 | 2.800191e-01 | 0.553 | 0 | 0 |
| Impaired BRCA2 binding to SEM1 (DSS1) | R-HSA-9763198 | 2.800191e-01 | 0.553 | 0 | 0 |
| Defective F8 binding to von Willebrand factor | R-HSA-9672393 | 2.800191e-01 | 0.553 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 2.800191e-01 | 0.553 | 0 | 0 |
| Impaired BRCA2 translocation to the nucleus | R-HSA-9709275 | 2.800191e-01 | 0.553 | 0 | 0 |
| SARS-CoV-1 targets PDZ proteins in cell-cell junction | R-HSA-9692912 | 2.800191e-01 | 0.553 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis Due to p14ARF Loss of Function | R-HSA-9645722 | 2.800191e-01 | 0.553 | 0 | 0 |
| Nef mediated downregulation of CD28 cell surface expression | R-HSA-164939 | 3.890934e-01 | 0.410 | 0 | 0 |
| Signaling by juxtamembrane domain KIT mutants | R-HSA-9669935 | 3.890934e-01 | 0.410 | 0 | 0 |
| NFG and proNGF binds to p75NTR | R-HSA-205017 | 3.890934e-01 | 0.410 | 0 | 0 |
| Signaling by extracellular domain mutants of KIT | R-HSA-9680187 | 3.890934e-01 | 0.410 | 0 | 0 |
| Defective SLC12A3 causes Gitelman syndrome (GS) | R-HSA-5619087 | 3.890934e-01 | 0.410 | 0 | 0 |
| XAV939 stabilizes AXIN | R-HSA-5545619 | 3.890934e-01 | 0.410 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 3.890934e-01 | 0.410 | 0 | 0 |
| TWIK-releated acid-sensitive K+ channel (TASK) | R-HSA-1299316 | 3.890934e-01 | 0.410 | 0 | 0 |
| Signaling by kinase domain mutants of KIT | R-HSA-9669933 | 3.890934e-01 | 0.410 | 0 | 0 |
| Defective VWF binding to collagen type I | R-HSA-9845622 | 3.890934e-01 | 0.410 | 0 | 0 |
| TALDO1 deficiency: failed conversion of Fru(6)P, E4P to SH7P, GA3P | R-HSA-6791462 | 3.890934e-01 | 0.410 | 0 | 0 |
| Defective PGM1 causes PGM1-CDG | R-HSA-5609974 | 3.890934e-01 | 0.410 | 0 | 0 |
| SMAD2/3 MH2 Domain Mutants in Cancer | R-HSA-3315487 | 3.890934e-01 | 0.410 | 0 | 0 |
| Variant SLC6A20 contributes towards hyperglycinuria (HG) and iminoglycinuria (IG) | R-HSA-5619101 | 3.890934e-01 | 0.410 | 0 | 0 |
| MyD88 deficiency (TLR5) | R-HSA-5602680 | 3.890934e-01 | 0.410 | 0 | 0 |
| Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS) | R-HSA-5619081 | 3.890934e-01 | 0.410 | 0 | 0 |
| Loss of Function of SMAD4 in Cancer | R-HSA-3304347 | 3.890934e-01 | 0.410 | 0 | 0 |
| MPS IIID - Sanfilippo syndrome D | R-HSA-2206305 | 3.890934e-01 | 0.410 | 0 | 0 |
| Defective SLC4A1 causes hereditary spherocytosis type 4 (HSP4), distal renal tubular acidosis (dRTA) and dRTA with hemolytic anemia (dRTA-HA) | R-HSA-5619050 | 3.890934e-01 | 0.410 | 0 | 0 |
| Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS) | R-HSA-5660724 | 3.890934e-01 | 0.410 | 0 | 0 |
| Variant SLC6A20 contributes towards hyperglycinuria (HG) and iminoglycinuria (IG) | R-HSA-5660686 | 3.890934e-01 | 0.410 | 0 | 0 |
| SMAD4 MH2 Domain Mutants in Cancer | R-HSA-3311021 | 3.890934e-01 | 0.410 | 0 | 0 |
| TALDO1 deficiency: failed conversion of SH7P, GA3P to Fru(6)P, E4P | R-HSA-6791055 | 3.890934e-01 | 0.410 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 3.191648e-01 | 0.496 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 3.191648e-01 | 0.496 | 0 | 0 |
| Activation of AKT2 | R-HSA-165158 | 3.191648e-01 | 0.496 | 0 | 0 |
| Suppression of autophagy | R-HSA-9636569 | 3.191648e-01 | 0.496 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 3.191648e-01 | 0.496 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 3.191648e-01 | 0.496 | 0 | 0 |
| NTRK2 activates RAC1 | R-HSA-9032759 | 3.191648e-01 | 0.496 | 0 | 0 |
| Defective binding of VWF variant to GPIb:IX:V | R-HSA-9846298 | 3.191648e-01 | 0.496 | 0 | 0 |
| Enhanced binding of GP1BA variant to VWF multimer:collagen | R-HSA-9845620 | 3.191648e-01 | 0.496 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 3.191648e-01 | 0.496 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 2.711845e-01 | 0.567 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 2.711845e-01 | 0.567 | 0 | 0 |
| FGFR1b ligand binding and activation | R-HSA-190370 | 2.711845e-01 | 0.567 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 2.711845e-01 | 0.567 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 2.700806e-01 | 0.569 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 2.700806e-01 | 0.569 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 2.700806e-01 | 0.569 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 2.700806e-01 | 0.569 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 3.154883e-01 | 0.501 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 3.154883e-01 | 0.501 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 3.154883e-01 | 0.501 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 3.154883e-01 | 0.501 | 0 | 0 |
| Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660825 | 3.781708e-01 | 0.422 | 0 | 0 |
| Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660826 | 3.781708e-01 | 0.422 | 0 | 0 |
| Defects of platelet adhesion to exposed collagen | R-HSA-9823587 | 3.781708e-01 | 0.422 | 0 | 0 |
| GLI proteins bind promoters of Hh responsive genes to promote transcription | R-HSA-5635851 | 3.781708e-01 | 0.422 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 3.781708e-01 | 0.422 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 3.781708e-01 | 0.422 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 3.781708e-01 | 0.422 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 3.781708e-01 | 0.422 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 3.781708e-01 | 0.422 | 0 | 0 |
| Signaling by MAPK mutants | R-HSA-9652817 | 3.781708e-01 | 0.422 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 4.816487e-01 | 0.317 | 0 | 0 |
| Defective UGT1A4 causes hyperbilirubinemia | R-HSA-5579016 | 4.816487e-01 | 0.317 | 0 | 0 |
| Loss of Function of TGFBR2 in Cancer | R-HSA-3642278 | 4.816487e-01 | 0.317 | 0 | 0 |
| TGFBR2 Kinase Domain Mutants in Cancer | R-HSA-3645790 | 4.816487e-01 | 0.317 | 0 | 0 |
| Defective SLC40A1 causes hemochromatosis 4 (HFE4) (duodenum) | R-HSA-5655799 | 4.816487e-01 | 0.317 | 0 | 0 |
| Potassium transport channels | R-HSA-1296067 | 4.816487e-01 | 0.317 | 0 | 0 |
| Defective VWF cleavage by ADAMTS13 variant | R-HSA-9845621 | 4.816487e-01 | 0.317 | 0 | 0 |
| Enhanced cleavage of VWF variant by ADAMTS13 | R-HSA-9845619 | 4.816487e-01 | 0.317 | 0 | 0 |
| Defective F8 cleavage by thrombin | R-HSA-9672391 | 4.816487e-01 | 0.317 | 0 | 0 |
| TGFBR1 LBD Mutants in Cancer | R-HSA-3656535 | 4.816487e-01 | 0.317 | 0 | 0 |
| Defective SLC12A1 causes Bartter syndrome 1 (BS1) | R-HSA-5619104 | 4.816487e-01 | 0.317 | 0 | 0 |
| Defective visual phototransduction due to STRA6 loss of function | R-HSA-9918449 | 4.816487e-01 | 0.317 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 2.649615e-01 | 0.577 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 3.063337e-01 | 0.514 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 3.063337e-01 | 0.514 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 3.599105e-01 | 0.444 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 3.599105e-01 | 0.444 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 3.599105e-01 | 0.444 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 2.961159e-01 | 0.529 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 2.961159e-01 | 0.529 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 2.961159e-01 | 0.529 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 2.961159e-01 | 0.529 | 0 | 0 |
| Small interfering RNA (siRNA) biogenesis | R-HSA-426486 | 4.349293e-01 | 0.362 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 4.349293e-01 | 0.362 | 1 | 1 |
| STAT5 Activation | R-HSA-9645135 | 4.349293e-01 | 0.362 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 4.349293e-01 | 0.362 | 0 | 0 |
| Intracellular metabolism of fatty acids regulates insulin secretion | R-HSA-434313 | 4.349293e-01 | 0.362 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 4.349293e-01 | 0.362 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 3.140324e-01 | 0.503 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 3.140324e-01 | 0.503 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 4.038821e-01 | 0.394 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 4.038821e-01 | 0.394 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 4.038821e-01 | 0.394 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 3.014154e-01 | 0.521 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 3.798373e-01 | 0.420 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 3.798373e-01 | 0.420 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 3.598489e-01 | 0.444 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 3.272464e-01 | 0.485 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 2.892303e-01 | 0.539 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 2.892303e-01 | 0.539 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 2.892303e-01 | 0.539 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 2.866521e-01 | 0.543 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 3.713352e-01 | 0.430 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 3.713352e-01 | 0.430 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 3.919522e-01 | 0.407 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 4.164077e-01 | 0.380 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 4.469307e-01 | 0.350 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 4.469307e-01 | 0.350 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 4.469307e-01 | 0.350 | 0 | 0 |
| PI3K events in ERBB4 signaling | R-HSA-1250342 | 4.469307e-01 | 0.350 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 4.887673e-01 | 0.311 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 4.887673e-01 | 0.311 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 4.887673e-01 | 0.311 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 4.887673e-01 | 0.311 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 3.309890e-01 | 0.480 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 3.617372e-01 | 0.442 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 2.891208e-01 | 0.539 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 3.797398e-01 | 0.421 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 4.239224e-01 | 0.373 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 4.239224e-01 | 0.373 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 4.239224e-01 | 0.373 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 4.239224e-01 | 0.373 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 3.683749e-01 | 0.434 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 4.524646e-01 | 0.344 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 4.524646e-01 | 0.344 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 3.737919e-01 | 0.427 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 4.106804e-01 | 0.386 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 3.148836e-01 | 0.502 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 3.954105e-01 | 0.403 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 4.555643e-01 | 0.341 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 4.555643e-01 | 0.341 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 4.555643e-01 | 0.341 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 3.733239e-01 | 0.428 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 3.760621e-01 | 0.425 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 4.041405e-01 | 0.393 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 4.194121e-01 | 0.377 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 3.928078e-01 | 0.406 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 4.399889e-01 | 0.357 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 4.856409e-01 | 0.314 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 4.817784e-01 | 0.317 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 5.171845e-01 | 0.286 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 5.133347e-01 | 0.290 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 5.133347e-01 | 0.290 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 5.101665e-01 | 0.292 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 5.074713e-01 | 0.295 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 5.074713e-01 | 0.295 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 5.074713e-01 | 0.295 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 5.162935e-01 | 0.287 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 5.186227e-01 | 0.285 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 4.289364e-01 | 0.368 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 3.702236e-01 | 0.432 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 3.842840e-01 | 0.415 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 4.061479e-01 | 0.391 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 4.433598e-01 | 0.353 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 4.867031e-01 | 0.313 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 2.897839e-01 | 0.538 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 3.007594e-01 | 0.522 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 2.594753e-01 | 0.586 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 3.599105e-01 | 0.444 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 2.961159e-01 | 0.529 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 4.038821e-01 | 0.394 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 2.892303e-01 | 0.539 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 4.239224e-01 | 0.373 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 4.229597e-01 | 0.374 | 0 | 0 |
| mRNA Editing | R-HSA-75072 | 3.154883e-01 | 0.501 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 4.164077e-01 | 0.380 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 2.601899e-01 | 0.585 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 3.912752e-01 | 0.408 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 3.798373e-01 | 0.420 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 3.599105e-01 | 0.444 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 3.008359e-01 | 0.522 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 4.001772e-01 | 0.398 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 4.827998e-01 | 0.316 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 4.886750e-01 | 0.311 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 3.733239e-01 | 0.428 | 0 | 0 |
| Toxicity of botulinum toxin type E (botE) | R-HSA-5250992 | 3.781708e-01 | 0.422 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 4.887673e-01 | 0.311 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 4.886750e-01 | 0.311 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 4.867031e-01 | 0.313 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 4.429445e-01 | 0.354 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 4.444928e-01 | 0.352 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 3.374562e-01 | 0.472 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 4.164077e-01 | 0.380 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 4.164077e-01 | 0.380 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 4.886750e-01 | 0.311 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 4.586924e-01 | 0.338 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 2.859083e-01 | 0.544 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 3.374562e-01 | 0.472 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 4.239224e-01 | 0.373 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 2.762603e-01 | 0.559 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 2.829507e-01 | 0.548 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 3.278265e-01 | 0.484 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 2.762603e-01 | 0.559 | 0 | 0 |
| NADPH regeneration | R-HSA-389542 | 4.349293e-01 | 0.362 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 3.134371e-01 | 0.504 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 4.887673e-01 | 0.311 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 4.886750e-01 | 0.311 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 4.106804e-01 | 0.386 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 3.132713e-01 | 0.504 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 3.853681e-01 | 0.414 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 4.867031e-01 | 0.313 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 4.718214e-01 | 0.326 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 2.746061e-01 | 0.561 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 3.571735e-01 | 0.447 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 3.571735e-01 | 0.447 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 3.132713e-01 | 0.504 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 3.008359e-01 | 0.522 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 3.444767e-01 | 0.463 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 4.770158e-01 | 0.321 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 3.954105e-01 | 0.403 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 2.760371e-01 | 0.559 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 2.656754e-01 | 0.576 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 4.151211e-01 | 0.382 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 3.626147e-01 | 0.441 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 3.453924e-01 | 0.462 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 5.051216e-01 | 0.297 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 3.148723e-01 | 0.502 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 3.099606e-01 | 0.509 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 4.120367e-01 | 0.385 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 3.191648e-01 | 0.496 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 3.008359e-01 | 0.522 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 3.374562e-01 | 0.472 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 4.469307e-01 | 0.350 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 4.469307e-01 | 0.350 | 0 | 0 |
| Ca2+ activated K+ channels | R-HSA-1296052 | 4.887673e-01 | 0.311 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 2.789057e-01 | 0.555 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 3.617372e-01 | 0.442 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 4.586924e-01 | 0.338 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 3.048985e-01 | 0.516 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 4.026400e-01 | 0.395 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 3.176821e-01 | 0.498 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 3.530048e-01 | 0.452 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 4.524646e-01 | 0.344 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 3.481402e-01 | 0.458 | 0 | 0 |
| S Phase | R-HSA-69242 | 3.243792e-01 | 0.489 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 3.063337e-01 | 0.514 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 3.430385e-01 | 0.465 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 3.134371e-01 | 0.504 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 3.130313e-01 | 0.504 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 2.606909e-01 | 0.584 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 3.191648e-01 | 0.496 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 4.349293e-01 | 0.362 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 2.664173e-01 | 0.574 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 4.600091e-01 | 0.337 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 4.051339e-01 | 0.392 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 5.162935e-01 | 0.287 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 4.297503e-01 | 0.367 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 4.142325e-01 | 0.383 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 3.612621e-01 | 0.442 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 4.106804e-01 | 0.386 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 3.780700e-01 | 0.422 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 3.798373e-01 | 0.420 | 0 | 0 |
| Microbial modulation of RIPK1-mediated regulated necrosis | R-HSA-9686347 | 4.887673e-01 | 0.311 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 4.877617e-01 | 0.312 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 2.653005e-01 | 0.576 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 4.777447e-01 | 0.321 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 4.524646e-01 | 0.344 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 4.016365e-01 | 0.396 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 4.854478e-01 | 0.314 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 3.140324e-01 | 0.503 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 4.164077e-01 | 0.380 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 4.863416e-01 | 0.313 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 2.897748e-01 | 0.538 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 4.826823e-01 | 0.316 | 0 | 0 |
| Inhibition of PKR | R-HSA-169131 | 2.800191e-01 | 0.553 | 0 | 0 |
| Transport of connexins along the secretory pathway | R-HSA-190827 | 3.890934e-01 | 0.410 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH2 | R-HSA-5632928 | 3.890934e-01 | 0.410 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 3.191648e-01 | 0.496 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 3.781708e-01 | 0.422 | 0 | 0 |
| Neurophilin interactions with VEGF and VEGFR | R-HSA-194306 | 4.816487e-01 | 0.317 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 3.063337e-01 | 0.514 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 3.598489e-01 | 0.444 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 4.164077e-01 | 0.380 | 0 | 0 |
| Phase 3 - rapid repolarisation | R-HSA-5576890 | 4.887673e-01 | 0.311 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 3.737919e-01 | 0.427 | 0 | 0 |
| Erythrocytes take up oxygen and release carbon dioxide | R-HSA-1247673 | 4.886750e-01 | 0.311 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 4.555643e-01 | 0.341 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 4.574683e-01 | 0.340 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 4.062346e-01 | 0.391 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 4.603289e-01 | 0.337 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 4.605770e-01 | 0.337 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 3.243792e-01 | 0.489 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 2.706141e-01 | 0.568 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 3.859925e-01 | 0.413 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 4.041405e-01 | 0.393 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 4.586924e-01 | 0.338 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 4.718214e-01 | 0.326 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 3.014154e-01 | 0.521 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 3.224326e-01 | 0.492 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 3.052385e-01 | 0.515 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 4.038821e-01 | 0.394 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 4.005284e-01 | 0.397 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 4.602124e-01 | 0.337 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 4.555643e-01 | 0.341 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 4.041405e-01 | 0.393 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 2.784643e-01 | 0.555 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 4.887673e-01 | 0.311 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 4.026400e-01 | 0.395 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 4.444693e-01 | 0.352 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 2.700806e-01 | 0.569 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 4.856409e-01 | 0.314 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 4.877617e-01 | 0.312 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 3.497481e-01 | 0.456 | 0 | 0 |
| Oligomerization of connexins into connexons | R-HSA-190704 | 3.890934e-01 | 0.410 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 3.154883e-01 | 0.501 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 3.278265e-01 | 0.484 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 4.886750e-01 | 0.311 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 3.781708e-01 | 0.422 | 0 | 0 |
| Diseases of Base Excision Repair | R-HSA-9605308 | 3.781708e-01 | 0.422 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 2.711845e-01 | 0.567 | 0 | 0 |
| Release of apoptotic factors from the mitochondria | R-HSA-111457 | 3.781708e-01 | 0.422 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 2.689174e-01 | 0.570 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 4.887673e-01 | 0.311 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 4.877617e-01 | 0.312 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 2.866521e-01 | 0.543 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 3.798373e-01 | 0.420 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 3.617372e-01 | 0.442 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 4.038821e-01 | 0.394 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 3.617372e-01 | 0.442 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 5.206956e-01 | 0.283 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 5.211883e-01 | 0.283 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 5.220909e-01 | 0.282 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 5.220909e-01 | 0.282 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 5.220909e-01 | 0.282 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 5.220909e-01 | 0.282 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 5.240443e-01 | 0.281 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 5.246596e-01 | 0.280 | 0 | 0 |
| Adenylate cyclase activating pathway | R-HSA-170660 | 5.288176e-01 | 0.277 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 5.288176e-01 | 0.277 | 0 | 0 |
| FGFR1c ligand binding and activation | R-HSA-190373 | 5.288176e-01 | 0.277 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 5.288176e-01 | 0.277 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 5.288176e-01 | 0.277 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 5.288176e-01 | 0.277 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 5.309547e-01 | 0.275 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 5.335653e-01 | 0.273 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 5.392669e-01 | 0.268 | 0 | 0 |
| phospho-PLA2 pathway | R-HSA-111995 | 5.392669e-01 | 0.268 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 5.392669e-01 | 0.268 | 0 | 0 |
| Activation of RAS in B cells | R-HSA-1169092 | 5.392669e-01 | 0.268 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 5.392669e-01 | 0.268 | 0 | 0 |
| Interleukin-9 signaling | R-HSA-8985947 | 5.392669e-01 | 0.268 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 5.392669e-01 | 0.268 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 5.392669e-01 | 0.268 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 5.392669e-01 | 0.268 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 5.392669e-01 | 0.268 | 0 | 0 |
| RSK activation | R-HSA-444257 | 5.392669e-01 | 0.268 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 5.404432e-01 | 0.267 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 5.409691e-01 | 0.267 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 5.447569e-01 | 0.264 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 5.468757e-01 | 0.262 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 5.468757e-01 | 0.262 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 5.468757e-01 | 0.262 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 5.490548e-01 | 0.260 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 5.490548e-01 | 0.260 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 5.534264e-01 | 0.257 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 5.540101e-01 | 0.256 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 5.552808e-01 | 0.255 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 5.552808e-01 | 0.255 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 5.552808e-01 | 0.255 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 5.552808e-01 | 0.255 | 0 | 0 |
| Erythrocytes take up carbon dioxide and release oxygen | R-HSA-1237044 | 5.552808e-01 | 0.255 | 0 | 0 |
| O2/CO2 exchange in erythrocytes | R-HSA-1480926 | 5.552808e-01 | 0.255 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 5.552808e-01 | 0.255 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 5.552808e-01 | 0.255 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 5.552808e-01 | 0.255 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 5.598386e-01 | 0.252 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in metabolism | R-HSA-9854907 | 5.601859e-01 | 0.252 | 0 | 0 |
| Activation of Na-permeable kainate receptors | R-HSA-451307 | 5.601859e-01 | 0.252 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 5.601859e-01 | 0.252 | 0 | 0 |
| Defective ABCA1 causes TGD | R-HSA-5682113 | 5.601859e-01 | 0.252 | 0 | 0 |
| Defective SLC7A7 causes lysinuric protein intolerance (LPI) | R-HSA-5660862 | 5.601859e-01 | 0.252 | 0 | 0 |
| Defective HPRT1 disrupts guanine and hypoxanthine salvage | R-HSA-9734281 | 5.601859e-01 | 0.252 | 0 | 0 |
| Defective GCLC causes HAGGSD | R-HSA-5578999 | 5.601859e-01 | 0.252 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 5.601859e-01 | 0.252 | 0 | 0 |
| Classical Kir channels | R-HSA-1296053 | 5.601859e-01 | 0.252 | 0 | 0 |
| Invadopodia formation | R-HSA-8941237 | 5.601859e-01 | 0.252 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 5.601859e-01 | 0.252 | 0 | 0 |
| Tachykinin receptors bind tachykinins | R-HSA-380095 | 5.601859e-01 | 0.252 | 0 | 0 |
| CASP5-mediated substrate cleavage | R-HSA-9960525 | 5.601859e-01 | 0.252 | 0 | 0 |
| Histamine receptors | R-HSA-390650 | 5.601859e-01 | 0.252 | 0 | 0 |
| CASP4-mediated substrate cleavage | R-HSA-9960519 | 5.601859e-01 | 0.252 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 5.625291e-01 | 0.250 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 5.651263e-01 | 0.248 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 5.668737e-01 | 0.247 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 5.668737e-01 | 0.247 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 5.668737e-01 | 0.247 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 5.671363e-01 | 0.246 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 5.671363e-01 | 0.246 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 5.671363e-01 | 0.246 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 5.671363e-01 | 0.246 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 5.671363e-01 | 0.246 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 5.684596e-01 | 0.245 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 5.704391e-01 | 0.244 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 5.756639e-01 | 0.240 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 5.756639e-01 | 0.240 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 5.765776e-01 | 0.239 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 5.765776e-01 | 0.239 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 5.851104e-01 | 0.233 | 0 | 0 |
| Estrogen-stimulated signaling through PRKCZ | R-HSA-9634635 | 5.862040e-01 | 0.232 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 5.862040e-01 | 0.232 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 5.862040e-01 | 0.232 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 5.862040e-01 | 0.232 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 5.862040e-01 | 0.232 | 0 | 0 |
| 5-Phosphoribose 1-diphosphate biosynthesis | R-HSA-73843 | 5.862040e-01 | 0.232 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 5.862040e-01 | 0.232 | 0 | 0 |
| Toxicity of botulinum toxin type A (botA) | R-HSA-5250968 | 5.862040e-01 | 0.232 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 5.862040e-01 | 0.232 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 5.862040e-01 | 0.232 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 5.862040e-01 | 0.232 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 5.862040e-01 | 0.232 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 5.862040e-01 | 0.232 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 5.862040e-01 | 0.232 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 5.862040e-01 | 0.232 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 5.862040e-01 | 0.232 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 5.862040e-01 | 0.232 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 5.870502e-01 | 0.231 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 5.871949e-01 | 0.231 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 5.871949e-01 | 0.231 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 5.871949e-01 | 0.231 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 5.871949e-01 | 0.231 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 5.913707e-01 | 0.228 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 5.913707e-01 | 0.228 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 5.913707e-01 | 0.228 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 5.919724e-01 | 0.228 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 5.983971e-01 | 0.223 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 5.983971e-01 | 0.223 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 5.986044e-01 | 0.223 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 5.986044e-01 | 0.223 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 5.992346e-01 | 0.222 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 6.034566e-01 | 0.219 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 6.034566e-01 | 0.219 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 6.034749e-01 | 0.219 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 6.034749e-01 | 0.219 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 6.034749e-01 | 0.219 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 6.034749e-01 | 0.219 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 6.034749e-01 | 0.219 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 6.034749e-01 | 0.219 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 6.034749e-01 | 0.219 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 6.034749e-01 | 0.219 | 0 | 0 |
| Immune System | R-HSA-168256 | 6.045542e-01 | 0.219 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 6.046712e-01 | 0.218 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 6.046712e-01 | 0.218 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 6.046712e-01 | 0.218 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 6.116287e-01 | 0.214 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 6.118077e-01 | 0.213 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 6.126224e-01 | 0.213 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 6.168436e-01 | 0.210 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 6.169794e-01 | 0.210 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 6.173934e-01 | 0.209 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 6.173934e-01 | 0.209 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 6.177287e-01 | 0.209 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 6.177287e-01 | 0.209 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 6.177287e-01 | 0.209 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 6.177287e-01 | 0.209 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 6.203040e-01 | 0.207 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 6.203040e-01 | 0.207 | 0 | 0 |
| MTF1 activates gene expression | R-HSA-5660489 | 6.268274e-01 | 0.203 | 0 | 0 |
| HCN channels | R-HSA-1296061 | 6.268274e-01 | 0.203 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 6.268274e-01 | 0.203 | 0 | 0 |
| Defective PNP disrupts phosphorolysis of (deoxy)guanosine and (deoxy)inosine | R-HSA-9735763 | 6.268274e-01 | 0.203 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 6.268274e-01 | 0.203 | 0 | 0 |
| ATP sensitive Potassium channels | R-HSA-1296025 | 6.268274e-01 | 0.203 | 0 | 0 |
| Nucleotide catabolism defects | R-HSA-9735786 | 6.268274e-01 | 0.203 | 0 | 0 |
| Abnormal conversion of 2-oxoglutarate to 2-hydroxyglutarate | R-HSA-2978092 | 6.268274e-01 | 0.203 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 6.268274e-01 | 0.203 | 0 | 0 |
| RUNX2 regulates genes involved in differentiation of myeloid cells | R-HSA-8941333 | 6.268274e-01 | 0.203 | 0 | 0 |
| Drug-mediated inhibition of CDK4/CDK6 activity | R-HSA-9754119 | 6.268274e-01 | 0.203 | 0 | 0 |
| p75NTR negatively regulates cell cycle via SC1 | R-HSA-193670 | 6.268274e-01 | 0.203 | 0 | 0 |
| Regulation of HMOX1 expression and activity | R-HSA-9707587 | 6.268274e-01 | 0.203 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 6.279338e-01 | 0.202 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 6.294988e-01 | 0.201 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 6.294988e-01 | 0.201 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 6.294988e-01 | 0.201 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 6.294988e-01 | 0.201 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 6.294988e-01 | 0.201 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 6.294988e-01 | 0.201 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 6.294988e-01 | 0.201 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 6.294988e-01 | 0.201 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 6.294988e-01 | 0.201 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 6.297234e-01 | 0.201 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 6.297234e-01 | 0.201 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 6.297234e-01 | 0.201 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 6.301799e-01 | 0.201 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 6.301799e-01 | 0.201 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 6.301799e-01 | 0.201 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 6.319085e-01 | 0.199 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 6.377342e-01 | 0.195 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 6.377342e-01 | 0.195 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 6.377342e-01 | 0.195 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 6.377342e-01 | 0.195 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 6.377342e-01 | 0.195 | 0 | 0 |
| Atorvastatin ADME | R-HSA-9754706 | 6.377342e-01 | 0.195 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 6.377342e-01 | 0.195 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 6.377342e-01 | 0.195 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 6.377342e-01 | 0.195 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 6.413609e-01 | 0.193 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 6.449058e-01 | 0.191 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 6.449058e-01 | 0.191 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 6.449058e-01 | 0.191 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 6.468071e-01 | 0.189 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 6.468071e-01 | 0.189 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 6.468071e-01 | 0.189 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 6.468071e-01 | 0.189 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 6.510558e-01 | 0.186 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 6.510558e-01 | 0.186 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 6.510558e-01 | 0.186 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 6.515734e-01 | 0.186 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 6.515734e-01 | 0.186 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 6.515734e-01 | 0.186 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 6.515734e-01 | 0.186 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 6.546584e-01 | 0.184 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 6.557774e-01 | 0.183 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 6.557774e-01 | 0.183 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 6.557774e-01 | 0.183 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 6.557774e-01 | 0.183 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 6.565532e-01 | 0.183 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 6.565532e-01 | 0.183 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 6.610111e-01 | 0.180 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 6.614576e-01 | 0.179 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 6.635717e-01 | 0.178 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 6.644055e-01 | 0.178 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 6.686639e-01 | 0.175 | 0 | 0 |
| FGFR2b ligand binding and activation | R-HSA-190377 | 6.691773e-01 | 0.174 | 0 | 0 |
| Presynaptic depolarization and calcium channel opening | R-HSA-112308 | 6.691773e-01 | 0.174 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 6.691773e-01 | 0.174 | 0 | 0 |
| Chylomicron assembly | R-HSA-8963888 | 6.691773e-01 | 0.174 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 6.691773e-01 | 0.174 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 6.691773e-01 | 0.174 | 0 | 0 |
| Prostanoid ligand receptors | R-HSA-391908 | 6.691773e-01 | 0.174 | 0 | 0 |
| LGI-ADAM interactions | R-HSA-5682910 | 6.691773e-01 | 0.174 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 6.691773e-01 | 0.174 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 6.698086e-01 | 0.174 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 6.698630e-01 | 0.174 | 0 | 0 |
| Passive transport by Aquaporins | R-HSA-432047 | 6.698630e-01 | 0.174 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 6.726376e-01 | 0.172 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 6.726376e-01 | 0.172 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 6.743809e-01 | 0.171 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 6.743809e-01 | 0.171 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 6.743809e-01 | 0.171 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 6.743809e-01 | 0.171 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 6.743809e-01 | 0.171 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 6.743809e-01 | 0.171 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 6.782041e-01 | 0.169 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 6.795373e-01 | 0.168 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 6.802092e-01 | 0.167 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 6.804780e-01 | 0.167 | 0 | 0 |
| NOSIP mediated eNOS trafficking | R-HSA-203754 | 6.833745e-01 | 0.165 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 6.833745e-01 | 0.165 | 0 | 0 |
| Defective SLC1A3 causes episodic ataxia 6 (EA6) | R-HSA-5619062 | 6.833745e-01 | 0.165 | 0 | 0 |
| Defective F9 activation | R-HSA-9673221 | 6.833745e-01 | 0.165 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 6.833745e-01 | 0.165 | 0 | 0 |
| Trafficking of myristoylated proteins to the cilium | R-HSA-5624138 | 6.833745e-01 | 0.165 | 0 | 0 |
| IRF3 mediated activation of type 1 IFN | R-HSA-1606341 | 6.833745e-01 | 0.165 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 6.833745e-01 | 0.165 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 6.833745e-01 | 0.165 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 6.833745e-01 | 0.165 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 6.833745e-01 | 0.165 | 0 | 0 |
| Toxicity of botulinum toxin type C (botC) | R-HSA-5250971 | 6.833745e-01 | 0.165 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 6.833745e-01 | 0.165 | 0 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 6.833745e-01 | 0.165 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 6.864950e-01 | 0.163 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 6.864950e-01 | 0.163 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 6.864950e-01 | 0.163 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 6.950804e-01 | 0.158 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 6.950804e-01 | 0.158 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 6.992372e-01 | 0.155 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 6.992372e-01 | 0.155 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 6.998502e-01 | 0.155 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 6.998502e-01 | 0.155 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 6.998502e-01 | 0.155 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 6.998502e-01 | 0.155 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 7.002496e-01 | 0.155 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 7.004242e-01 | 0.155 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 7.004242e-01 | 0.155 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 7.004242e-01 | 0.155 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 7.004242e-01 | 0.155 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 7.004242e-01 | 0.155 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 7.004242e-01 | 0.155 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 7.034497e-01 | 0.153 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 7.034497e-01 | 0.153 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 7.053414e-01 | 0.152 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 7.053414e-01 | 0.152 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 7.053414e-01 | 0.152 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 7.053414e-01 | 0.152 | 0 | 0 |
| Signaling by activated point mutants of FGFR1 | R-HSA-1839122 | 7.053414e-01 | 0.152 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 7.053414e-01 | 0.152 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 7.053414e-01 | 0.152 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 7.076075e-01 | 0.150 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 7.076075e-01 | 0.150 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 7.115297e-01 | 0.148 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 7.115297e-01 | 0.148 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 7.123126e-01 | 0.147 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 7.249308e-01 | 0.140 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 7.249308e-01 | 0.140 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 7.253759e-01 | 0.139 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 7.274010e-01 | 0.138 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 7.274010e-01 | 0.138 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 7.277171e-01 | 0.138 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 7.277171e-01 | 0.138 | 0 | 0 |
| FGFR1 ligand binding and activation | R-HSA-190242 | 7.277171e-01 | 0.138 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 7.277171e-01 | 0.138 | 0 | 0 |
| PKA activation | R-HSA-163615 | 7.277171e-01 | 0.138 | 0 | 0 |
| Vitamin D (calciferol) metabolism | R-HSA-196791 | 7.277171e-01 | 0.138 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 7.277300e-01 | 0.138 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 7.277300e-01 | 0.138 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 7.277300e-01 | 0.138 | 0 | 0 |
| TRAIL signaling | R-HSA-75158 | 7.313558e-01 | 0.136 | 0 | 0 |
| Plus-strand DNA synthesis | R-HSA-164525 | 7.313558e-01 | 0.136 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 7.313558e-01 | 0.136 | 0 | 0 |
| Phase 1 - inactivation of fast Na+ channels | R-HSA-5576894 | 7.313558e-01 | 0.136 | 0 | 0 |
| NGF-independant TRKA activation | R-HSA-187024 | 7.313558e-01 | 0.136 | 0 | 0 |
| Pentose phosphate pathway disease | R-HSA-6791465 | 7.313558e-01 | 0.136 | 0 | 0 |
| Proton/oligopeptide cotransporters | R-HSA-427975 | 7.313558e-01 | 0.136 | 0 | 0 |
| Formation of the Editosome | R-HSA-75094 | 7.313558e-01 | 0.136 | 0 | 0 |
| Ceramide signalling | R-HSA-193681 | 7.313558e-01 | 0.136 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 7.313558e-01 | 0.136 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 7.313558e-01 | 0.136 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 7.313558e-01 | 0.136 | 0 | 0 |
| VEGF binds to VEGFR leading to receptor dimerization | R-HSA-195399 | 7.313558e-01 | 0.136 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 7.313558e-01 | 0.136 | 0 | 0 |
| Ligand-receptor interactions | R-HSA-5632681 | 7.313558e-01 | 0.136 | 0 | 0 |
| VEGF ligand-receptor interactions | R-HSA-194313 | 7.313558e-01 | 0.136 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 7.324275e-01 | 0.135 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 7.365120e-01 | 0.133 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 7.381449e-01 | 0.132 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 7.381449e-01 | 0.132 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 7.381449e-01 | 0.132 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 7.381449e-01 | 0.132 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 7.381449e-01 | 0.132 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 7.381449e-01 | 0.132 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 7.381449e-01 | 0.132 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 7.381449e-01 | 0.132 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 7.385518e-01 | 0.132 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 7.417859e-01 | 0.130 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 7.426330e-01 | 0.129 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 7.429483e-01 | 0.129 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 7.468583e-01 | 0.127 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 7.468583e-01 | 0.127 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 7.470065e-01 | 0.127 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 7.479118e-01 | 0.126 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 7.479118e-01 | 0.126 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 7.479118e-01 | 0.126 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 7.479118e-01 | 0.126 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 7.511392e-01 | 0.124 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 7.515149e-01 | 0.124 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 7.535113e-01 | 0.123 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 7.541156e-01 | 0.123 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 7.562106e-01 | 0.121 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 7.606503e-01 | 0.119 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 7.631157e-01 | 0.117 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 7.631157e-01 | 0.117 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 7.631157e-01 | 0.117 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 7.643815e-01 | 0.117 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 7.649954e-01 | 0.116 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 7.649954e-01 | 0.116 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 7.655123e-01 | 0.116 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 7.655123e-01 | 0.116 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 7.659582e-01 | 0.116 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 7.669627e-01 | 0.115 | 0 | 0 |
| FGFR2c ligand binding and activation | R-HSA-190375 | 7.677757e-01 | 0.115 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 7.677757e-01 | 0.115 | 0 | 0 |
| Diseases of nucleotide metabolism | R-HSA-9735804 | 7.677757e-01 | 0.115 | 0 | 0 |
| FGFR4 ligand binding and activation | R-HSA-190322 | 7.677757e-01 | 0.115 | 0 | 0 |
| TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway | R-HSA-5676594 | 7.677757e-01 | 0.115 | 0 | 0 |
| Signaling by activated point mutants of FGFR3 | R-HSA-1839130 | 7.677757e-01 | 0.115 | 0 | 0 |
| Reversible hydration of carbon dioxide | R-HSA-1475029 | 7.677757e-01 | 0.115 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 7.677757e-01 | 0.115 | 0 | 0 |
| FGFR3 mutant receptor activation | R-HSA-2033514 | 7.677757e-01 | 0.115 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 7.677757e-01 | 0.115 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 7.693924e-01 | 0.114 | 0 | 0 |
| Defective B4GALT1 causes B4GALT1-CDG (CDG-2d) | R-HSA-3656244 | 7.720683e-01 | 0.112 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 7.720683e-01 | 0.112 | 0 | 0 |
| Uncoating of the HIV Virion | R-HSA-162585 | 7.720683e-01 | 0.112 | 0 | 0 |
| Defective CHST3 causes SEDCJD | R-HSA-3595172 | 7.720683e-01 | 0.112 | 0 | 0 |
| Defective ST3GAL3 causes MCT12 and EIEE15 | R-HSA-3656243 | 7.720683e-01 | 0.112 | 0 | 0 |
| Defective CHST6 causes MCDC1 | R-HSA-3656225 | 7.720683e-01 | 0.112 | 0 | 0 |
| Defective CHST14 causes EDS, musculocontractural type | R-HSA-3595174 | 7.720683e-01 | 0.112 | 0 | 0 |
| Toxicity of botulinum toxin type F (botF) | R-HSA-5250981 | 7.720683e-01 | 0.112 | 0 | 0 |
| Toxicity of botulinum toxin type D (botD) | R-HSA-5250955 | 7.720683e-01 | 0.112 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 7.720683e-01 | 0.112 | 0 | 0 |
| Abacavir transmembrane transport | R-HSA-2161517 | 7.720683e-01 | 0.112 | 0 | 0 |
| Defective factor VIII causes hemophilia A | R-HSA-9662001 | 7.720683e-01 | 0.112 | 0 | 0 |
| Metabolism of vitamin K | R-HSA-6806664 | 7.720683e-01 | 0.112 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 7.720683e-01 | 0.112 | 0 | 0 |
| VLDL assembly | R-HSA-8866423 | 7.720683e-01 | 0.112 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 7.771419e-01 | 0.109 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 7.773001e-01 | 0.109 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 7.773001e-01 | 0.109 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 7.773001e-01 | 0.109 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 7.773001e-01 | 0.109 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 7.784116e-01 | 0.109 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 7.798978e-01 | 0.108 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 7.815565e-01 | 0.107 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 7.820493e-01 | 0.107 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 7.821509e-01 | 0.107 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 7.832733e-01 | 0.106 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 7.894098e-01 | 0.103 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 7.894098e-01 | 0.103 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 7.894098e-01 | 0.103 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 7.894098e-01 | 0.103 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 7.944419e-01 | 0.100 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR3 | R-HSA-5654227 | 7.944419e-01 | 0.100 | 0 | 0 |
| cGMP effects | R-HSA-418457 | 7.944419e-01 | 0.100 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 7.944419e-01 | 0.100 | 0 | 0 |
| Synthesis of IPs in the nucleus | R-HSA-1855191 | 7.944419e-01 | 0.100 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 7.944419e-01 | 0.100 | 0 | 0 |
| FGFR3c ligand binding and activation | R-HSA-190372 | 7.944419e-01 | 0.100 | 0 | 0 |
| Prolactin receptor signaling | R-HSA-1170546 | 7.944419e-01 | 0.100 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 7.964057e-01 | 0.099 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 7.983403e-01 | 0.098 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 7.983403e-01 | 0.098 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 7.983403e-01 | 0.098 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 7.991661e-01 | 0.097 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 7.991661e-01 | 0.097 | 0 | 0 |
| Intrinsic Pathway of Fibrin Clot Formation | R-HSA-140837 | 7.991661e-01 | 0.097 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 7.991661e-01 | 0.097 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 7.994039e-01 | 0.097 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 7.994039e-01 | 0.097 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 7.994039e-01 | 0.097 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 8.017329e-01 | 0.096 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 8.017329e-01 | 0.096 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 8.017329e-01 | 0.096 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 8.017329e-01 | 0.096 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 8.017329e-01 | 0.096 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 8.060462e-01 | 0.094 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 8.066129e-01 | 0.093 | 0 | 0 |
| PP2A-mediated dephosphorylation of key metabolic factors | R-HSA-163767 | 8.066129e-01 | 0.093 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 8.066129e-01 | 0.093 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 8.066129e-01 | 0.093 | 0 | 0 |
| FGFR3b ligand binding and activation | R-HSA-190371 | 8.066129e-01 | 0.093 | 0 | 0 |
| Defective CHSY1 causes TPBS | R-HSA-3595177 | 8.066129e-01 | 0.093 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 8.066129e-01 | 0.093 | 0 | 0 |
| mRNA Editing: C to U Conversion | R-HSA-72200 | 8.066129e-01 | 0.093 | 0 | 0 |
| Attachment of GPI anchor to uPAR | R-HSA-162791 | 8.066129e-01 | 0.093 | 0 | 0 |
| LDL remodeling | R-HSA-8964041 | 8.066129e-01 | 0.093 | 0 | 0 |
| SLC-mediated transport of oligopeptides | R-HSA-9959399 | 8.066129e-01 | 0.093 | 0 | 0 |
| Synthesis of PIPs in the nucleus | R-HSA-8847453 | 8.066129e-01 | 0.093 | 0 | 0 |
| Activation of TRKA receptors | R-HSA-187015 | 8.066129e-01 | 0.093 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 8.066129e-01 | 0.093 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 8.066129e-01 | 0.093 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 8.080105e-01 | 0.093 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 8.080105e-01 | 0.093 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 8.080105e-01 | 0.093 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 8.080105e-01 | 0.093 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 8.135841e-01 | 0.090 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 8.142611e-01 | 0.089 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 8.176679e-01 | 0.087 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 8.179267e-01 | 0.087 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 8.179267e-01 | 0.087 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 8.179267e-01 | 0.087 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 8.183615e-01 | 0.087 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 8.183615e-01 | 0.087 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR4 | R-HSA-5654228 | 8.183615e-01 | 0.087 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 8.183615e-01 | 0.087 | 0 | 0 |
| FGFR3 ligand binding and activation | R-HSA-190239 | 8.183615e-01 | 0.087 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 8.183615e-01 | 0.087 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 8.183615e-01 | 0.087 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 8.183615e-01 | 0.087 | 0 | 0 |
| Signaling by Activin | R-HSA-1502540 | 8.183615e-01 | 0.087 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 8.192028e-01 | 0.087 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 8.192028e-01 | 0.087 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 8.229704e-01 | 0.085 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 8.244065e-01 | 0.084 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 8.252484e-01 | 0.083 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 8.252484e-01 | 0.083 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 8.252484e-01 | 0.083 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 8.252484e-01 | 0.083 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 8.289708e-01 | 0.081 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 8.289708e-01 | 0.081 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 8.296425e-01 | 0.081 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 8.306301e-01 | 0.081 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 8.330392e-01 | 0.079 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 8.353442e-01 | 0.078 | 0 | 0 |
| Reverse Transcription of HIV RNA | R-HSA-162589 | 8.359237e-01 | 0.078 | 0 | 0 |
| Minus-strand DNA synthesis | R-HSA-164516 | 8.359237e-01 | 0.078 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 8.359237e-01 | 0.078 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 8.359237e-01 | 0.078 | 0 | 0 |
| Co-stimulation by ICOS | R-HSA-9927354 | 8.359237e-01 | 0.078 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 8.359237e-01 | 0.078 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of keratinocytes | R-HSA-8939242 | 8.359237e-01 | 0.078 | 0 | 0 |
| Negative regulation of activity of TFAP2 (AP-2) family transcription factors | R-HSA-8866904 | 8.359237e-01 | 0.078 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 8.359237e-01 | 0.078 | 0 | 0 |
| Neurotransmitter uptake and metabolism In glial cells | R-HSA-112313 | 8.359237e-01 | 0.078 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 8.359237e-01 | 0.078 | 0 | 0 |
| Nucleotide salvage defects | R-HSA-9734207 | 8.359237e-01 | 0.078 | 0 | 0 |
| Astrocytic Glutamate-Glutamine Uptake And Metabolism | R-HSA-210455 | 8.359237e-01 | 0.078 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 8.359237e-01 | 0.078 | 0 | 0 |
| Interleukin-23 signaling | R-HSA-9020933 | 8.359237e-01 | 0.078 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 8.375107e-01 | 0.077 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 8.375107e-01 | 0.077 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 8.393877e-01 | 0.076 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 8.397542e-01 | 0.076 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 8.397542e-01 | 0.076 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 8.397542e-01 | 0.076 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 8.397542e-01 | 0.076 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 8.397542e-01 | 0.076 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 8.397542e-01 | 0.076 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 8.402357e-01 | 0.076 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 8.411829e-01 | 0.075 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 8.411829e-01 | 0.075 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 8.438639e-01 | 0.074 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 8.471111e-01 | 0.072 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 8.529518e-01 | 0.069 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 8.529518e-01 | 0.069 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 8.539043e-01 | 0.069 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 8.540333e-01 | 0.069 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 8.541945e-01 | 0.068 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 8.541945e-01 | 0.068 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 8.541945e-01 | 0.068 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 8.556596e-01 | 0.068 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 8.556596e-01 | 0.068 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 8.558774e-01 | 0.068 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 8.588366e-01 | 0.066 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 8.588366e-01 | 0.066 | 0 | 0 |
| Phase 2 - plateau phase | R-HSA-5576893 | 8.588366e-01 | 0.066 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 8.588366e-01 | 0.066 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 8.588366e-01 | 0.066 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) | R-HSA-400511 | 8.588366e-01 | 0.066 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 8.588366e-01 | 0.066 | 0 | 0 |
| Defects of contact activation system (CAS) and kallikrein/kinin system (KKS) | R-HSA-9651496 | 8.588366e-01 | 0.066 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 8.607934e-01 | 0.065 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 8.607934e-01 | 0.065 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 8.607934e-01 | 0.065 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 8.607934e-01 | 0.065 | 0 | 0 |
| Regulation of NPAS4 gene transcription | R-HSA-9768777 | 8.607934e-01 | 0.065 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 8.607934e-01 | 0.065 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 8.607934e-01 | 0.065 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 8.609478e-01 | 0.065 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 8.656429e-01 | 0.063 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 8.693608e-01 | 0.061 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 8.693608e-01 | 0.061 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 8.693608e-01 | 0.061 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 8.693608e-01 | 0.061 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 8.693977e-01 | 0.061 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 8.693977e-01 | 0.061 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 8.729580e-01 | 0.059 | 0 | 0 |
| Phospholipase C-mediated cascade: FGFR1 | R-HSA-5654219 | 8.758172e-01 | 0.058 | 0 | 0 |
| Sulfide oxidation to sulfate | R-HSA-1614517 | 8.758172e-01 | 0.058 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 8.765871e-01 | 0.057 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 8.765871e-01 | 0.057 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 8.765871e-01 | 0.057 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 8.765871e-01 | 0.057 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 8.772432e-01 | 0.057 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 8.777592e-01 | 0.057 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 8.784932e-01 | 0.056 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 8.815016e-01 | 0.055 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 8.818947e-01 | 0.055 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 8.818947e-01 | 0.055 | 0 | 0 |
| DNA replication initiation | R-HSA-68952 | 8.818947e-01 | 0.055 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 8.818947e-01 | 0.055 | 0 | 0 |
| Ion influx/efflux at host-pathogen interface | R-HSA-6803544 | 8.818947e-01 | 0.055 | 0 | 0 |
| Formation of intermediate mesoderm | R-HSA-9761174 | 8.818947e-01 | 0.055 | 0 | 0 |
| Maturation of spike protein | R-HSA-9683686 | 8.818947e-01 | 0.055 | 0 | 0 |
| Defective factor IX causes hemophilia B | R-HSA-9668250 | 8.818947e-01 | 0.055 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 8.818947e-01 | 0.055 | 0 | 0 |
| Tandem pore domain potassium channels | R-HSA-1296346 | 8.818947e-01 | 0.055 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 8.820689e-01 | 0.054 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 8.831157e-01 | 0.054 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 8.831157e-01 | 0.054 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 8.831157e-01 | 0.054 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 8.852432e-01 | 0.053 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 8.866746e-01 | 0.052 | 0 | 0 |
| Activated point mutants of FGFR2 | R-HSA-2033519 | 8.908949e-01 | 0.050 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 8.908949e-01 | 0.050 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 8.931849e-01 | 0.049 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 8.931849e-01 | 0.049 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 8.938971e-01 | 0.049 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 8.938971e-01 | 0.049 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 8.955637e-01 | 0.048 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 8.955637e-01 | 0.048 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 8.981656e-01 | 0.047 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 8.990997e-01 | 0.046 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 8.997985e-01 | 0.046 | 0 | 0 |
| FGFRL1 modulation of FGFR1 signaling | R-HSA-5658623 | 8.997985e-01 | 0.046 | 0 | 0 |
| Conjugation of benzoate with glycine | R-HSA-177135 | 8.997985e-01 | 0.046 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 8.997985e-01 | 0.046 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 8.997985e-01 | 0.046 | 0 | 0 |
| Transport of RCbl within the body | R-HSA-9758890 | 8.997985e-01 | 0.046 | 0 | 0 |
| Synthesis of PIPs at the ER membrane | R-HSA-1483248 | 8.997985e-01 | 0.046 | 0 | 0 |
| SARS-CoV-2 modulates autophagy | R-HSA-9754560 | 8.997985e-01 | 0.046 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 9.034553e-01 | 0.044 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 9.034553e-01 | 0.044 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 9.035860e-01 | 0.044 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 9.042561e-01 | 0.044 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 9.042561e-01 | 0.044 | 0 | 0 |
| Diseases of hemostasis | R-HSA-9671793 | 9.042561e-01 | 0.044 | 0 | 0 |
| mRNA decay by 3' to 5' exoribonuclease | R-HSA-429958 | 9.042561e-01 | 0.044 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 9.044244e-01 | 0.044 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 9.068060e-01 | 0.042 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 9.068060e-01 | 0.042 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.075298e-01 | 0.042 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 9.087247e-01 | 0.042 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 9.105816e-01 | 0.041 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 9.122539e-01 | 0.040 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 9.122539e-01 | 0.040 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 9.129920e-01 | 0.040 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 9.131454e-01 | 0.039 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 9.139216e-01 | 0.039 | 0 | 0 |
| DS-GAG biosynthesis | R-HSA-2022923 | 9.149890e-01 | 0.039 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 9.149890e-01 | 0.039 | 0 | 0 |
| Scavenging by Class H Receptors | R-HSA-3000497 | 9.149890e-01 | 0.039 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 9.149890e-01 | 0.039 | 0 | 0 |
| Viral RNP Complexes in the Host Cell Nucleus | R-HSA-168330 | 9.149890e-01 | 0.039 | 0 | 0 |
| Endosomal/Vacuolar pathway | R-HSA-1236977 | 9.149890e-01 | 0.039 | 0 | 0 |
| Sodium/Calcium exchangers | R-HSA-425561 | 9.149890e-01 | 0.039 | 0 | 0 |
| Synthesis of diphthamide-EEF2 | R-HSA-5358493 | 9.149890e-01 | 0.039 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.149997e-01 | 0.039 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 9.160747e-01 | 0.038 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR2 | R-HSA-5654221 | 9.160747e-01 | 0.038 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 9.160747e-01 | 0.038 | 0 | 0 |
| Keratan sulfate degradation | R-HSA-2022857 | 9.160747e-01 | 0.038 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 9.160747e-01 | 0.038 | 0 | 0 |
| Eicosanoid ligand-binding receptors | R-HSA-391903 | 9.160747e-01 | 0.038 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 9.160747e-01 | 0.038 | 0 | 0 |
| Prednisone ADME | R-HSA-9757110 | 9.169402e-01 | 0.038 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 9.173960e-01 | 0.037 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 9.203402e-01 | 0.036 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 9.206637e-01 | 0.036 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 9.206637e-01 | 0.036 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 9.223076e-01 | 0.035 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 9.260590e-01 | 0.033 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 9.264211e-01 | 0.033 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 9.265113e-01 | 0.033 | 0 | 0 |
| FGFR2 ligand binding and activation | R-HSA-190241 | 9.265113e-01 | 0.033 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 9.265113e-01 | 0.033 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 9.265113e-01 | 0.033 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 9.265113e-01 | 0.033 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 9.278774e-01 | 0.033 | 0 | 0 |
| Acetylation | R-HSA-156582 | 9.278774e-01 | 0.033 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 9.278774e-01 | 0.033 | 0 | 0 |
| Conjugation of salicylate with glycine | R-HSA-177128 | 9.278774e-01 | 0.033 | 0 | 0 |
| Trafficking and processing of endosomal TLR | R-HSA-1679131 | 9.278774e-01 | 0.033 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 9.278774e-01 | 0.033 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 9.278774e-01 | 0.033 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 9.278774e-01 | 0.033 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.284974e-01 | 0.032 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 9.296013e-01 | 0.032 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 9.296013e-01 | 0.032 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 9.342504e-01 | 0.030 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 9.342504e-01 | 0.030 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 9.344975e-01 | 0.029 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 9.344975e-01 | 0.029 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 9.345578e-01 | 0.029 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 9.345578e-01 | 0.029 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 9.345578e-01 | 0.029 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 9.345578e-01 | 0.029 | 0 | 0 |
| Serine metabolism | R-HSA-977347 | 9.357132e-01 | 0.029 | 0 | 0 |
| Ribavirin ADME | R-HSA-9755088 | 9.357132e-01 | 0.029 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 9.367490e-01 | 0.028 | 0 | 0 |
| Purine salvage | R-HSA-74217 | 9.367490e-01 | 0.028 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.372560e-01 | 0.028 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 9.380344e-01 | 0.028 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 9.388125e-01 | 0.027 | 0 | 0 |
| IL-6-type cytokine receptor ligand interactions | R-HSA-6788467 | 9.388125e-01 | 0.027 | 0 | 0 |
| Chylomicron remodeling | R-HSA-8963901 | 9.388125e-01 | 0.027 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 9.388125e-01 | 0.027 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 9.388125e-01 | 0.027 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 9.388125e-01 | 0.027 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 9.400499e-01 | 0.027 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 9.407768e-01 | 0.027 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.408749e-01 | 0.026 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 9.415969e-01 | 0.026 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 9.432308e-01 | 0.025 | 0 | 0 |
| Free fatty acid receptors | R-HSA-444209 | 9.438149e-01 | 0.025 | 0 | 0 |
| Neurotoxicity of clostridium toxins | R-HSA-168799 | 9.438149e-01 | 0.025 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 9.438149e-01 | 0.025 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 9.438948e-01 | 0.025 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 9.438948e-01 | 0.025 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.438948e-01 | 0.025 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.448984e-01 | 0.025 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 9.453206e-01 | 0.024 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 9.480804e-01 | 0.023 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 9.480901e-01 | 0.023 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 9.480901e-01 | 0.023 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 9.480901e-01 | 0.023 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 9.480901e-01 | 0.023 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 9.480901e-01 | 0.023 | 0 | 0 |
| N-glycan trimming and elongation in the cis-Golgi | R-HSA-964739 | 9.480901e-01 | 0.023 | 0 | 0 |
| Formation of the active cofactor, UDP-glucuronate | R-HSA-173599 | 9.480901e-01 | 0.023 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 9.480901e-01 | 0.023 | 0 | 0 |
| Non-canonical inflammasome activation | R-HSA-9686114 | 9.480901e-01 | 0.023 | 0 | 0 |
| Acyl chain remodeling of CL | R-HSA-1482798 | 9.480901e-01 | 0.023 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 9.480901e-01 | 0.023 | 0 | 0 |
| P2Y receptors | R-HSA-417957 | 9.480901e-01 | 0.023 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 9.480901e-01 | 0.023 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 9.481757e-01 | 0.023 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 9.491002e-01 | 0.023 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 9.509382e-01 | 0.022 | 0 | 0 |
| Mitochondrial mRNA modification | R-HSA-9937008 | 9.509382e-01 | 0.022 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.511157e-01 | 0.022 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 9.528179e-01 | 0.021 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.545668e-01 | 0.020 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.548486e-01 | 0.020 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 9.557052e-01 | 0.020 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 9.559614e-01 | 0.020 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 9.559614e-01 | 0.020 | 0 | 0 |
| Synthesis of 12-eicosatetraenoic acid derivatives | R-HSA-2142712 | 9.559614e-01 | 0.020 | 0 | 0 |
| Dopamine clearance from the synaptic cleft | R-HSA-379401 | 9.559614e-01 | 0.020 | 0 | 0 |
| Transport and metabolism of PAPS | R-HSA-174362 | 9.559614e-01 | 0.020 | 0 | 0 |
| Biotin transport and metabolism | R-HSA-196780 | 9.559614e-01 | 0.020 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 9.559614e-01 | 0.020 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 9.559614e-01 | 0.020 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 9.563641e-01 | 0.019 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 9.571937e-01 | 0.019 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 9.571937e-01 | 0.019 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 9.571937e-01 | 0.019 | 0 | 0 |
| Assembly of active LPL and LIPC lipase complexes | R-HSA-8963889 | 9.571937e-01 | 0.019 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 9.581922e-01 | 0.019 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 9.592006e-01 | 0.018 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 9.592006e-01 | 0.018 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 9.592006e-01 | 0.018 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 9.592006e-01 | 0.018 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 9.593120e-01 | 0.018 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 9.593120e-01 | 0.018 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 9.593120e-01 | 0.018 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.599111e-01 | 0.018 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 9.600368e-01 | 0.018 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.619054e-01 | 0.017 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 9.619054e-01 | 0.017 | 0 | 0 |
| Entry of Influenza Virion into Host Cell via Endocytosis | R-HSA-168275 | 9.626396e-01 | 0.017 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 9.626396e-01 | 0.017 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 9.626396e-01 | 0.017 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 9.626807e-01 | 0.017 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 9.626807e-01 | 0.017 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 9.626807e-01 | 0.017 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 9.626807e-01 | 0.017 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.628733e-01 | 0.016 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 9.631376e-01 | 0.016 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 9.639973e-01 | 0.016 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 9.639973e-01 | 0.016 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 9.674883e-01 | 0.014 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 9.674883e-01 | 0.014 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 9.674883e-01 | 0.014 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.681706e-01 | 0.014 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 9.681706e-01 | 0.014 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 9.683054e-01 | 0.014 | 0 | 0 |
| Defective B3GALT6 causes EDSP2 and SEMDJL1 | R-HSA-4420332 | 9.683054e-01 | 0.014 | 0 | 0 |
| Defective B4GALT7 causes EDS, progeroid type | R-HSA-3560783 | 9.683054e-01 | 0.014 | 0 | 0 |
| Scavenging by Class B Receptors | R-HSA-3000471 | 9.683054e-01 | 0.014 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 9.683054e-01 | 0.014 | 0 | 0 |
| Vitamin B6 activation to pyridoxal phosphate | R-HSA-964975 | 9.683054e-01 | 0.014 | 0 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 9.683054e-01 | 0.014 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 9.683054e-01 | 0.014 | 0 | 0 |
| Formation of xylulose-5-phosphate | R-HSA-5661270 | 9.683054e-01 | 0.014 | 0 | 0 |
| Galactose catabolism | R-HSA-70370 | 9.683054e-01 | 0.014 | 0 | 0 |
| Biosynthesis of maresin-like SPMs | R-HSA-9027307 | 9.683054e-01 | 0.014 | 0 | 0 |
| Response to metal ions | R-HSA-5660526 | 9.683054e-01 | 0.014 | 0 | 0 |
| tRNA modification in the mitochondrion | R-HSA-6787450 | 9.683054e-01 | 0.014 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 9.685789e-01 | 0.014 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 9.693862e-01 | 0.014 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.697133e-01 | 0.013 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.708132e-01 | 0.013 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 9.709202e-01 | 0.013 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 9.709202e-01 | 0.013 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 9.716964e-01 | 0.012 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 9.718837e-01 | 0.012 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 9.718837e-01 | 0.012 | 0 | 0 |
| Defective B3GAT3 causes JDSSDHD | R-HSA-3560801 | 9.731122e-01 | 0.012 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 9.731122e-01 | 0.012 | 0 | 0 |
| Synthesis of 15-eicosatetraenoic acid derivatives | R-HSA-2142770 | 9.731122e-01 | 0.012 | 0 | 0 |
| Metabolism of ingested H2SeO4 and H2SeO3 into H2Se | R-HSA-2408550 | 9.731122e-01 | 0.012 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 9.731122e-01 | 0.012 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 9.740685e-01 | 0.011 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 9.753762e-01 | 0.011 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 9.753762e-01 | 0.011 | 0 | 0 |
| Pyrimidine salvage | R-HSA-73614 | 9.753762e-01 | 0.011 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 9.771038e-01 | 0.010 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 9.771903e-01 | 0.010 | 0 | 0 |
| Cytosolic iron-sulfur cluster assembly | R-HSA-2564830 | 9.771903e-01 | 0.010 | 0 | 0 |
| Organic anion transport by SLC5/17/25 transporters | R-HSA-428643 | 9.771903e-01 | 0.010 | 0 | 0 |
| Nucleotide-like (purinergic) receptors | R-HSA-418038 | 9.771903e-01 | 0.010 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 9.773495e-01 | 0.010 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.778941e-01 | 0.010 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 9.785911e-01 | 0.009 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 9.785911e-01 | 0.009 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 9.785911e-01 | 0.009 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.791470e-01 | 0.009 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 9.792346e-01 | 0.009 | 0 | 0 |
| Pyrimidine biosynthesis | R-HSA-500753 | 9.806500e-01 | 0.008 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 9.806500e-01 | 0.008 | 0 | 0 |
| Amino Acid conjugation | R-HSA-156587 | 9.806500e-01 | 0.008 | 0 | 0 |
| Conjugation of carboxylic acids | R-HSA-159424 | 9.806500e-01 | 0.008 | 0 | 0 |
| Synthesis of 5-eicosatetraenoic acids | R-HSA-2142688 | 9.806500e-01 | 0.008 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 9.806500e-01 | 0.008 | 0 | 0 |
| Strand-asynchronous mitochondrial DNA replication | R-HSA-9913635 | 9.806500e-01 | 0.008 | 0 | 0 |
| Transport of nucleotide sugars | R-HSA-727802 | 9.806500e-01 | 0.008 | 0 | 0 |
| HDL remodeling | R-HSA-8964058 | 9.806500e-01 | 0.008 | 0 | 0 |
| Crosslinking of collagen fibrils | R-HSA-2243919 | 9.806500e-01 | 0.008 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 9.806500e-01 | 0.008 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.807111e-01 | 0.008 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 9.807111e-01 | 0.008 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.813975e-01 | 0.008 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.814070e-01 | 0.008 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.817364e-01 | 0.008 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 9.819436e-01 | 0.008 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 9.828556e-01 | 0.008 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 9.835851e-01 | 0.007 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 9.838453e-01 | 0.007 | 0 | 0 |
| Aspartate and asparagine metabolism | R-HSA-8963693 | 9.838453e-01 | 0.007 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 9.840610e-01 | 0.007 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 9.850949e-01 | 0.007 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.850949e-01 | 0.007 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.857487e-01 | 0.006 | 0 | 0 |
| Synthesis, secretion, and deacylation of Ghrelin | R-HSA-422085 | 9.860752e-01 | 0.006 | 0 | 0 |
| Vitamin C (ascorbate) metabolism | R-HSA-196836 | 9.860752e-01 | 0.006 | 0 | 0 |
| Acyl chain remodelling of PG | R-HSA-1482925 | 9.860752e-01 | 0.006 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 9.866690e-01 | 0.006 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.866690e-01 | 0.006 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.870038e-01 | 0.006 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.870190e-01 | 0.006 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.880850e-01 | 0.005 | 0 | 0 |
| CS-GAG biosynthesis | R-HSA-2022870 | 9.881877e-01 | 0.005 | 0 | 0 |
| Eicosanoids | R-HSA-211979 | 9.881877e-01 | 0.005 | 0 | 0 |
| Miscellaneous substrates | R-HSA-211958 | 9.881877e-01 | 0.005 | 0 | 0 |
| Molybdenum cofactor biosynthesis | R-HSA-947581 | 9.881877e-01 | 0.005 | 0 | 0 |
| Glutathione synthesis and recycling | R-HSA-174403 | 9.881877e-01 | 0.005 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 9.881877e-01 | 0.005 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 9.883592e-01 | 0.005 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.884446e-01 | 0.005 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 9.884446e-01 | 0.005 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 9.886186e-01 | 0.005 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.892366e-01 | 0.005 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.892366e-01 | 0.005 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.894399e-01 | 0.005 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.894539e-01 | 0.005 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 9.894539e-01 | 0.005 | 0 | 0 |
| Glutamate and glutamine metabolism | R-HSA-8964539 | 9.894539e-01 | 0.005 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.899100e-01 | 0.004 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in lysosome biogenesis and autophagy | R-HSA-9857377 | 9.899797e-01 | 0.004 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 9.899797e-01 | 0.004 | 0 | 0 |
| Reactions specific to the complex N-glycan synthesis pathway | R-HSA-975578 | 9.899797e-01 | 0.004 | 0 | 0 |
| Cholesterol biosynthesis via lathosterol | R-HSA-6807062 | 9.899797e-01 | 0.004 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 9.908604e-01 | 0.004 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.914402e-01 | 0.004 | 0 | 0 |
| Fatty acids | R-HSA-211935 | 9.915000e-01 | 0.004 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 9.915000e-01 | 0.004 | 0 | 0 |
| Synthesis of UDP-N-acetyl-glucosamine | R-HSA-446210 | 9.915000e-01 | 0.004 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 9.915000e-01 | 0.004 | 0 | 0 |
| Biosynthesis of maresins | R-HSA-9018682 | 9.915000e-01 | 0.004 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 9.920830e-01 | 0.003 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.920850e-01 | 0.003 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 9.927897e-01 | 0.003 | 0 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 9.927897e-01 | 0.003 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 9.931451e-01 | 0.003 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.934040e-01 | 0.003 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 9.938838e-01 | 0.003 | 0 | 0 |
| Beta-oxidation of pristanoyl-CoA | R-HSA-389887 | 9.938838e-01 | 0.003 | 0 | 0 |
| Retinoid cycle disease events | R-HSA-2453864 | 9.938838e-01 | 0.003 | 0 | 0 |
| Diseases associated with visual transduction | R-HSA-2474795 | 9.938838e-01 | 0.003 | 0 | 0 |
| Diseases of the neuronal system | R-HSA-9675143 | 9.938838e-01 | 0.003 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 9.938838e-01 | 0.003 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 9.938838e-01 | 0.003 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.940077e-01 | 0.003 | 0 | 0 |
| Beta-oxidation of very long chain fatty acids | R-HSA-390247 | 9.940672e-01 | 0.003 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 9.940672e-01 | 0.003 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 9.940672e-01 | 0.003 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.943964e-01 | 0.002 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.945256e-01 | 0.002 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 9.945445e-01 | 0.002 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.947395e-01 | 0.002 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 9.947395e-01 | 0.002 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 9.948119e-01 | 0.002 | 0 | 0 |
| Abacavir ADME | R-HSA-2161522 | 9.948119e-01 | 0.002 | 0 | 0 |
| alpha-linolenic acid (ALA) metabolism | R-HSA-2046106 | 9.948674e-01 | 0.002 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.951642e-01 | 0.002 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.951642e-01 | 0.002 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 9.955279e-01 | 0.002 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 9.955992e-01 | 0.002 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 9.955992e-01 | 0.002 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 9.955992e-01 | 0.002 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 9.955992e-01 | 0.002 | 0 | 0 |
| Glutathione conjugation | R-HSA-156590 | 9.957307e-01 | 0.002 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.957307e-01 | 0.002 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 9.959706e-01 | 0.002 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.960679e-01 | 0.002 | 0 | 0 |
| Maturation of TCA enzymes and regulation of TCA cycle | R-HSA-9854311 | 9.961630e-01 | 0.002 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.962937e-01 | 0.002 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.966748e-01 | 0.001 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 9.966843e-01 | 0.001 | 0 | 0 |
| Thyroxine biosynthesis | R-HSA-209968 | 9.968337e-01 | 0.001 | 0 | 0 |
| Activation of Matrix Metalloproteinases | R-HSA-1592389 | 9.968337e-01 | 0.001 | 0 | 0 |
| Regulation of pyruvate dehydrogenase (PDH) complex | R-HSA-204174 | 9.968337e-01 | 0.001 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.973085e-01 | 0.001 | 0 | 0 |
| Mucopolysaccharidoses | R-HSA-2206281 | 9.973143e-01 | 0.001 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.973335e-01 | 0.001 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.973826e-01 | 0.001 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.976037e-01 | 0.001 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.976304e-01 | 0.001 | 0 | 0 |
| Glucuronidation | R-HSA-156588 | 9.976493e-01 | 0.001 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 9.977219e-01 | 0.001 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 9.977219e-01 | 0.001 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.977560e-01 | 0.001 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 9.980678e-01 | 0.001 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.980959e-01 | 0.001 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.980959e-01 | 0.001 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 9.982403e-01 | 0.001 | 0 | 0 |
| Keratan sulfate biosynthesis | R-HSA-2022854 | 9.983611e-01 | 0.001 | 0 | 0 |
| Diseases associated with glycosylation precursor biosynthesis | R-HSA-5609975 | 9.983611e-01 | 0.001 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 9.984042e-01 | 0.001 | 0 | 0 |
| Diseases associated with glycosaminoglycan metabolism | R-HSA-3560782 | 9.984103e-01 | 0.001 | 0 | 0 |
| Degradation of cysteine and homocysteine | R-HSA-1614558 | 9.984103e-01 | 0.001 | 0 | 0 |
| CS/DS degradation | R-HSA-2024101 | 9.986099e-01 | 0.001 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 9.986290e-01 | 0.001 | 0 | 0 |
| alpha-linolenic (omega3) and linoleic (omega6) acid metabolism | R-HSA-2046104 | 9.988179e-01 | 0.001 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.988179e-01 | 0.001 | 0 | 0 |
| Glycosaminoglycan-protein linkage region biosynthesis | R-HSA-1971475 | 9.988210e-01 | 0.001 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 9.988210e-01 | 0.001 | 0 | 0 |
| Phosphate bond hydrolysis by NUDT proteins | R-HSA-2393930 | 9.988210e-01 | 0.001 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.988795e-01 | 0.000 | 0 | 0 |
| Disease | R-HSA-1643685 | 9.989155e-01 | 0.000 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.990993e-01 | 0.000 | 0 | 0 |
| Keratan sulfate/keratin metabolism | R-HSA-1638074 | 9.991219e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 9.991518e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.991543e-01 | 0.000 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.991913e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.992443e-01 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.992709e-01 | 0.000 | 0 | 0 |
| Ubiquinol biosynthesis | R-HSA-2142789 | 9.992806e-01 | 0.000 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 9.992806e-01 | 0.000 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 9.992806e-01 | 0.000 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.993484e-01 | 0.000 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.993484e-01 | 0.000 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.993779e-01 | 0.000 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.993779e-01 | 0.000 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 9.993899e-01 | 0.000 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 9.994825e-01 | 0.000 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 9.994825e-01 | 0.000 | 0 | 0 |
| N-glycan antennae elongation in the medial/trans-Golgi | R-HSA-975576 | 9.995611e-01 | 0.000 | 0 | 0 |
| Tryptophan catabolism | R-HSA-71240 | 9.995611e-01 | 0.000 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 9.995611e-01 | 0.000 | 0 | 0 |
| Aflatoxin activation and detoxification | R-HSA-5423646 | 9.996278e-01 | 0.000 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.996380e-01 | 0.000 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.996380e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.996609e-01 | 0.000 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.996609e-01 | 0.000 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 9.996843e-01 | 0.000 | 0 | 0 |
| Synthesis of very long-chain fatty acyl-CoAs | R-HSA-75876 | 9.997729e-01 | 0.000 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.997833e-01 | 0.000 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.998073e-01 | 0.000 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.998074e-01 | 0.000 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 9.998074e-01 | 0.000 | 0 | 0 |
| Methylation | R-HSA-156581 | 9.998074e-01 | 0.000 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.998074e-01 | 0.000 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 9.998319e-01 | 0.000 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.998331e-01 | 0.000 | 0 | 0 |
| The canonical retinoid cycle in rods (twilight vision) | R-HSA-2453902 | 9.998367e-01 | 0.000 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.998749e-01 | 0.000 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.998844e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.998989e-01 | 0.000 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.999083e-01 | 0.000 | 0 | 0 |
| Xenobiotics | R-HSA-211981 | 9.999083e-01 | 0.000 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.999155e-01 | 0.000 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.999181e-01 | 0.000 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.999181e-01 | 0.000 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.999268e-01 | 0.000 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.999291e-01 | 0.000 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.999377e-01 | 0.000 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.999420e-01 | 0.000 | 0 | 0 |
| Translation | R-HSA-72766 | 9.999435e-01 | 0.000 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.999468e-01 | 0.000 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.999482e-01 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.999490e-01 | 0.000 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.999633e-01 | 0.000 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.999685e-01 | 0.000 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.999685e-01 | 0.000 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.999685e-01 | 0.000 | 0 | 0 |
| Chondroitin sulfate/dermatan sulfate metabolism | R-HSA-1793185 | 9.999686e-01 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.999727e-01 | 0.000 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 9.999734e-01 | 0.000 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.999768e-01 | 0.000 | 0 | 0 |
| Transport of vitamins, nucleosides, and related molecules | R-HSA-425397 | 9.999801e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.999841e-01 | 0.000 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.999862e-01 | 0.000 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.999875e-01 | 0.000 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 9.999883e-01 | 0.000 | 0 | 0 |
| Metabolic disorders of biological oxidation enzymes | R-HSA-5579029 | 9.999908e-01 | 0.000 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.999916e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.999924e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 9.999957e-01 | 0.000 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.999958e-01 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.999959e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.999971e-01 | 0.000 | 0 | 0 |
| Sulfur amino acid metabolism | R-HSA-1614635 | 9.999973e-01 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.999980e-01 | 0.000 | 0 | 0 |
| Class C/3 (Metabotropic glutamate/pheromone receptors) | R-HSA-420499 | 9.999980e-01 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.999989e-01 | 0.000 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.999992e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.999993e-01 | 0.000 | 0 | 0 |
| Biosynthesis of DHA-derived SPMs | R-HSA-9018677 | 9.999996e-01 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.999996e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.999996e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.999998e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.999999e-01 | 0.000 | 0 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 9.999999e-01 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 9.999999e-01 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.999999e-01 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 1.000000e+00 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 1.000000e+00 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 1.000000e+00 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 1.000000e+00 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 1.000000e+00 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 1.000000e+00 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 1.000000e+00 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 1.000000e+00 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 1.000000e+00 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 1.000000e+00 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 1.000000e+00 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 1.000000e+00 | 0.000 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 1.000000e+00 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 1.000000e+00 | 0.000 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 1.000000e+00 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 1.000000e+00 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of specialized proresolving mediators (SPMs) | R-HSA-9018678 | 1.000000e+00 | 0.000 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Expression and translocation of olfactory receptors | R-HSA-9752946 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | -0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | -0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | -0.000 | 0 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 1.110223e-16 | 15.955 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 1.110223e-16 | 15.955 | 0 | 0 |
| M Phase | R-HSA-68886 | 1.110223e-16 | 15.955 | 1 | 0 |
| Axon guidance | R-HSA-422475 | 1.110223e-16 | 15.955 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 1.110223e-16 | 15.955 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 1.110223e-16 | 15.955 | 1 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 1.110223e-16 | 15.955 | 1 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 1.110223e-16 | 15.955 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 3.330669e-16 | 15.477 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 1.443290e-15 | 14.841 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 4.996004e-15 | 14.301 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 6.106227e-15 | 14.214 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 9.214851e-15 | 14.036 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 1.121325e-14 | 13.950 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 2.320366e-14 | 13.634 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 7.016610e-14 | 13.154 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 6.894485e-14 | 13.161 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 9.980905e-14 | 13.001 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 1.119105e-13 | 12.951 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 1.367795e-13 | 12.864 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 3.713696e-13 | 12.430 | 1 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 3.885781e-13 | 12.411 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 5.088152e-13 | 12.293 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 5.381251e-13 | 12.269 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 9.174883e-13 | 12.037 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 1.011857e-12 | 11.995 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 1.000533e-12 | 12.000 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 1.000533e-12 | 12.000 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 1.196265e-12 | 11.922 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 1.266764e-12 | 11.897 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 1.314615e-12 | 11.881 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 3.446687e-12 | 11.463 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 4.318879e-12 | 11.365 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 4.917178e-12 | 11.308 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 5.083378e-12 | 11.294 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 6.264544e-12 | 11.203 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 6.264544e-12 | 11.203 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 6.273759e-12 | 11.202 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 7.284839e-12 | 11.138 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 8.148260e-12 | 11.089 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 1.069189e-11 | 10.971 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 1.170697e-11 | 10.932 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 1.513667e-11 | 10.820 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 2.578326e-11 | 10.589 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 3.517320e-11 | 10.454 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 8.333656e-11 | 10.079 | 1 | 1 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 8.602652e-11 | 10.065 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 8.602652e-11 | 10.065 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 1.196903e-10 | 9.922 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 1.394315e-10 | 9.856 | 1 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 1.947724e-10 | 9.710 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 2.261770e-10 | 9.646 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 2.972090e-10 | 9.527 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 2.972090e-10 | 9.527 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 3.324447e-10 | 9.478 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 3.294069e-10 | 9.482 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 3.712288e-10 | 9.430 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 5.306563e-10 | 9.275 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 5.396908e-10 | 9.268 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 6.116367e-10 | 9.214 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 7.233136e-10 | 9.141 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 7.576824e-10 | 9.121 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 8.377633e-10 | 9.077 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 1.113946e-09 | 8.953 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 1.684438e-09 | 8.774 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 2.065366e-09 | 8.685 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 2.524764e-09 | 8.598 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 3.869588e-09 | 8.412 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 4.782281e-09 | 8.320 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 4.782281e-09 | 8.320 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 5.409176e-09 | 8.267 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 5.718188e-09 | 8.243 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 6.473701e-09 | 8.189 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 6.900707e-09 | 8.161 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 9.493477e-09 | 8.023 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 1.036836e-08 | 7.984 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 1.351114e-08 | 7.869 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 1.415383e-08 | 7.849 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 1.501845e-08 | 7.823 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 1.678044e-08 | 7.775 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 1.678044e-08 | 7.775 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 2.239618e-08 | 7.650 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 2.973534e-08 | 7.527 | 0 | 0 |
| Translation | R-HSA-72766 | 3.315390e-08 | 7.479 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 3.918456e-08 | 7.407 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 5.057714e-08 | 7.296 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 5.545405e-08 | 7.256 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 5.642021e-08 | 7.249 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 5.961693e-08 | 7.225 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 6.369662e-08 | 7.196 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 6.545625e-08 | 7.184 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 7.127123e-08 | 7.147 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 8.198510e-08 | 7.086 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 8.183937e-08 | 7.087 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 8.825370e-08 | 7.054 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 8.826473e-08 | 7.054 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 1.008287e-07 | 6.996 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 1.042094e-07 | 6.982 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 1.123059e-07 | 6.950 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 1.526993e-07 | 6.816 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 1.648873e-07 | 6.783 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 1.718240e-07 | 6.765 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 1.720272e-07 | 6.764 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 1.919482e-07 | 6.717 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 1.953580e-07 | 6.709 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 2.161166e-07 | 6.665 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 2.313551e-07 | 6.636 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 2.385388e-07 | 6.622 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 2.520124e-07 | 6.599 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 2.752820e-07 | 6.560 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 2.802813e-07 | 6.552 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 3.107566e-07 | 6.508 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 3.080469e-07 | 6.511 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 3.107566e-07 | 6.508 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 3.824646e-07 | 6.417 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 3.824646e-07 | 6.417 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 4.073781e-07 | 6.390 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 4.344910e-07 | 6.362 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 4.541136e-07 | 6.343 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 4.741828e-07 | 6.324 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 4.707422e-07 | 6.327 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 4.811139e-07 | 6.318 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 5.348826e-07 | 6.272 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 5.749890e-07 | 6.240 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 5.879058e-07 | 6.231 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 6.651818e-07 | 6.177 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 7.402855e-07 | 6.131 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 8.392064e-07 | 6.076 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 9.342501e-07 | 6.030 | 1 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 1.179289e-06 | 5.928 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 1.193136e-06 | 5.923 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 1.288456e-06 | 5.890 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 1.399879e-06 | 5.854 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 1.787337e-06 | 5.748 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 1.787382e-06 | 5.748 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 1.821062e-06 | 5.740 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 1.892283e-06 | 5.723 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 2.184269e-06 | 5.661 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 2.309255e-06 | 5.637 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 2.319236e-06 | 5.635 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 2.516714e-06 | 5.599 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 2.583727e-06 | 5.588 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 2.844902e-06 | 5.546 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 3.276106e-06 | 5.485 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 3.360130e-06 | 5.474 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 3.947488e-06 | 5.404 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 3.947488e-06 | 5.404 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 4.459675e-06 | 5.351 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 4.511548e-06 | 5.346 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 4.555880e-06 | 5.341 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 4.555880e-06 | 5.341 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 4.626525e-06 | 5.335 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 4.839929e-06 | 5.315 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 4.868267e-06 | 5.313 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 4.868267e-06 | 5.313 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 4.872255e-06 | 5.312 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 5.387091e-06 | 5.269 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 6.224963e-06 | 5.206 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 6.660349e-06 | 5.177 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 6.660349e-06 | 5.177 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 7.144514e-06 | 5.146 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 7.588557e-06 | 5.120 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 7.778807e-06 | 5.109 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 8.705329e-06 | 5.060 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 8.705329e-06 | 5.060 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 9.231109e-06 | 5.035 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 9.775943e-06 | 5.010 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 1.050352e-05 | 4.979 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 1.141680e-05 | 4.942 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 1.151646e-05 | 4.939 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 1.249662e-05 | 4.903 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 1.296008e-05 | 4.887 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 1.576965e-05 | 4.802 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 1.631137e-05 | 4.788 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 1.508248e-05 | 4.822 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 1.562722e-05 | 4.806 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 1.619040e-05 | 4.791 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 1.631137e-05 | 4.788 | 0 | 0 |
| Depurination | R-HSA-73927 | 1.508248e-05 | 4.822 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 1.533649e-05 | 4.814 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 1.706339e-05 | 4.768 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 1.855415e-05 | 4.732 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 1.886500e-05 | 4.724 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 1.992727e-05 | 4.701 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 2.112473e-05 | 4.675 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 2.133884e-05 | 4.671 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 2.303169e-05 | 4.638 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 2.378735e-05 | 4.624 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 2.753602e-05 | 4.560 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 2.817225e-05 | 4.550 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 3.094610e-05 | 4.509 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 3.293475e-05 | 4.482 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 3.756751e-05 | 4.425 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 3.363804e-05 | 4.473 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 4.021909e-05 | 4.396 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 4.114999e-05 | 4.386 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 4.261056e-05 | 4.370 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 4.441608e-05 | 4.352 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 4.482888e-05 | 4.348 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 4.542584e-05 | 4.343 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 4.611535e-05 | 4.336 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 4.995000e-05 | 4.301 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 5.198010e-05 | 4.284 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 5.198010e-05 | 4.284 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 5.437938e-05 | 4.265 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 5.587561e-05 | 4.253 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 5.703105e-05 | 4.244 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 5.703105e-05 | 4.244 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 5.703105e-05 | 4.244 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 5.980746e-05 | 4.223 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 6.279998e-05 | 4.202 | 0 | 0 |
| Kinesins | R-HSA-983189 | 6.539447e-05 | 4.184 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 7.162412e-05 | 4.145 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 7.895262e-05 | 4.103 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 8.067070e-05 | 4.093 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 7.640526e-05 | 4.117 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 7.193308e-05 | 4.143 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 7.162412e-05 | 4.145 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 8.139448e-05 | 4.089 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 8.323472e-05 | 4.080 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 9.045239e-05 | 4.044 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 9.816631e-05 | 4.008 | 1 | 1 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 1.009484e-04 | 3.996 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 1.057512e-04 | 3.976 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 1.097263e-04 | 3.960 | 0 | 0 |
| Protein folding | R-HSA-391251 | 1.101944e-04 | 3.958 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 1.133048e-04 | 3.946 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 1.191749e-04 | 3.924 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 1.288909e-04 | 3.890 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 1.314374e-04 | 3.881 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 1.374590e-04 | 3.862 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 1.576552e-04 | 3.802 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 1.631786e-04 | 3.787 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 1.714407e-04 | 3.766 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 1.840939e-04 | 3.735 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 1.904246e-04 | 3.720 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 2.156526e-04 | 3.666 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 2.181315e-04 | 3.661 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 2.181315e-04 | 3.661 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 2.215009e-04 | 3.655 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 2.261684e-04 | 3.646 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 2.306749e-04 | 3.637 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 2.458543e-04 | 3.609 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 2.468219e-04 | 3.608 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 2.535149e-04 | 3.596 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 2.713306e-04 | 3.567 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 2.753083e-04 | 3.560 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 2.974006e-04 | 3.527 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 2.997830e-04 | 3.523 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 3.000825e-04 | 3.523 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 3.042732e-04 | 3.517 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 3.091885e-04 | 3.510 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 3.523168e-04 | 3.453 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 3.523168e-04 | 3.453 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 3.523168e-04 | 3.453 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 3.701094e-04 | 3.432 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 3.819074e-04 | 3.418 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 3.819074e-04 | 3.418 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 3.892887e-04 | 3.410 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 4.095652e-04 | 3.388 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 4.225543e-04 | 3.374 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 4.287262e-04 | 3.368 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 4.450186e-04 | 3.352 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 5.153837e-04 | 3.288 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 5.281079e-04 | 3.277 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 5.293537e-04 | 3.276 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 5.346567e-04 | 3.272 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 5.444047e-04 | 3.264 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 5.560211e-04 | 3.255 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 5.633623e-04 | 3.249 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 5.812985e-04 | 3.236 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 5.925261e-04 | 3.227 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 6.029152e-04 | 3.220 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 6.029152e-04 | 3.220 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 6.062366e-04 | 3.217 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 6.845961e-04 | 3.165 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 7.060173e-04 | 3.151 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 7.106977e-04 | 3.148 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 8.619576e-04 | 3.065 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 8.117457e-04 | 3.091 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 8.595758e-04 | 3.066 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 8.595758e-04 | 3.066 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 8.117457e-04 | 3.091 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 8.585736e-04 | 3.066 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 8.053150e-04 | 3.094 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 7.485458e-04 | 3.126 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 7.541095e-04 | 3.123 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 8.083917e-04 | 3.092 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 8.924592e-04 | 3.049 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 9.626360e-04 | 3.017 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 9.813043e-04 | 3.008 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 9.862832e-04 | 3.006 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 1.019150e-03 | 2.992 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 1.110641e-03 | 2.954 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 1.110641e-03 | 2.954 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 1.145037e-03 | 2.941 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 1.145037e-03 | 2.941 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 1.145037e-03 | 2.941 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 1.145037e-03 | 2.941 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 1.145037e-03 | 2.941 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 1.153324e-03 | 2.938 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 1.180864e-03 | 2.928 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 1.194479e-03 | 2.923 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 1.194479e-03 | 2.923 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 1.232932e-03 | 2.909 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 1.232932e-03 | 2.909 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 1.270800e-03 | 2.896 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 1.270800e-03 | 2.896 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 1.270800e-03 | 2.896 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 1.302642e-03 | 2.885 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 1.302642e-03 | 2.885 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 1.309879e-03 | 2.883 | 0 | 0 |
| S Phase | R-HSA-69242 | 1.336142e-03 | 2.874 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 1.338744e-03 | 2.873 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 1.355557e-03 | 2.868 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 1.382562e-03 | 2.859 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 1.382562e-03 | 2.859 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 1.522391e-03 | 2.817 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 1.646975e-03 | 2.783 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 1.650508e-03 | 2.782 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 1.656009e-03 | 2.781 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 1.656975e-03 | 2.781 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 1.656975e-03 | 2.781 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 1.770943e-03 | 2.752 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 1.819478e-03 | 2.740 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 1.857937e-03 | 2.731 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 1.875448e-03 | 2.727 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 1.994457e-03 | 2.700 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 1.994457e-03 | 2.700 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 2.053254e-03 | 2.688 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 2.053254e-03 | 2.688 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 2.128943e-03 | 2.672 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 2.186815e-03 | 2.660 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 2.186815e-03 | 2.660 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 2.261971e-03 | 2.646 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 2.266329e-03 | 2.645 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 2.266329e-03 | 2.645 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 2.867891e-03 | 2.542 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 3.045752e-03 | 2.516 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 3.045752e-03 | 2.516 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 2.910965e-03 | 2.536 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 2.818678e-03 | 2.550 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 2.816370e-03 | 2.550 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 2.904391e-03 | 2.537 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 2.816370e-03 | 2.550 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 3.141049e-03 | 2.503 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 3.141049e-03 | 2.503 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 2.655061e-03 | 2.576 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 2.762840e-03 | 2.559 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 2.543886e-03 | 2.595 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 3.208851e-03 | 2.494 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 3.317685e-03 | 2.479 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 3.324209e-03 | 2.478 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 3.330188e-03 | 2.478 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 3.427599e-03 | 2.465 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 3.663719e-03 | 2.436 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 3.687795e-03 | 2.433 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 3.710372e-03 | 2.431 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 3.710372e-03 | 2.431 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 3.903543e-03 | 2.409 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 3.903543e-03 | 2.409 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 3.921244e-03 | 2.407 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 3.999896e-03 | 2.398 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 3.999896e-03 | 2.398 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 4.015112e-03 | 2.396 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 4.045204e-03 | 2.393 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 4.045204e-03 | 2.393 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 4.073438e-03 | 2.390 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 4.173318e-03 | 2.380 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 4.206499e-03 | 2.376 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 4.254090e-03 | 2.371 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 4.425216e-03 | 2.354 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 4.582221e-03 | 2.339 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 4.624633e-03 | 2.335 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 4.641277e-03 | 2.333 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 4.641277e-03 | 2.333 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 4.669718e-03 | 2.331 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 4.812677e-03 | 2.318 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 4.945990e-03 | 2.306 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 4.945990e-03 | 2.306 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 4.955005e-03 | 2.305 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 4.955005e-03 | 2.305 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 5.100963e-03 | 2.292 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 5.201836e-03 | 2.284 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 5.515257e-03 | 2.258 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 5.648531e-03 | 2.248 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 5.792928e-03 | 2.237 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 5.808676e-03 | 2.236 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 5.808676e-03 | 2.236 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 5.808676e-03 | 2.236 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 5.898573e-03 | 2.229 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 5.952949e-03 | 2.225 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 5.952949e-03 | 2.225 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 5.995106e-03 | 2.222 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 5.995106e-03 | 2.222 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 6.056547e-03 | 2.218 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 6.141802e-03 | 2.212 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 6.607855e-03 | 2.180 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 6.634080e-03 | 2.178 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 6.986084e-03 | 2.156 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 6.988762e-03 | 2.156 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 7.074489e-03 | 2.150 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 7.147466e-03 | 2.146 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 7.466850e-03 | 2.127 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 7.682805e-03 | 2.114 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 8.126966e-03 | 2.090 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 8.145981e-03 | 2.089 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 8.215985e-03 | 2.085 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 8.215985e-03 | 2.085 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 8.215985e-03 | 2.085 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 8.324251e-03 | 2.080 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 8.340357e-03 | 2.079 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 8.370785e-03 | 2.077 | 0 | 0 |
| Maturation of protein E | R-HSA-9694493 | 8.421571e-03 | 2.075 | 0 | 0 |
| Maturation of protein E | R-HSA-9683683 | 8.421571e-03 | 2.075 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 8.706651e-03 | 2.060 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 8.889086e-03 | 2.051 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 8.889086e-03 | 2.051 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 9.291487e-03 | 2.032 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 9.369762e-03 | 2.028 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 9.756890e-03 | 2.011 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 9.756890e-03 | 2.011 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 1.195751e-02 | 1.922 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 1.195751e-02 | 1.922 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 1.195751e-02 | 1.922 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 1.034916e-02 | 1.985 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 1.050693e-02 | 1.979 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 1.018601e-02 | 1.992 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 1.018601e-02 | 1.992 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 1.204743e-02 | 1.919 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 9.602420e-03 | 2.018 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 1.023675e-02 | 1.990 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 1.198317e-02 | 1.921 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 1.268856e-02 | 1.897 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 1.198317e-02 | 1.921 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 9.602420e-03 | 2.018 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 9.602420e-03 | 2.018 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 1.023675e-02 | 1.990 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 1.204743e-02 | 1.919 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 1.116055e-02 | 1.952 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 9.548431e-03 | 2.020 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 9.923177e-03 | 2.003 | 0 | 0 |
| Immune System | R-HSA-168256 | 1.243113e-02 | 1.905 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 1.290294e-02 | 1.889 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 1.290294e-02 | 1.889 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 1.316301e-02 | 1.881 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 1.339700e-02 | 1.873 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 1.341895e-02 | 1.872 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 1.357335e-02 | 1.867 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 1.407084e-02 | 1.852 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 1.501094e-02 | 1.824 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 1.529182e-02 | 1.816 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 1.529182e-02 | 1.816 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 1.627227e-02 | 1.789 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 1.627227e-02 | 1.789 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 1.627227e-02 | 1.789 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 1.656645e-02 | 1.781 | 0 | 0 |
| Formation of editosomes by ADAR proteins | R-HSA-77042 | 1.682345e-02 | 1.774 | 0 | 0 |
| Loss of MECP2 binding ability to 5hmC-DNA | R-HSA-9022534 | 1.682345e-02 | 1.774 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 1.699050e-02 | 1.770 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 1.705934e-02 | 1.768 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 1.705934e-02 | 1.768 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 1.717015e-02 | 1.765 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 1.720004e-02 | 1.764 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 1.724543e-02 | 1.763 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 1.724543e-02 | 1.763 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 1.724543e-02 | 1.763 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 1.724543e-02 | 1.763 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 1.742785e-02 | 1.759 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 1.755893e-02 | 1.756 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 1.755893e-02 | 1.756 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 1.846036e-02 | 1.734 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 1.856678e-02 | 1.731 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 1.879507e-02 | 1.726 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 2.052593e-02 | 1.688 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 2.052593e-02 | 1.688 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 2.080194e-02 | 1.682 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 2.158996e-02 | 1.666 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 2.158996e-02 | 1.666 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 2.178785e-02 | 1.662 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 2.178785e-02 | 1.662 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 2.178785e-02 | 1.662 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 2.178785e-02 | 1.662 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 2.178785e-02 | 1.662 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 2.184638e-02 | 1.661 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 2.186306e-02 | 1.660 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 2.195759e-02 | 1.658 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 2.196360e-02 | 1.658 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 2.196360e-02 | 1.658 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 2.216166e-02 | 1.654 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 2.265873e-02 | 1.645 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 2.271051e-02 | 1.644 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 2.383223e-02 | 1.623 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 2.383223e-02 | 1.623 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 2.383223e-02 | 1.623 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 2.400003e-02 | 1.620 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 2.400003e-02 | 1.620 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 2.400003e-02 | 1.620 | 0 | 0 |
| Modulation by Mtb of host immune system | R-HSA-9637628 | 2.400003e-02 | 1.620 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 2.400026e-02 | 1.620 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 2.422862e-02 | 1.616 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 2.448493e-02 | 1.611 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 2.467122e-02 | 1.608 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 2.514481e-02 | 1.600 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 2.656193e-02 | 1.576 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 2.656193e-02 | 1.576 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 2.729429e-02 | 1.564 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 2.731692e-02 | 1.564 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 2.732810e-02 | 1.563 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 2.732810e-02 | 1.563 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 2.732810e-02 | 1.563 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 2.984538e-02 | 1.525 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 3.021045e-02 | 1.520 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 3.025467e-02 | 1.519 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 3.068673e-02 | 1.513 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 3.128741e-02 | 1.505 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 3.153021e-02 | 1.501 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 3.153021e-02 | 1.501 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 3.153745e-02 | 1.501 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 3.153745e-02 | 1.501 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 3.153745e-02 | 1.501 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 3.161343e-02 | 1.500 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 3.171988e-02 | 1.499 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 3.174635e-02 | 1.498 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 3.190258e-02 | 1.496 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 3.231889e-02 | 1.491 | 0 | 0 |
| NFE2L2 regulating TCA cycle genes | R-HSA-9818025 | 3.231889e-02 | 1.491 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 3.551237e-02 | 1.450 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 4.496150e-02 | 1.347 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 4.496150e-02 | 1.347 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 3.361307e-02 | 1.473 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 4.076989e-02 | 1.390 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 4.878165e-02 | 1.312 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 4.077456e-02 | 1.390 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 4.481821e-02 | 1.349 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 3.455580e-02 | 1.461 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 3.576489e-02 | 1.447 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 3.922860e-02 | 1.406 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 3.922860e-02 | 1.406 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 3.256759e-02 | 1.487 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 4.077456e-02 | 1.390 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 3.922860e-02 | 1.406 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 3.361307e-02 | 1.473 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 3.727352e-02 | 1.429 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 4.392533e-02 | 1.357 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 3.510118e-02 | 1.455 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 3.551237e-02 | 1.450 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 4.076989e-02 | 1.390 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 3.843274e-02 | 1.415 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 3.371402e-02 | 1.472 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 3.256759e-02 | 1.487 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 4.076989e-02 | 1.390 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 3.886934e-02 | 1.410 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 4.496150e-02 | 1.347 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 3.811747e-02 | 1.419 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 4.594524e-02 | 1.338 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 3.361307e-02 | 1.473 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 4.734165e-02 | 1.325 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 3.361307e-02 | 1.473 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 4.261358e-02 | 1.370 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 4.878165e-02 | 1.312 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 4.110997e-02 | 1.386 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 3.440605e-02 | 1.463 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 3.700979e-02 | 1.432 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 3.922860e-02 | 1.406 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 4.031511e-02 | 1.395 | 0 | 0 |
| Disease | R-HSA-1643685 | 3.770642e-02 | 1.424 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 3.886934e-02 | 1.410 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 4.734165e-02 | 1.325 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 3.493533e-02 | 1.457 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 4.039003e-02 | 1.394 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 4.076989e-02 | 1.390 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 3.886934e-02 | 1.410 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 4.496150e-02 | 1.347 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 4.433150e-02 | 1.353 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 4.031511e-02 | 1.395 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 4.987140e-02 | 1.302 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 4.987140e-02 | 1.302 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 5.016974e-02 | 1.300 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 5.034238e-02 | 1.298 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 5.034238e-02 | 1.298 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 5.067701e-02 | 1.295 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 5.067701e-02 | 1.295 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 5.139406e-02 | 1.289 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 5.148922e-02 | 1.288 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 5.166269e-02 | 1.287 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 5.166269e-02 | 1.287 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 5.207197e-02 | 1.283 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 5.207197e-02 | 1.283 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 5.353047e-02 | 1.271 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 5.412579e-02 | 1.267 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 5.412579e-02 | 1.267 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 5.412579e-02 | 1.267 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 5.548569e-02 | 1.256 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 5.548826e-02 | 1.256 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 5.732349e-02 | 1.242 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 5.765655e-02 | 1.239 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 5.765655e-02 | 1.239 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 5.765655e-02 | 1.239 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 5.765655e-02 | 1.239 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 5.926214e-02 | 1.227 | 0 | 0 |
| mRNA Editing: A to I Conversion | R-HSA-75064 | 5.926214e-02 | 1.227 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 5.926214e-02 | 1.227 | 0 | 0 |
| C6 deamination of adenosine | R-HSA-75102 | 5.926214e-02 | 1.227 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 5.926214e-02 | 1.227 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 5.926214e-02 | 1.227 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 5.926214e-02 | 1.227 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 5.926214e-02 | 1.227 | 0 | 0 |
| Tandem of pore domain in a weak inwardly rectifying K+ channels (TWIK) | R-HSA-1299308 | 5.926214e-02 | 1.227 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 5.926214e-02 | 1.227 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 5.926214e-02 | 1.227 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 5.926214e-02 | 1.227 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 5.926214e-02 | 1.227 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 5.926214e-02 | 1.227 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 5.948876e-02 | 1.226 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 5.968719e-02 | 1.224 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 5.986727e-02 | 1.223 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 5.986727e-02 | 1.223 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 6.160987e-02 | 1.210 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 6.160987e-02 | 1.210 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 6.160987e-02 | 1.210 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 6.236818e-02 | 1.205 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 6.426431e-02 | 1.192 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 6.513214e-02 | 1.186 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 6.722179e-02 | 1.172 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 6.739439e-02 | 1.171 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 6.739439e-02 | 1.171 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 6.739439e-02 | 1.171 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 6.766234e-02 | 1.170 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 7.190348e-02 | 1.143 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 7.204442e-02 | 1.142 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 7.375139e-02 | 1.132 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 7.375139e-02 | 1.132 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 7.375139e-02 | 1.132 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 7.409131e-02 | 1.130 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 7.409131e-02 | 1.130 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 7.409131e-02 | 1.130 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 7.409131e-02 | 1.130 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 7.519343e-02 | 1.124 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 7.542834e-02 | 1.122 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 7.636833e-02 | 1.117 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 7.636833e-02 | 1.117 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 7.662858e-02 | 1.116 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 7.742746e-02 | 1.111 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 7.798691e-02 | 1.108 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 7.798691e-02 | 1.108 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 7.850665e-02 | 1.105 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 7.992628e-02 | 1.097 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 8.065856e-02 | 1.093 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 8.065856e-02 | 1.093 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 8.147763e-02 | 1.089 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 8.541738e-02 | 1.068 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 8.645814e-02 | 1.063 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 8.645814e-02 | 1.063 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 8.645814e-02 | 1.063 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 8.681165e-02 | 1.061 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 8.696777e-02 | 1.061 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 8.696777e-02 | 1.061 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 8.696777e-02 | 1.061 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 8.696777e-02 | 1.061 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 8.718601e-02 | 1.060 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 8.718601e-02 | 1.060 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 8.774566e-02 | 1.057 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 8.774566e-02 | 1.057 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 8.794393e-02 | 1.056 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 8.921803e-02 | 1.050 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 8.941837e-02 | 1.049 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 8.941837e-02 | 1.049 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 8.995286e-02 | 1.046 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 9.223374e-02 | 1.035 | 0 | 0 |
| Defective SFTPA2 causes IPF | R-HSA-5687868 | 9.323595e-02 | 1.030 | 0 | 0 |
| Defective translocation of RB1 mutants to the nucleus | R-HSA-9661070 | 9.323595e-02 | 1.030 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 9.484847e-02 | 1.023 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 9.484847e-02 | 1.023 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 9.758542e-02 | 1.011 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 9.758542e-02 | 1.011 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 9.918795e-02 | 1.004 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 1.013851e-01 | 0.994 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 1.016661e-01 | 0.993 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 1.016661e-01 | 0.993 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 1.025192e-01 | 0.989 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 1.028449e-01 | 0.988 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 1.034500e-01 | 0.985 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 1.049652e-01 | 0.979 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 1.086120e-01 | 0.964 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 1.086120e-01 | 0.964 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 1.096457e-01 | 0.960 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 1.117324e-01 | 0.952 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 1.147011e-01 | 0.940 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 1.147011e-01 | 0.940 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 1.147011e-01 | 0.940 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 1.147011e-01 | 0.940 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 1.149464e-01 | 0.940 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 1.149521e-01 | 0.939 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 1.149521e-01 | 0.939 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 1.149521e-01 | 0.939 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 1.149521e-01 | 0.939 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 1.149521e-01 | 0.939 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 1.149521e-01 | 0.939 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 1.149521e-01 | 0.939 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 1.176861e-01 | 0.929 | 0 | 0 |
| MECP2 regulates transcription of genes involved in GABA signaling | R-HSA-9022927 | 1.176861e-01 | 0.929 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 1.176861e-01 | 0.929 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 1.176861e-01 | 0.929 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 1.176861e-01 | 0.929 | 0 | 0 |
| MTF1 activates gene expression | R-HSA-5660489 | 1.176861e-01 | 0.929 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 1.183476e-01 | 0.927 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 1.183476e-01 | 0.927 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 1.183476e-01 | 0.927 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 1.777839e-01 | 0.750 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 1.777839e-01 | 0.750 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 1.777839e-01 | 0.750 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 1.777839e-01 | 0.750 | 0 | 0 |
| Hereditary fructose intolerance | R-HSA-5657560 | 1.777839e-01 | 0.750 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 1.777839e-01 | 0.750 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 1.777839e-01 | 0.750 | 0 | 0 |
| RPIA deficiency: failed conversion of RU5P to R5P | R-HSA-6791461 | 1.777839e-01 | 0.750 | 0 | 0 |
| SARS-CoV-1 targets PDZ proteins in cell-cell junction | R-HSA-9692912 | 1.777839e-01 | 0.750 | 0 | 0 |
| RPIA deficiency: failed conversion of R5P to RU5P | R-HSA-5659996 | 1.777839e-01 | 0.750 | 0 | 0 |
| Defective F8 binding to von Willebrand factor | R-HSA-9672393 | 1.777839e-01 | 0.750 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 1.777839e-01 | 0.750 | 0 | 0 |
| TICAM1 deficiency - HSE | R-HSA-5602566 | 1.777839e-01 | 0.750 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 1.777839e-01 | 0.750 | 0 | 0 |
| Defective ACTH causes obesity and POMCD | R-HSA-5579031 | 1.777839e-01 | 0.750 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 1.506153e-01 | 0.822 | 0 | 0 |
| Co-inhibition by BTLA | R-HSA-9927353 | 1.506153e-01 | 0.822 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 1.506153e-01 | 0.822 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 1.506153e-01 | 0.822 | 0 | 0 |
| Defective binding of VWF variant to GPIb:IX:V | R-HSA-9846298 | 1.506153e-01 | 0.822 | 0 | 0 |
| Enhanced binding of GP1BA variant to VWF multimer:collagen | R-HSA-9845620 | 1.506153e-01 | 0.822 | 0 | 0 |
| Defects of platelet adhesion to exposed collagen | R-HSA-9823587 | 1.850767e-01 | 0.733 | 0 | 0 |
| Pentose phosphate pathway disease | R-HSA-6791465 | 1.850767e-01 | 0.733 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 1.850767e-01 | 0.733 | 0 | 0 |
| Defective CSF2RA causes SMDP4 | R-HSA-5688890 | 1.850767e-01 | 0.733 | 0 | 0 |
| Defective CSF2RB causes SMDP5 | R-HSA-5688849 | 1.850767e-01 | 0.733 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 1.364923e-01 | 0.865 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 1.364923e-01 | 0.865 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 2.204988e-01 | 0.657 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 2.204988e-01 | 0.657 | 0 | 0 |
| Small interfering RNA (siRNA) biogenesis | R-HSA-426486 | 2.204988e-01 | 0.657 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 2.204988e-01 | 0.657 | 1 | 1 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 2.204988e-01 | 0.657 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 2.204988e-01 | 0.657 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 1.351580e-01 | 0.869 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 1.351580e-01 | 0.869 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 1.351580e-01 | 0.869 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 1.831151e-01 | 0.737 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 1.831151e-01 | 0.737 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 1.831151e-01 | 0.737 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 1.831151e-01 | 0.737 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 1.528707e-01 | 0.816 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 1.528707e-01 | 0.816 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 2.078176e-01 | 0.682 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 2.078176e-01 | 0.682 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 2.078176e-01 | 0.682 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 2.078176e-01 | 0.682 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 2.078176e-01 | 0.682 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 2.078176e-01 | 0.682 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 2.078176e-01 | 0.682 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 2.078176e-01 | 0.682 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 2.078176e-01 | 0.682 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 2.078176e-01 | 0.682 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 1.429897e-01 | 0.845 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 1.202483e-01 | 0.920 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 1.202483e-01 | 0.920 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 2.332033e-01 | 0.632 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 1.452631e-01 | 0.838 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 2.310128e-01 | 0.636 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 1.724259e-01 | 0.763 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 2.245559e-01 | 0.649 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 2.245559e-01 | 0.649 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 2.245559e-01 | 0.649 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 2.014926e-01 | 0.696 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 2.032551e-01 | 0.692 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 2.383365e-01 | 0.623 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 2.273204e-01 | 0.643 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 1.882333e-01 | 0.725 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 1.880716e-01 | 0.726 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 1.204615e-01 | 0.919 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 2.034453e-01 | 0.692 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 1.565916e-01 | 0.805 | 0 | 0 |
| Toxicity of botulinum toxin type G (botG) | R-HSA-5250989 | 1.506153e-01 | 0.822 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 1.364923e-01 | 0.865 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 1.351580e-01 | 0.869 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 1.816853e-01 | 0.741 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 2.204988e-01 | 0.657 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 1.528707e-01 | 0.816 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 2.072038e-01 | 0.684 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 1.644460e-01 | 0.784 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 2.218826e-01 | 0.654 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 2.218826e-01 | 0.654 | 0 | 0 |
| SLC15A4:TASL-dependent IRF5 activation | R-HSA-9860276 | 1.850767e-01 | 0.733 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 1.714012e-01 | 0.766 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 1.903183e-01 | 0.721 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 2.221690e-01 | 0.653 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 2.347686e-01 | 0.629 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 2.332033e-01 | 0.632 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 2.332033e-01 | 0.632 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 2.021585e-01 | 0.694 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 1.585904e-01 | 0.800 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 1.689332e-01 | 0.772 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 1.506153e-01 | 0.822 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 1.324734e-01 | 0.878 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 2.389876e-01 | 0.622 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 2.161368e-01 | 0.665 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 1.394583e-01 | 0.856 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 1.678151e-01 | 0.775 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 1.542301e-01 | 0.812 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 1.221529e-01 | 0.913 | 0 | 0 |
| Inhibition of PKR | R-HSA-169131 | 1.777839e-01 | 0.750 | 0 | 0 |
| Proton/oligopeptide cotransporters | R-HSA-427975 | 1.850767e-01 | 0.733 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 1.284888e-01 | 0.891 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 1.714012e-01 | 0.766 | 0 | 0 |
| Reversible hydration of carbon dioxide | R-HSA-1475029 | 2.332033e-01 | 0.632 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 1.324734e-01 | 0.878 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 2.166552e-01 | 0.664 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 1.867378e-01 | 0.729 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 1.449145e-01 | 0.839 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 2.221690e-01 | 0.653 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 1.807612e-01 | 0.743 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 1.528707e-01 | 0.816 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 2.162588e-01 | 0.665 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 1.532959e-01 | 0.814 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 1.960328e-01 | 0.708 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 1.867378e-01 | 0.729 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 1.724259e-01 | 0.763 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 2.310128e-01 | 0.636 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 1.319874e-01 | 0.879 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 1.332240e-01 | 0.875 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 1.926880e-01 | 0.715 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 2.321894e-01 | 0.634 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 1.429897e-01 | 0.845 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 1.221600e-01 | 0.913 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in invasion | R-HSA-9854909 | 1.506153e-01 | 0.822 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 2.204988e-01 | 0.657 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 2.332033e-01 | 0.632 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 2.332033e-01 | 0.632 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 1.724259e-01 | 0.763 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 1.867378e-01 | 0.729 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 1.364923e-01 | 0.865 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 1.520162e-01 | 0.818 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 1.394583e-01 | 0.856 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 2.105623e-01 | 0.677 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 1.222356e-01 | 0.913 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 2.245559e-01 | 0.649 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 2.083280e-01 | 0.681 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 2.245559e-01 | 0.649 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 2.055674e-01 | 0.687 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 1.948250e-01 | 0.710 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 1.846375e-01 | 0.734 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 1.528707e-01 | 0.816 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 2.310128e-01 | 0.636 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 1.906616e-01 | 0.720 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 2.072038e-01 | 0.684 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 2.270624e-01 | 0.644 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 1.351580e-01 | 0.869 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 2.105623e-01 | 0.677 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 2.083280e-01 | 0.681 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 1.714012e-01 | 0.766 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 1.452631e-01 | 0.838 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 2.474795e-01 | 0.606 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 2.480581e-01 | 0.605 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 2.480581e-01 | 0.605 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 2.487550e-01 | 0.604 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 2.516415e-01 | 0.599 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 2.519235e-01 | 0.599 | 0 | 0 |
| Abasic sugar-phosphate removal via the single-nucleotide replacement pathway | R-HSA-73930 | 2.544531e-01 | 0.594 | 0 | 0 |
| Interactions of Tat with host cellular proteins | R-HSA-176034 | 2.544531e-01 | 0.594 | 0 | 0 |
| PTEN Loss of Function in Cancer | R-HSA-5674404 | 2.544531e-01 | 0.594 | 0 | 0 |
| Defective SLC20A2 causes idiopathic basal ganglia calcification 1 (IBGC1) | R-HSA-5619111 | 2.544531e-01 | 0.594 | 0 | 0 |
| IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR) | R-HSA-5603027 | 2.544531e-01 | 0.594 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 2.544531e-01 | 0.594 | 0 | 0 |
| Defective VWF binding to collagen type I | R-HSA-9845622 | 2.544531e-01 | 0.594 | 0 | 0 |
| TALDO1 deficiency: failed conversion of Fru(6)P, E4P to SH7P, GA3P | R-HSA-6791462 | 2.544531e-01 | 0.594 | 0 | 0 |
| Defective PGM1 causes PGM1-CDG | R-HSA-5609974 | 2.544531e-01 | 0.594 | 0 | 0 |
| Defective POMGNT1 causes MDDGA3, MDDGB3 and MDDGC3 | R-HSA-5083628 | 2.544531e-01 | 0.594 | 0 | 0 |
| TALDO1 deficiency: failed conversion of SH7P, GA3P to Fru(6)P, E4P | R-HSA-6791055 | 2.544531e-01 | 0.594 | 0 | 0 |
| TRAF3 deficiency - HSE | R-HSA-5602571 | 2.544531e-01 | 0.594 | 0 | 0 |
| IKBKB deficiency causes SCID | R-HSA-5602636 | 2.544531e-01 | 0.594 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 2.544531e-01 | 0.594 | 0 | 0 |
| Transport of connexins along the secretory pathway | R-HSA-190827 | 2.544531e-01 | 0.594 | 0 | 0 |
| Inhibition of Host mRNA Processing and RNA Silencing | R-HSA-168315 | 2.544531e-01 | 0.594 | 0 | 0 |
| Oligomerization of connexins into connexons | R-HSA-190704 | 2.544531e-01 | 0.594 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 2.564033e-01 | 0.591 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 2.564033e-01 | 0.591 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 2.564033e-01 | 0.591 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 2.564033e-01 | 0.591 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 2.564033e-01 | 0.591 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 2.564033e-01 | 0.591 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 2.564033e-01 | 0.591 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 2.564033e-01 | 0.591 | 0 | 0 |
| Synthesis of PIPs in the nucleus | R-HSA-8847453 | 2.564033e-01 | 0.591 | 0 | 0 |
| SLC-mediated transport of oligopeptides | R-HSA-9959399 | 2.564033e-01 | 0.591 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 2.564033e-01 | 0.591 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 2.590997e-01 | 0.587 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 2.590997e-01 | 0.587 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 2.604410e-01 | 0.584 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 2.614865e-01 | 0.583 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 2.621166e-01 | 0.582 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 2.732061e-01 | 0.564 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 2.732061e-01 | 0.564 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 2.732061e-01 | 0.564 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 2.776294e-01 | 0.557 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 2.777683e-01 | 0.556 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 2.788639e-01 | 0.555 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 2.789148e-01 | 0.555 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 2.789148e-01 | 0.555 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 2.803757e-01 | 0.552 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 2.803757e-01 | 0.552 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 2.825804e-01 | 0.549 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 2.853446e-01 | 0.545 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 2.853446e-01 | 0.545 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 2.853446e-01 | 0.545 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 2.853446e-01 | 0.545 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 2.853446e-01 | 0.545 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 2.853446e-01 | 0.545 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 2.853446e-01 | 0.545 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 2.923926e-01 | 0.534 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 2.923926e-01 | 0.534 | 0 | 0 |
| Toxicity of botulinum toxin type B (botB) | R-HSA-5250958 | 2.923926e-01 | 0.534 | 0 | 0 |
| Neurotransmitter uptake and metabolism In glial cells | R-HSA-112313 | 2.923926e-01 | 0.534 | 0 | 0 |
| Astrocytic Glutamate-Glutamine Uptake And Metabolism | R-HSA-210455 | 2.923926e-01 | 0.534 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 2.923926e-01 | 0.534 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 2.923926e-01 | 0.534 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 2.923926e-01 | 0.534 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 2.928395e-01 | 0.533 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 2.954992e-01 | 0.529 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 2.972925e-01 | 0.527 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 2.972925e-01 | 0.527 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 2.972925e-01 | 0.527 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 2.975343e-01 | 0.526 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 2.975343e-01 | 0.526 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 2.975343e-01 | 0.526 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 3.064544e-01 | 0.514 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 3.066944e-01 | 0.513 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 3.117874e-01 | 0.506 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 3.117874e-01 | 0.506 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 3.117874e-01 | 0.506 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 3.118628e-01 | 0.506 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 3.141201e-01 | 0.503 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 3.160146e-01 | 0.500 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 3.206110e-01 | 0.494 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 3.234223e-01 | 0.490 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 3.239772e-01 | 0.489 | 0 | 0 |
| Defective ALG9 causes CDG-1l | R-HSA-4720454 | 3.239772e-01 | 0.489 | 0 | 0 |
| Defective POMT1 causes MDDGA1, MDDGB1 and MDDGC1 | R-HSA-5083633 | 3.239772e-01 | 0.489 | 0 | 0 |
| Defective F8 cleavage by thrombin | R-HSA-9672391 | 3.239772e-01 | 0.489 | 0 | 0 |
| Defective AHCY causes HMAHCHD | R-HSA-5578997 | 3.239772e-01 | 0.489 | 0 | 0 |
| Defective SLC40A1 causes hemochromatosis 4 (HFE4) (duodenum) | R-HSA-5655799 | 3.239772e-01 | 0.489 | 0 | 0 |
| Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | R-HSA-5619089 | 3.239772e-01 | 0.489 | 0 | 0 |
| TGFBR1 LBD Mutants in Cancer | R-HSA-3656535 | 3.239772e-01 | 0.489 | 0 | 0 |
| Defective POMT2 causes MDDGA2, MDDGB2 and MDDGC2 | R-HSA-5083629 | 3.239772e-01 | 0.489 | 0 | 0 |
| Defective VWF cleavage by ADAMTS13 variant | R-HSA-9845621 | 3.239772e-01 | 0.489 | 0 | 0 |
| Enhanced cleavage of VWF variant by ADAMTS13 | R-HSA-9845619 | 3.239772e-01 | 0.489 | 0 | 0 |
| Potassium transport channels | R-HSA-1296067 | 3.239772e-01 | 0.489 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 3.239772e-01 | 0.489 | 0 | 0 |
| Activation, myristolyation of BID and translocation to mitochondria | R-HSA-75108 | 3.239772e-01 | 0.489 | 0 | 0 |
| ATF6B (ATF6-beta) activates chaperones | R-HSA-8874177 | 3.239772e-01 | 0.489 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 3.281389e-01 | 0.484 | 0 | 0 |
| 5-Phosphoribose 1-diphosphate biosynthesis | R-HSA-73843 | 3.281389e-01 | 0.484 | 0 | 0 |
| mRNA Editing | R-HSA-75072 | 3.281389e-01 | 0.484 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 3.281389e-01 | 0.484 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 3.281389e-01 | 0.484 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 3.281389e-01 | 0.484 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 3.281389e-01 | 0.484 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 3.281389e-01 | 0.484 | 0 | 0 |
| Butyrophilin (BTN) family interactions | R-HSA-8851680 | 3.281389e-01 | 0.484 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 3.310932e-01 | 0.480 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 3.354047e-01 | 0.474 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 3.354047e-01 | 0.474 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 3.355014e-01 | 0.474 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 3.382893e-01 | 0.471 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 3.382893e-01 | 0.471 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 3.384415e-01 | 0.471 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 3.384415e-01 | 0.471 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 3.495134e-01 | 0.457 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 3.563663e-01 | 0.448 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 3.565805e-01 | 0.448 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 3.565805e-01 | 0.448 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 3.574347e-01 | 0.447 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 3.633749e-01 | 0.440 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 3.633749e-01 | 0.440 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 3.633749e-01 | 0.440 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 3.633749e-01 | 0.440 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 3.633749e-01 | 0.440 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 3.633749e-01 | 0.440 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 3.633749e-01 | 0.440 | 0 | 0 |
| Tandem pore domain potassium channels | R-HSA-1296346 | 3.633749e-01 | 0.440 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 3.642535e-01 | 0.439 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 3.647241e-01 | 0.438 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 3.653297e-01 | 0.437 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 3.653297e-01 | 0.437 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 3.736411e-01 | 0.428 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 3.736411e-01 | 0.428 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 3.736411e-01 | 0.428 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 3.790327e-01 | 0.421 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 3.823069e-01 | 0.418 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 3.823069e-01 | 0.418 | 0 | 0 |
| PLC-gamma1 signalling | R-HSA-167021 | 3.870217e-01 | 0.412 | 0 | 0 |
| Activated NTRK3 signals through PLCG1 | R-HSA-9034793 | 3.870217e-01 | 0.412 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 3.870217e-01 | 0.412 | 0 | 0 |
| Defective SLC7A7 causes lysinuric protein intolerance (LPI) | R-HSA-5660862 | 3.870217e-01 | 0.412 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 3.870217e-01 | 0.412 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 3.870217e-01 | 0.412 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 3.870217e-01 | 0.412 | 0 | 0 |
| Activation of BIM and translocation to mitochondria | R-HSA-111446 | 3.870217e-01 | 0.412 | 0 | 0 |
| Intracellular oxygen transport | R-HSA-8981607 | 3.870217e-01 | 0.412 | 0 | 0 |
| FasL/ CD95L signaling | R-HSA-75157 | 3.870217e-01 | 0.412 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 3.888802e-01 | 0.410 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 3.909778e-01 | 0.408 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 3.909778e-01 | 0.408 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 3.909778e-01 | 0.408 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 3.909778e-01 | 0.408 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 3.909778e-01 | 0.408 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 3.978850e-01 | 0.400 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 3.978850e-01 | 0.400 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 3.978850e-01 | 0.400 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 3.978850e-01 | 0.400 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 3.978850e-01 | 0.400 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 3.978850e-01 | 0.400 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 3.978850e-01 | 0.400 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 3.997188e-01 | 0.398 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 3.997188e-01 | 0.398 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 4.023483e-01 | 0.395 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 4.082502e-01 | 0.389 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 4.118615e-01 | 0.385 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 4.118615e-01 | 0.385 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 4.168869e-01 | 0.380 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 4.169485e-01 | 0.380 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 4.179955e-01 | 0.379 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 4.287990e-01 | 0.368 | 0 | 0 |
| PI3K events in ERBB4 signaling | R-HSA-1250342 | 4.314983e-01 | 0.365 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 4.314983e-01 | 0.365 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 4.314983e-01 | 0.365 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 4.314983e-01 | 0.365 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 4.314983e-01 | 0.365 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 4.314983e-01 | 0.365 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 4.425462e-01 | 0.354 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 4.425462e-01 | 0.354 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 4.425462e-01 | 0.354 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 4.425462e-01 | 0.354 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 4.429486e-01 | 0.354 | 0 | 0 |
| HCN channels | R-HSA-1296061 | 4.441902e-01 | 0.352 | 0 | 0 |
| Activated NTRK2 signals through PLCG1 | R-HSA-9026527 | 4.441902e-01 | 0.352 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 4.441902e-01 | 0.352 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 4.441902e-01 | 0.352 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 4.441902e-01 | 0.352 | 0 | 0 |
| Extrinsic Pathway of Fibrin Clot Formation | R-HSA-140834 | 4.441902e-01 | 0.352 | 0 | 0 |
| SARS-CoV-1-mediated effects on programmed cell death | R-HSA-9692913 | 4.441902e-01 | 0.352 | 0 | 0 |
| Dopamine receptors | R-HSA-390651 | 4.441902e-01 | 0.352 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 4.441902e-01 | 0.352 | 0 | 0 |
| Regulation of HMOX1 expression and activity | R-HSA-9707587 | 4.441902e-01 | 0.352 | 0 | 0 |
| Toxicity of tetanus toxin (tetX) | R-HSA-5250982 | 4.441902e-01 | 0.352 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 4.472988e-01 | 0.349 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 4.477264e-01 | 0.349 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 4.497198e-01 | 0.347 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 4.497198e-01 | 0.347 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 4.499048e-01 | 0.347 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 4.508512e-01 | 0.346 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 4.512589e-01 | 0.346 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 4.519651e-01 | 0.345 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 4.585967e-01 | 0.339 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 4.640821e-01 | 0.333 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 4.640821e-01 | 0.333 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 4.640821e-01 | 0.333 | 0 | 0 |
| Diseases associated with surfactant metabolism | R-HSA-5687613 | 4.640821e-01 | 0.333 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 4.640821e-01 | 0.333 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 4.655841e-01 | 0.332 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 4.676921e-01 | 0.330 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 4.676921e-01 | 0.330 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 4.676921e-01 | 0.330 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 12 | R-HSA-392170 | 4.676921e-01 | 0.330 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 4.676921e-01 | 0.330 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 4.679172e-01 | 0.330 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 4.679172e-01 | 0.330 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 4.679172e-01 | 0.330 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 4.684157e-01 | 0.329 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 4.719273e-01 | 0.326 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 4.826597e-01 | 0.316 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 4.843579e-01 | 0.315 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 4.843579e-01 | 0.315 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 4.846755e-01 | 0.315 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 4.846755e-01 | 0.315 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 4.869094e-01 | 0.313 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 4.869094e-01 | 0.313 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 4.869094e-01 | 0.313 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 4.869094e-01 | 0.313 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 4.869094e-01 | 0.313 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 4.869094e-01 | 0.313 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 4.869094e-01 | 0.313 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 4.902026e-01 | 0.310 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 4.923180e-01 | 0.308 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 4.923180e-01 | 0.308 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 4.923180e-01 | 0.308 | 0 | 0 |
| Ribavirin ADME | R-HSA-9755088 | 4.923180e-01 | 0.308 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 4.955359e-01 | 0.305 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 4.955359e-01 | 0.305 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 4.955359e-01 | 0.305 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 4.955359e-01 | 0.305 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 4.960301e-01 | 0.304 | 0 | 0 |
| IRS activation | R-HSA-74713 | 4.960301e-01 | 0.304 | 0 | 0 |
| Defective F9 activation | R-HSA-9673221 | 4.960301e-01 | 0.304 | 0 | 0 |
| Defective SLC1A3 causes episodic ataxia 6 (EA6) | R-HSA-5619062 | 4.960301e-01 | 0.304 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 4.960301e-01 | 0.304 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 4.960301e-01 | 0.304 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 4.960301e-01 | 0.304 | 0 | 0 |
| NTRK2 activates RAC1 | R-HSA-9032759 | 4.960301e-01 | 0.304 | 0 | 0 |
| Suppression of autophagy | R-HSA-9636569 | 4.960301e-01 | 0.304 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 4.960301e-01 | 0.304 | 0 | 0 |
| Muscarinic acetylcholine receptors | R-HSA-390648 | 4.960301e-01 | 0.304 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 4.960301e-01 | 0.304 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 4.979675e-01 | 0.303 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 4.979675e-01 | 0.303 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 4.979675e-01 | 0.303 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 4.979675e-01 | 0.303 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 4.979675e-01 | 0.303 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 4.979675e-01 | 0.303 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 5.001924e-01 | 0.301 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 5.001924e-01 | 0.301 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 5.001924e-01 | 0.301 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 5.012651e-01 | 0.300 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 5.051692e-01 | 0.297 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 5.092056e-01 | 0.293 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 5.099941e-01 | 0.292 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 5.131289e-01 | 0.290 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 5.163659e-01 | 0.287 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 5.163659e-01 | 0.287 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 5.206175e-01 | 0.283 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 5.233052e-01 | 0.281 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 5.257873e-01 | 0.279 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 5.257873e-01 | 0.279 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 5.257873e-01 | 0.279 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 5.257873e-01 | 0.279 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 5.281261e-01 | 0.277 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 5.301743e-01 | 0.276 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 5.301743e-01 | 0.276 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 5.338470e-01 | 0.273 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 5.391938e-01 | 0.268 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 5.391938e-01 | 0.268 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 5.395833e-01 | 0.268 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 5.397871e-01 | 0.268 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 5.397871e-01 | 0.268 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 5.397871e-01 | 0.268 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 5.403000e-01 | 0.267 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 5.408733e-01 | 0.267 | 0 | 0 |
| Plus-strand DNA synthesis | R-HSA-164525 | 5.430376e-01 | 0.265 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 5.430376e-01 | 0.265 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 5.430376e-01 | 0.265 | 0 | 0 |
| PKA-mediated phosphorylation of key metabolic factors | R-HSA-163358 | 5.430376e-01 | 0.265 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 5.430376e-01 | 0.265 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 5.430376e-01 | 0.265 | 0 | 0 |
| Intestinal hexose absorption | R-HSA-8981373 | 5.430376e-01 | 0.265 | 0 | 0 |
| Orexin and neuropeptides FF and QRFP bind to their respective receptors | R-HSA-389397 | 5.430376e-01 | 0.265 | 0 | 0 |
| Sodium-coupled phosphate cotransporters | R-HSA-427652 | 5.430376e-01 | 0.265 | 0 | 0 |
| TRAIL signaling | R-HSA-75158 | 5.430376e-01 | 0.265 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 5.430376e-01 | 0.265 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 5.499366e-01 | 0.260 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 5.499366e-01 | 0.260 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 5.499366e-01 | 0.260 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 5.509345e-01 | 0.259 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 5.544233e-01 | 0.256 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 5.547869e-01 | 0.256 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 5.547869e-01 | 0.256 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 5.547869e-01 | 0.256 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 5.582672e-01 | 0.253 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 5.582672e-01 | 0.253 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 5.625417e-01 | 0.250 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 5.646597e-01 | 0.248 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 5.676896e-01 | 0.246 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 5.692524e-01 | 0.245 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 5.692524e-01 | 0.245 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 5.692524e-01 | 0.245 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 5.692524e-01 | 0.245 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 5.708142e-01 | 0.244 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 5.753264e-01 | 0.240 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 5.778821e-01 | 0.238 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 5.779760e-01 | 0.238 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 5.820666e-01 | 0.235 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 5.825050e-01 | 0.235 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 5.825050e-01 | 0.235 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 5.825050e-01 | 0.235 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 5.825050e-01 | 0.235 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 5.825050e-01 | 0.235 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 5.833553e-01 | 0.234 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 5.845978e-01 | 0.233 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 5.845978e-01 | 0.233 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 5.845978e-01 | 0.233 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 5.856631e-01 | 0.232 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 5.856631e-01 | 0.232 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 5.856631e-01 | 0.232 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 5.856631e-01 | 0.232 | 0 | 0 |
| Uncoating of the HIV Virion | R-HSA-162585 | 5.856631e-01 | 0.232 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 5.856631e-01 | 0.232 | 0 | 0 |
| H139Hfs13* PPM1K causes a mild variant of MSUD | R-HSA-9912529 | 5.856631e-01 | 0.232 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 5.856631e-01 | 0.232 | 0 | 0 |
| Defective factor VIII causes hemophilia A | R-HSA-9662001 | 5.856631e-01 | 0.232 | 0 | 0 |
| HDL clearance | R-HSA-8964011 | 5.856631e-01 | 0.232 | 0 | 0 |
| Leukotriene receptors | R-HSA-391906 | 5.856631e-01 | 0.232 | 0 | 0 |
| VLDL assembly | R-HSA-8866423 | 5.856631e-01 | 0.232 | 0 | 0 |
| Toxicity of botulinum toxin type D (botD) | R-HSA-5250955 | 5.856631e-01 | 0.232 | 0 | 0 |
| Toxicity of botulinum toxin type F (botF) | R-HSA-5250981 | 5.856631e-01 | 0.232 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 5.856631e-01 | 0.232 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 5.856631e-01 | 0.232 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 6.043872e-01 | 0.219 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 6.059306e-01 | 0.218 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 6.059306e-01 | 0.218 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 6.059306e-01 | 0.218 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 6.064502e-01 | 0.217 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 6.089285e-01 | 0.215 | 0 | 0 |
| Biosynthesis of maresin-like SPMs | R-HSA-9027307 | 6.089285e-01 | 0.215 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 6.089285e-01 | 0.215 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 6.089285e-01 | 0.215 | 0 | 0 |
| Defects of contact activation system (CAS) and kallikrein/kinin system (KKS) | R-HSA-9651496 | 6.089285e-01 | 0.215 | 0 | 0 |
| Response to metal ions | R-HSA-5660526 | 6.089285e-01 | 0.215 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 6.109284e-01 | 0.214 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 6.243148e-01 | 0.205 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 6.243148e-01 | 0.205 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 6.243148e-01 | 0.205 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 6.243148e-01 | 0.205 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 6.243148e-01 | 0.205 | 0 | 0 |
| DAG1 core M1 glycosylations | R-HSA-8932506 | 6.243148e-01 | 0.205 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 6.243148e-01 | 0.205 | 0 | 0 |
| Microbial modulation of RIPK1-mediated regulated necrosis | R-HSA-9686347 | 6.243148e-01 | 0.205 | 0 | 0 |
| LDL remodeling | R-HSA-8964041 | 6.243148e-01 | 0.205 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 6.243148e-01 | 0.205 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 6.243148e-01 | 0.205 | 0 | 0 |
| Defective HLCS causes multiple carboxylase deficiency | R-HSA-3371599 | 6.243148e-01 | 0.205 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 6.243188e-01 | 0.205 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 6.243188e-01 | 0.205 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 6.265223e-01 | 0.203 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 6.265223e-01 | 0.203 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 6.265223e-01 | 0.203 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 6.340575e-01 | 0.198 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 6.340575e-01 | 0.198 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 6.398736e-01 | 0.194 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 6.404252e-01 | 0.194 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 6.416169e-01 | 0.193 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 6.419664e-01 | 0.192 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 6.463607e-01 | 0.190 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 6.463607e-01 | 0.190 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 6.535957e-01 | 0.185 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 6.573247e-01 | 0.182 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 6.579037e-01 | 0.182 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 6.579037e-01 | 0.182 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 6.579037e-01 | 0.182 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 6.579037e-01 | 0.182 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 6.579037e-01 | 0.182 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 6.584067e-01 | 0.182 | 0 | 0 |
| Reverse Transcription of HIV RNA | R-HSA-162589 | 6.593629e-01 | 0.181 | 0 | 0 |
| Minus-strand DNA synthesis | R-HSA-164516 | 6.593629e-01 | 0.181 | 0 | 0 |
| DAG1 core M2 glycosylations | R-HSA-8932504 | 6.593629e-01 | 0.181 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 6.593629e-01 | 0.181 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 6.593629e-01 | 0.181 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 6.593629e-01 | 0.181 | 0 | 0 |
| Negative regulation of activity of TFAP2 (AP-2) family transcription factors | R-HSA-8866904 | 6.593629e-01 | 0.181 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 6.593629e-01 | 0.181 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 6.593629e-01 | 0.181 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 6.593629e-01 | 0.181 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 6.593629e-01 | 0.181 | 0 | 0 |
| SLC-mediated bile acid transport | R-HSA-9958517 | 6.593629e-01 | 0.181 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 6.593629e-01 | 0.181 | 0 | 0 |
| Intestinal absorption | R-HSA-8963676 | 6.593629e-01 | 0.181 | 0 | 0 |
| Interleukin-23 signaling | R-HSA-9020933 | 6.593629e-01 | 0.181 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 6.654394e-01 | 0.177 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 6.654394e-01 | 0.177 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 6.654394e-01 | 0.177 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 6.729419e-01 | 0.172 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 6.748555e-01 | 0.171 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 6.782910e-01 | 0.169 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 6.804876e-01 | 0.167 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 6.804876e-01 | 0.167 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 6.804876e-01 | 0.167 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 6.804876e-01 | 0.167 | 0 | 0 |
| Prostacyclin signalling through prostacyclin receptor | R-HSA-392851 | 6.804876e-01 | 0.167 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 6.804876e-01 | 0.167 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 6.804876e-01 | 0.167 | 0 | 0 |
| Diseases of hemostasis | R-HSA-9671793 | 6.804876e-01 | 0.167 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 6.804876e-01 | 0.167 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 6.811562e-01 | 0.167 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 6.837564e-01 | 0.165 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 6.837564e-01 | 0.165 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 6.837564e-01 | 0.165 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 6.837564e-01 | 0.165 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 6.837564e-01 | 0.165 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 6.903626e-01 | 0.161 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 6.911431e-01 | 0.160 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 6.911431e-01 | 0.160 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 6.911431e-01 | 0.160 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 6.911431e-01 | 0.160 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 6.911431e-01 | 0.160 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 6.911431e-01 | 0.160 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 6.911431e-01 | 0.160 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 6.911431e-01 | 0.160 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 6.911431e-01 | 0.160 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 6.911431e-01 | 0.160 | 0 | 0 |
| Defects in biotin (Btn) metabolism | R-HSA-3323169 | 6.911431e-01 | 0.160 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 6.979603e-01 | 0.156 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 7.006800e-01 | 0.154 | 0 | 0 |
| Aspartate and asparagine metabolism | R-HSA-8963693 | 7.013141e-01 | 0.154 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 7.018372e-01 | 0.154 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 7.018372e-01 | 0.154 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 7.018372e-01 | 0.154 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 7.018372e-01 | 0.154 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 7.018372e-01 | 0.154 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 7.018372e-01 | 0.154 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 7.055221e-01 | 0.151 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 7.055221e-01 | 0.151 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 7.181187e-01 | 0.144 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 7.181187e-01 | 0.144 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 7.181187e-01 | 0.144 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 7.199601e-01 | 0.143 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 7.199601e-01 | 0.143 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 7.199601e-01 | 0.143 | 0 | 0 |
| DNA replication initiation | R-HSA-68952 | 7.199601e-01 | 0.143 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 7.199601e-01 | 0.143 | 0 | 0 |
| Defective factor IX causes hemophilia B | R-HSA-9668250 | 7.199601e-01 | 0.143 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 7.199601e-01 | 0.143 | 0 | 0 |
| Peptide hormone biosynthesis | R-HSA-209952 | 7.199601e-01 | 0.143 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 7.219862e-01 | 0.141 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 7.219862e-01 | 0.141 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 7.219862e-01 | 0.141 | 0 | 0 |
| Intrinsic Pathway of Fibrin Clot Formation | R-HSA-140837 | 7.219862e-01 | 0.141 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 7.237520e-01 | 0.140 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 7.336576e-01 | 0.135 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 7.341795e-01 | 0.134 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 7.341795e-01 | 0.134 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 7.355184e-01 | 0.133 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 7.380591e-01 | 0.132 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 7.409727e-01 | 0.130 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 7.409727e-01 | 0.130 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 7.409727e-01 | 0.130 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 7.460900e-01 | 0.127 | 0 | 0 |
| DAG1 core M3 glycosylations | R-HSA-8932505 | 7.460900e-01 | 0.127 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 7.460900e-01 | 0.127 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 7.460900e-01 | 0.127 | 0 | 0 |
| Conjugation of benzoate with glycine | R-HSA-177135 | 7.460900e-01 | 0.127 | 0 | 0 |
| vRNA Synthesis | R-HSA-192814 | 7.460900e-01 | 0.127 | 0 | 0 |
| Chylomicron assembly | R-HSA-8963888 | 7.460900e-01 | 0.127 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 7.460900e-01 | 0.127 | 0 | 0 |
| Propionyl-CoA catabolism | R-HSA-71032 | 7.460900e-01 | 0.127 | 0 | 0 |
| SARS-CoV-2 modulates autophagy | R-HSA-9754560 | 7.460900e-01 | 0.127 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 7.460900e-01 | 0.127 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 7.460900e-01 | 0.127 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 7.477353e-01 | 0.126 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 7.495086e-01 | 0.125 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 7.495086e-01 | 0.125 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 7.523690e-01 | 0.124 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 7.588382e-01 | 0.120 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 7.588382e-01 | 0.120 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 7.588382e-01 | 0.120 | 0 | 0 |
| Neurotoxicity of clostridium toxins | R-HSA-168799 | 7.588382e-01 | 0.120 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in lysosome biogenesis and autophagy | R-HSA-9857377 | 7.588382e-01 | 0.120 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 7.588382e-01 | 0.120 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 7.607318e-01 | 0.119 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 7.607318e-01 | 0.119 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 7.641205e-01 | 0.117 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 7.641205e-01 | 0.117 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 7.641205e-01 | 0.117 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 7.654998e-01 | 0.116 | 0 | 0 |
| Synthesis of diphthamide-EEF2 | R-HSA-5358493 | 7.697832e-01 | 0.114 | 0 | 0 |
| Proton-coupled monocarboxylate transport | R-HSA-433692 | 7.697832e-01 | 0.114 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 7.697832e-01 | 0.114 | 0 | 0 |
| Plasmalogen biosynthesis | R-HSA-75896 | 7.697832e-01 | 0.114 | 0 | 0 |
| Viral RNP Complexes in the Host Cell Nucleus | R-HSA-168330 | 7.697832e-01 | 0.114 | 0 | 0 |
| Endosomal/Vacuolar pathway | R-HSA-1236977 | 7.697832e-01 | 0.114 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 7.697832e-01 | 0.114 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 7.702795e-01 | 0.113 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 7.723281e-01 | 0.112 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 7.732021e-01 | 0.112 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 7.756265e-01 | 0.110 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 7.756265e-01 | 0.110 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 7.756265e-01 | 0.110 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 7.756265e-01 | 0.110 | 0 | 0 |
| Biosynthesis of maresins | R-HSA-9018682 | 7.756265e-01 | 0.110 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 7.756265e-01 | 0.110 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 7.756265e-01 | 0.110 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 7.780317e-01 | 0.109 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 7.780317e-01 | 0.109 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 7.780317e-01 | 0.109 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 7.780317e-01 | 0.109 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 7.780317e-01 | 0.109 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 7.790781e-01 | 0.108 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 7.836140e-01 | 0.106 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 7.912603e-01 | 0.102 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 7.912603e-01 | 0.102 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 7.912603e-01 | 0.102 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 7.912603e-01 | 0.102 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 7.912667e-01 | 0.102 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 7.912667e-01 | 0.102 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 7.912667e-01 | 0.102 | 0 | 0 |
| Acetylation | R-HSA-156582 | 7.912667e-01 | 0.102 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 7.912667e-01 | 0.102 | 0 | 0 |
| Conjugation of salicylate with glycine | R-HSA-177128 | 7.912667e-01 | 0.102 | 0 | 0 |
| Trafficking and processing of endosomal TLR | R-HSA-1679131 | 7.912667e-01 | 0.102 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 7.912667e-01 | 0.102 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 7.912667e-01 | 0.102 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 7.912667e-01 | 0.102 | 0 | 0 |
| Maple Syrup Urine Disease | R-HSA-9865114 | 7.912667e-01 | 0.102 | 0 | 0 |
| Erythrocytes take up oxygen and release carbon dioxide | R-HSA-1247673 | 7.912667e-01 | 0.102 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 7.912667e-01 | 0.102 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 7.912667e-01 | 0.102 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 7.913831e-01 | 0.102 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 7.913831e-01 | 0.102 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 7.913831e-01 | 0.102 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 7.913831e-01 | 0.102 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 7.913831e-01 | 0.102 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 7.933381e-01 | 0.101 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 7.937554e-01 | 0.100 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 7.937554e-01 | 0.100 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 7.963057e-01 | 0.099 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 7.984462e-01 | 0.098 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 8.027233e-01 | 0.095 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 8.061543e-01 | 0.094 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 8.061543e-01 | 0.094 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 8.061543e-01 | 0.094 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 8.061543e-01 | 0.094 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 8.061543e-01 | 0.094 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 8.061543e-01 | 0.094 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 8.061543e-01 | 0.094 | 0 | 0 |
| PDH complex synthesizes acetyl-CoA from PYR | R-HSA-9861559 | 8.107466e-01 | 0.091 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 8.107466e-01 | 0.091 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 8.107466e-01 | 0.091 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 8.107466e-01 | 0.091 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 8.107466e-01 | 0.091 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 8.107466e-01 | 0.091 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 8.107466e-01 | 0.091 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 8.135697e-01 | 0.090 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 8.135697e-01 | 0.090 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 8.157489e-01 | 0.088 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 8.199866e-01 | 0.086 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 8.199866e-01 | 0.086 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 8.199866e-01 | 0.086 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 8.202309e-01 | 0.086 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 8.270507e-01 | 0.082 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 8.284095e-01 | 0.082 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 8.284095e-01 | 0.082 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR3 | R-HSA-5654227 | 8.284095e-01 | 0.082 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 8.284095e-01 | 0.082 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 8.284095e-01 | 0.082 | 0 | 0 |
| Prolactin receptor signaling | R-HSA-1170546 | 8.284095e-01 | 0.082 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 8.284095e-01 | 0.082 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 8.284095e-01 | 0.082 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 8.284095e-01 | 0.082 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 8.329267e-01 | 0.079 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 8.329267e-01 | 0.079 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 8.444250e-01 | 0.073 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 8.444250e-01 | 0.073 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 8.444250e-01 | 0.073 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 8.444250e-01 | 0.073 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR4 | R-HSA-5654228 | 8.444250e-01 | 0.073 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 8.444250e-01 | 0.073 | 0 | 0 |
| Biotin transport and metabolism | R-HSA-196780 | 8.444250e-01 | 0.073 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 8.444250e-01 | 0.073 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 8.450206e-01 | 0.073 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 8.450206e-01 | 0.073 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 8.450206e-01 | 0.073 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 8.450206e-01 | 0.073 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 8.450206e-01 | 0.073 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 8.450206e-01 | 0.073 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 8.466152e-01 | 0.072 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 8.471265e-01 | 0.072 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 8.548649e-01 | 0.068 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 8.563134e-01 | 0.067 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 8.563134e-01 | 0.067 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 8.563134e-01 | 0.067 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 8.564595e-01 | 0.067 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 8.574504e-01 | 0.067 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 8.574504e-01 | 0.067 | 0 | 0 |
| Entry of Influenza Virion into Host Cell via Endocytosis | R-HSA-168275 | 8.589465e-01 | 0.066 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 8.589465e-01 | 0.066 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 8.589465e-01 | 0.066 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 8.589465e-01 | 0.066 | 0 | 0 |
| Activation of the phototransduction cascade | R-HSA-2485179 | 8.589465e-01 | 0.066 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 8.589465e-01 | 0.066 | 0 | 0 |
| Atorvastatin ADME | R-HSA-9754706 | 8.589465e-01 | 0.066 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 8.589465e-01 | 0.066 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 8.589465e-01 | 0.066 | 0 | 0 |
| Fructose catabolism | R-HSA-70350 | 8.589465e-01 | 0.066 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 8.589465e-01 | 0.066 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 8.589465e-01 | 0.066 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 8.634986e-01 | 0.064 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 8.661636e-01 | 0.062 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 8.664900e-01 | 0.062 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 8.664900e-01 | 0.062 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 8.668492e-01 | 0.062 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 8.713266e-01 | 0.060 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 8.721133e-01 | 0.059 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 8.721133e-01 | 0.059 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 8.721133e-01 | 0.059 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 8.721133e-01 | 0.059 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 8.721133e-01 | 0.059 | 0 | 0 |
| Passive transport by Aquaporins | R-HSA-432047 | 8.721133e-01 | 0.059 | 0 | 0 |
| tRNA modification in the mitochondrion | R-HSA-6787450 | 8.721133e-01 | 0.059 | 0 | 0 |
| Galactose catabolism | R-HSA-70370 | 8.721133e-01 | 0.059 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) | R-HSA-400511 | 8.721133e-01 | 0.059 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 8.733051e-01 | 0.059 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 8.766711e-01 | 0.057 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 8.814331e-01 | 0.055 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 8.830639e-01 | 0.054 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 8.840518e-01 | 0.054 | 0 | 0 |
| Phospholipase C-mediated cascade: FGFR1 | R-HSA-5654219 | 8.840518e-01 | 0.054 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 8.840518e-01 | 0.054 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 8.840518e-01 | 0.054 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 8.840518e-01 | 0.054 | 0 | 0 |
| Sulfide oxidation to sulfate | R-HSA-1614517 | 8.840518e-01 | 0.054 | 0 | 0 |
| Metabolism of ingested H2SeO4 and H2SeO3 into H2Se | R-HSA-2408550 | 8.840518e-01 | 0.054 | 0 | 0 |
| Choline catabolism | R-HSA-6798163 | 8.840518e-01 | 0.054 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 8.840518e-01 | 0.054 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 8.840518e-01 | 0.054 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 8.858203e-01 | 0.053 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 8.858261e-01 | 0.053 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 8.925264e-01 | 0.049 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 8.925264e-01 | 0.049 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 8.927304e-01 | 0.049 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 8.943369e-01 | 0.048 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 8.943369e-01 | 0.048 | 0 | 0 |
| PKA activation | R-HSA-163615 | 8.948764e-01 | 0.048 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 8.948764e-01 | 0.048 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 8.948764e-01 | 0.048 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 8.948764e-01 | 0.048 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 8.948764e-01 | 0.048 | 0 | 0 |
| Vitamin D (calciferol) metabolism | R-HSA-196791 | 8.948764e-01 | 0.048 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 8.948764e-01 | 0.048 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 8.977779e-01 | 0.047 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 8.977779e-01 | 0.047 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 8.977779e-01 | 0.047 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 8.993758e-01 | 0.046 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 8.993758e-01 | 0.046 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 8.993758e-01 | 0.046 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 9.022592e-01 | 0.045 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 9.023890e-01 | 0.045 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 9.046910e-01 | 0.043 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 9.046910e-01 | 0.043 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 9.046910e-01 | 0.043 | 0 | 0 |
| Conjugation of carboxylic acids | R-HSA-159424 | 9.046910e-01 | 0.043 | 0 | 0 |
| Amino Acid conjugation | R-HSA-156587 | 9.046910e-01 | 0.043 | 0 | 0 |
| mRNA decay by 3' to 5' exoribonuclease | R-HSA-429958 | 9.046910e-01 | 0.043 | 0 | 0 |
| Erythrocytes take up carbon dioxide and release oxygen | R-HSA-1237044 | 9.046910e-01 | 0.043 | 0 | 0 |
| O2/CO2 exchange in erythrocytes | R-HSA-1480926 | 9.046910e-01 | 0.043 | 0 | 0 |
| Strand-asynchronous mitochondrial DNA replication | R-HSA-9913635 | 9.046910e-01 | 0.043 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 9.046910e-01 | 0.043 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 9.048985e-01 | 0.043 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.104888e-01 | 0.041 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 9.105982e-01 | 0.041 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 9.119742e-01 | 0.040 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 9.135899e-01 | 0.039 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR2 | R-HSA-5654221 | 9.135899e-01 | 0.039 | 0 | 0 |
| Wax and plasmalogen biosynthesis | R-HSA-8848584 | 9.135899e-01 | 0.039 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 9.135899e-01 | 0.039 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 9.135899e-01 | 0.039 | 0 | 0 |
| Pregnenolone biosynthesis | R-HSA-196108 | 9.135899e-01 | 0.039 | 0 | 0 |
| Eicosanoid ligand-binding receptors | R-HSA-391903 | 9.135899e-01 | 0.039 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.174466e-01 | 0.037 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 9.177846e-01 | 0.037 | 0 | 0 |
| Matriglycan biosynthesis on DAG1 | R-HSA-9939291 | 9.216583e-01 | 0.035 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 9.216583e-01 | 0.035 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 9.216583e-01 | 0.035 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 9.216583e-01 | 0.035 | 0 | 0 |
| Synthesis, secretion, and deacylation of Ghrelin | R-HSA-422085 | 9.216583e-01 | 0.035 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 9.216583e-01 | 0.035 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 9.223029e-01 | 0.035 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 9.223029e-01 | 0.035 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 9.228190e-01 | 0.035 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 9.287144e-01 | 0.032 | 0 | 0 |
| Androgen biosynthesis | R-HSA-193048 | 9.289738e-01 | 0.032 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 9.289738e-01 | 0.032 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 9.289738e-01 | 0.032 | 0 | 0 |
| Serine metabolism | R-HSA-977347 | 9.289738e-01 | 0.032 | 0 | 0 |
| Glucocorticoid biosynthesis | R-HSA-194002 | 9.289738e-01 | 0.032 | 0 | 0 |
| Glutathione synthesis and recycling | R-HSA-174403 | 9.289738e-01 | 0.032 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 9.289738e-01 | 0.032 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 9.356066e-01 | 0.029 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 9.356066e-01 | 0.029 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 9.356066e-01 | 0.029 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 9.356066e-01 | 0.029 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 9.356066e-01 | 0.029 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 9.356066e-01 | 0.029 | 0 | 0 |
| Fructose metabolism | R-HSA-5652084 | 9.356066e-01 | 0.029 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 9.356066e-01 | 0.029 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.370246e-01 | 0.028 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.392510e-01 | 0.027 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 9.392510e-01 | 0.027 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.414441e-01 | 0.026 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 9.416203e-01 | 0.026 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 9.416203e-01 | 0.026 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 9.416203e-01 | 0.026 | 0 | 0 |
| Mitochondrial mRNA modification | R-HSA-9937008 | 9.416203e-01 | 0.026 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 9.416203e-01 | 0.026 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 9.422796e-01 | 0.026 | 0 | 0 |
| CYP2E1 reactions | R-HSA-211999 | 9.470728e-01 | 0.024 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 9.470728e-01 | 0.024 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 9.470728e-01 | 0.024 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 9.470728e-01 | 0.024 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 9.470728e-01 | 0.024 | 0 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 9.470728e-01 | 0.024 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.482970e-01 | 0.023 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 9.520163e-01 | 0.021 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 9.520163e-01 | 0.021 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 9.520163e-01 | 0.021 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 9.520163e-01 | 0.021 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 9.520163e-01 | 0.021 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 9.520163e-01 | 0.021 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 9.523233e-01 | 0.021 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 9.526573e-01 | 0.021 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.547311e-01 | 0.020 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.558669e-01 | 0.020 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.560489e-01 | 0.020 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 9.564983e-01 | 0.019 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 9.564983e-01 | 0.019 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 9.564983e-01 | 0.019 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 9.564983e-01 | 0.019 | 0 | 0 |
| Diseases of branched-chain amino acid catabolism | R-HSA-9865118 | 9.564983e-01 | 0.019 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 9.564983e-01 | 0.019 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.581853e-01 | 0.019 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.581853e-01 | 0.019 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.590371e-01 | 0.018 | 0 | 0 |
| Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane | R-HSA-83936 | 9.605619e-01 | 0.017 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 9.605619e-01 | 0.017 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 9.613637e-01 | 0.017 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 9.619156e-01 | 0.017 | 0 | 0 |
| Methylation | R-HSA-156581 | 9.626807e-01 | 0.017 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 9.642461e-01 | 0.016 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 9.642461e-01 | 0.016 | 0 | 0 |
| Prednisone ADME | R-HSA-9757110 | 9.642461e-01 | 0.016 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 9.642461e-01 | 0.016 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 9.642491e-01 | 0.016 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 9.646031e-01 | 0.016 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.646844e-01 | 0.016 | 0 | 0 |
| Degradation of cysteine and homocysteine | R-HSA-1614558 | 9.656252e-01 | 0.015 | 0 | 0 |
| Thyroxine biosynthesis | R-HSA-209968 | 9.675864e-01 | 0.014 | 0 | 0 |
| Regulation of pyruvate dehydrogenase (PDH) complex | R-HSA-204174 | 9.675864e-01 | 0.014 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 9.706148e-01 | 0.013 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 9.706148e-01 | 0.013 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.706148e-01 | 0.013 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 9.706148e-01 | 0.013 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 9.706148e-01 | 0.013 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 9.707807e-01 | 0.013 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 9.716321e-01 | 0.012 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 9.716321e-01 | 0.012 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 9.731769e-01 | 0.012 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 9.733604e-01 | 0.012 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 9.736654e-01 | 0.012 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 9.742729e-01 | 0.011 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 9.749739e-01 | 0.011 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.753174e-01 | 0.011 | 0 | 0 |
| DAG1 glycosylations | R-HSA-8931838 | 9.758496e-01 | 0.011 | 0 | 0 |
| Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | R-HSA-2162123 | 9.772922e-01 | 0.010 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 9.781063e-01 | 0.010 | 0 | 0 |
| Diseases associated with glycosylation precursor biosynthesis | R-HSA-5609975 | 9.781063e-01 | 0.010 | 0 | 0 |
| Recycling of bile acids and salts | R-HSA-159418 | 9.781063e-01 | 0.010 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.791137e-01 | 0.009 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.799207e-01 | 0.009 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.801523e-01 | 0.009 | 0 | 0 |
| Glutamate and glutamine metabolism | R-HSA-8964539 | 9.801523e-01 | 0.009 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 9.820072e-01 | 0.008 | 0 | 0 |
| Glycosaminoglycan-protein linkage region biosynthesis | R-HSA-1971475 | 9.820072e-01 | 0.008 | 0 | 0 |
| Phosphate bond hydrolysis by NUDT proteins | R-HSA-2393930 | 9.820072e-01 | 0.008 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 9.820072e-01 | 0.008 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.836889e-01 | 0.007 | 0 | 0 |
| Metabolism of ingested SeMet, Sec, MeSec into H2Se | R-HSA-2408508 | 9.836889e-01 | 0.007 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 9.836889e-01 | 0.007 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 9.852134e-01 | 0.006 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 9.865956e-01 | 0.006 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 9.865956e-01 | 0.006 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.866767e-01 | 0.006 | 0 | 0 |
| tRNA processing in the mitochondrion | R-HSA-6785470 | 9.878486e-01 | 0.005 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 9.878486e-01 | 0.005 | 0 | 0 |
| Diseases associated with N-glycosylation of proteins | R-HSA-3781860 | 9.889846e-01 | 0.005 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.893773e-01 | 0.005 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.893781e-01 | 0.005 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.899093e-01 | 0.004 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 9.900144e-01 | 0.004 | 0 | 0 |
| rRNA processing in the mitochondrion | R-HSA-8868766 | 9.900144e-01 | 0.004 | 0 | 0 |
| Tryptophan catabolism | R-HSA-71240 | 9.900144e-01 | 0.004 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 9.900144e-01 | 0.004 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 9.900144e-01 | 0.004 | 0 | 0 |
| Aflatoxin activation and detoxification | R-HSA-5423646 | 9.909480e-01 | 0.004 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 9.909516e-01 | 0.004 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.910874e-01 | 0.004 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 9.917944e-01 | 0.004 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 9.917944e-01 | 0.004 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 9.917944e-01 | 0.004 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 9.917944e-01 | 0.004 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 9.924579e-01 | 0.003 | 0 | 0 |
| Xenobiotics | R-HSA-211981 | 9.930794e-01 | 0.003 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 9.932573e-01 | 0.003 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 9.938878e-01 | 0.003 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.938897e-01 | 0.003 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.941758e-01 | 0.003 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 9.944595e-01 | 0.002 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.946582e-01 | 0.002 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 9.946582e-01 | 0.002 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.946582e-01 | 0.002 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.951013e-01 | 0.002 | 0 | 0 |
| Sulfur amino acid metabolism | R-HSA-1614635 | 9.951803e-01 | 0.002 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.952354e-01 | 0.002 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.958733e-01 | 0.002 | 0 | 0 |
| Glycosphingolipid catabolism | R-HSA-9840310 | 9.958821e-01 | 0.002 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.960677e-01 | 0.002 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.961364e-01 | 0.002 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.962253e-01 | 0.002 | 0 | 0 |
| Glyoxylate metabolism and glycine degradation | R-HSA-389661 | 9.962593e-01 | 0.002 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.964266e-01 | 0.002 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.964890e-01 | 0.002 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.964981e-01 | 0.002 | 0 | 0 |
| Branched-chain amino acid catabolism | R-HSA-70895 | 9.969265e-01 | 0.001 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.974625e-01 | 0.001 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 9.979544e-01 | 0.001 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.979544e-01 | 0.001 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.979544e-01 | 0.001 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 9.981194e-01 | 0.001 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 9.981659e-01 | 0.001 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.981834e-01 | 0.001 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.982954e-01 | 0.001 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.982954e-01 | 0.001 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.983433e-01 | 0.001 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.983433e-01 | 0.001 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.984111e-01 | 0.001 | 0 | 0 |
| Biosynthesis of DHA-derived SPMs | R-HSA-9018677 | 9.984296e-01 | 0.001 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 9.985996e-01 | 0.001 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.986325e-01 | 0.001 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.986796e-01 | 0.001 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.987168e-01 | 0.001 | 0 | 0 |
| Glutathione conjugation | R-HSA-156590 | 9.987306e-01 | 0.001 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.987306e-01 | 0.001 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 9.988495e-01 | 0.000 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.990548e-01 | 0.000 | 0 | 0 |
| Digestion and absorption | R-HSA-8963743 | 9.990548e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.990582e-01 | 0.000 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.993235e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.994219e-01 | 0.000 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.994640e-01 | 0.000 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.995251e-01 | 0.000 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.995481e-01 | 0.000 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.995498e-01 | 0.000 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.995696e-01 | 0.000 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.996099e-01 | 0.000 | 0 | 0 |
| Mitochondrial Fatty Acid Beta-Oxidation | R-HSA-77289 | 9.996223e-01 | 0.000 | 0 | 0 |
| Transport of vitamins, nucleosides, and related molecules | R-HSA-425397 | 9.996796e-01 | 0.000 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.997096e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.997450e-01 | 0.000 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.997760e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.997778e-01 | 0.000 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.998041e-01 | 0.000 | 0 | 0 |
| Metabolic disorders of biological oxidation enzymes | R-HSA-5579029 | 9.998041e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.998837e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.999188e-01 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.999391e-01 | 0.000 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.999571e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.999600e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.999727e-01 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.999746e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.999775e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid metabolism | R-HSA-1660662 | 9.999794e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.999797e-01 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.999853e-01 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.999863e-01 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.999892e-01 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.999913e-01 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 9.999921e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.999931e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.999957e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.999967e-01 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 9.999977e-01 | 0.000 | 0 | 0 |
| Biosynthesis of specialized proresolving mediators (SPMs) | R-HSA-9018678 | 9.999978e-01 | 0.000 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 9.999988e-01 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.999990e-01 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 9.999990e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.999998e-01 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 9.999998e-01 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 9.999998e-01 | 0.000 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 9.999999e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.999999e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999999e-01 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| Expression and translocation of olfactory receptors | R-HSA-9752946 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | -0.000 | 0 | 0 |